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I.  Enantio- and Diastereoselective 1,2-Additions of 1,1-Diborylalkanes to a-
Ketoesters  
 
 An enantio- and diastereoselective addition of 1,1-diborylalkanes to a-ketoesters is 
reported. The reaction is catalyzed by a copper-phosphoramidite catalyst system and yields 
products in up to 70% yield, 99:1 er and >20:1 dr after oxidation to the corresponding diol. The 
utility of the products is illustrated through functionalizations including homologation, cross-
metathesis, and tetrahydropyran synthesis. 
II. Stereoselective 3-Component Bis-Electrophile Couplings of 1,1-Diborylalkanes 
 A stereoselective tandem epoxide ring-opening/allylation reaction facilitated by a copper 
catalyst is reported. The reaction is tolerant of alkyl and aryl epoxides in good yield (up to 99%) 
and diastereoselectivity (up to >20:1). The application of this technique to the synthesis of 
polyol motifs is explored. Cross coupling, amination, and alkene functionalization reactions 
illustrate the versatility of the products. 
III. Synthesis of Stereodefined Alkenyl Boronates from Epoxides and 
Diborylmethane through Pd-Catalyzed Dehydroboration 
 
 The palladium catalyzed synthesis of alkenyl boronate esters from epoxides and 
diborylmethane via a dehydroboration process is reported. Products are obtained in up to 75% 
yield as single olefin isomer. The substrate scope includes alkyl, aryl, and complex steroid 
derived molecules. The products are further functionalized through cross coupling and 
cycloproponation procedures.  
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Chapter 1 Enantio- and Diastereoselective 1,2-Additions of 1,1-
Diborylalkanes to a-Ketoesters1 
 
1.1 Introduction 
The efficient synthesis of pharmaceutical molecules requires the development of new 
methodologies in organic chemistry. In particular, stereoselective reactions are important as 
they allow for the synthesis of biologically active molecules as single enantiomer compounds 
which is often required for pharmaceuticals. Boronate ester functional groups possess unique 
reactivity that renders them highly desirable as building blocks for the synthesis of important 
biologically active molecules. Boronate esters can be easily transformed into a multitude of 
common functional groups through stereospecific means (Figure 1.1).1,2 Due to the diverse array 
of stereospecific transformations that can be carried out on boronate esters, being able to easily 
access small molecule building blocks that contain stereodefined boronate esters is of great use 
to the scientific community. Therefore, the development of methods for stereoselective 
incorporation of boronate esters into molecules is necessary. Methods that incorporate these 
boronate ester groups via carbon-carbon bond formation are of even greater value to the 
synthetic community as they allow for fast construction of complex structures by building the 
carbon framework and simultaneously introducing an easily transformed functional group. 
Accomplishing this in a stereoselective manner would be very useful for organic synthesis. 
																																																						
1 A portion of this chapter appeared as a communication in Angewandte Chemie International 
Edition, the full reference is as follows: Murray, S. A.*; Green, J. C.*; Tailor, S. B.; Meek, S. J. 
Angew. Chem. Int. Ed. 2016, 55, 9065-9069 (* indicates authors contributed equally). 
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Figure 1.1 Examples of stereoselective functionalizations of boronate esters 
1.2 Background 
The stereoselective incorporation of boron into molecules via C-B bond forming 
reactions has been well studied. Established methods such as hydroboration2–8, diboration9–14, 
and conjugate boration15–18 can generate C(sp3)-boryl species in high yield and stereoselectivity. 
While these methods provide access to versatile C(sp3)-boryl species that can be further 
functionalized, they do not typically generate any additional new functionality beyond the 
installation of the boryl group. Therefore, our focus began with the development of methods that 
not only stereospecifically introduce a boronate ester but also generate additional functionality 
in the molecule. Our initial focus was on the formation of carbon-carbon bonds and alcohol 
functional groups. This would allow for rapid construction of highly complex molecular scaffolds 
that can be applied towards the total synthesis of important biologically active molecules.  
While the previously mentioned methods that install boron into molecules via 
hydroboration, diboration, and conjugate boration typically utilize boron sources such as 





















to focus on a different boron source that would allow us to incorporate the boron group 
stereoselectively via C-C bond formation instead of C-B bond formation.  
1.2.1 Proposed reaction 
In order to accomplish this goal of stereoselective boron incorporation via C-C bond 
formation, we wanted to employ readily available and bench stable 1,1-diborylmethane or a 
substituted derivative, as our nucleophile for the addition to carbonyls. Using an 1,1-
organodiboronate reagent in a 1,2-addition reaction with a carbonyl substrate had the potential 
to generate up to two new stereocenters, form a new C-C bond, and install a versatile boron 
functional group (Scheme 1.1).  
 
Scheme 1.1 General proposed 1,2-addition reaction of 1,1-diborylalkanes and carbonyl or imine 
electrophiles 
1.2.2 Synthesis and use of 1,1-diborylalkanes 
Diborylmethane, along with other polyborylated species, was first synthesized in the 
1960s by Matteson and coworkers, however its use was severely limited by the methods required 
to synthesize it (Figure 1.2a and b).19,20 In 2001, Srebnik and co-workers published a new 
methodology for synthesizing unsubstituted diborylmethane utilizing B2(pin)2, a platinum 
catalyst, and diazomethane (Figure 1.2c).21 While this method generated the desired product in 
high yields and was an improvement over previous methods, the use of highly explosive 
diazomethane gas is undesirable. In 2009, Shibata and co-workers developed a rhodium 
catalyzed hydroboration of alkynes for the synthesis of substituted variants of diborylmethane 
(Figure 1.2d).22 This methodology uses a commercially available metal salt, ligand, and boron 
source (pinacol borane) and is conducted under ambient temperature and pressure making it a 









R1 = H or alkyl G = alkyl, alkenyl, 
      aryl, heteroaryl
X = O or N
R2 = H, Me, CF3, CO2R
New C-C bond




methodology is only applicable for the synthesis of substituted diborylalkanes since the main 
carbon framework is derived from the alkyne that is used. This method cannot be used to 
produce the simple unsubstituted 1,1-diborylmethane. Additionally, these substituted variants 
can already be synthesized from diborylmethane via known methodology that involves 
deprotonation using lithium 2,2,6,6,-tetramethylpiperidine (LTMP) at the relatively acidic 
methylene position followed by quenching with the desired electrophile (Figure 1.2b).20  
In 2014, Morken and co-workers published the first truly scalable synthesis of 1,1-
diborylmethane (Figure 1.2e).23 Their methodology involves the diboration of 1,1-
dibromoalkanes using a copper catalyst, B2(pin)2 and super-stoichiometric lithium methoxide 
which serves to activate the B2(pin)2 for transmetallation to the copper catalyst. While this 
methodology was a great improvement over those previously developed, a major drawback is the 
large excess of B2(pin)2 required as only one boron group from each molecule of B2(pin)2 can be 
incorporated into the product which results in poor overall atom economy. While B2(pin)2 is 
commercially available, it can be an expensive reagent making this a less than ideal 
stoichiometry for this reaction.  
In 2015, our group disclosed an alternative preparation for 1,1-diborylmethane that 
allows B2(pin)2 to serve as the limiting reagent in the synthesis leading to higher atom 
economy.24 Utilizing isopropyl magnesium chloride, an a-iodomethyl Grignard can be generated 
at cryogenic (-78 ºC) temperature from insertion into diiodomethane. The a-iodomethyl 
Grignard can then add to the empty p-orbital on one of the boron groups of B2(pin)2 forming an 
-ate complex that then undergoes a borotropic shift releasing the adjacent iodine leaving group, 
and resulting in the formation of diborylmethane. This methodology allows for the large scale 
(>10 g) synthesis of diborylmethane using commercially available reagents and in high atom 
economy relative to the boron starting material as both boron groups from the B2(pin)2 are 
incorporated into the product.  
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1.2.3 Applications of 1,1-diborylalkanes in organic synthesis 
With a straightforward method of obtaining large quantities of diborylmethane in hand, 
the focus shifted to the development of new methodologies that utilize this versatile reagent. 
Initial work by Matteson had illustrated that deprotonated diborylmethane could be added to 
alkyl halides to generate alkyl substituted 1,1-diborylalkanes (Figure 1.2b). Additionally, he 
showed that these substituted 1,1-diborylalkanes could be deprotonated and added to aldehydes 
to generate 1,2-hydroxy bisboronate products. These products then undergo a boron-Wittig 
reaction to yield vinyl boronate esters which can be oxidized to the corresponding ketone 
(Figure 1.3).25 
 
Figure 1.3 1,2-Addition of 1,1-diborylalkanes to aldehydes 
 This initial work by Matteson focused on deprotonating these diboronate esters at the 
carbon bound to the two boron groups. The presence of the two boron groups stabilize the 
resulting carbanion through interactions with the empty p-orbital on the boron moieties. This 
stabilization lead to the significantly decreased pka at that position (pka ~ 30)20,25 making these 
protons easily deprotonated by large amide bases such as LTMP.  
 In addition to deprotonation, 1,1-diborylalkanes can also be activated via complexation 
of a Lewis base to the empty p-orbtial of the boron moiety. In 2011, Endo and Shibata took this 

























reaction (Scheme 1.2). They were able to achieve good yields of the cross-coupled products 
under mild reaction conditions in short reaction times. They also illustrated that the gem-
diboryl functionality was necessary for this cross coupling to occur as a substrate containing a 
pendant boronate ester (1.13) did not react through this pendant group.26  
 
Scheme 1.2 Initial use of 1,1-diborylalkanes in a Suzkui reaction. 
In 2014, Morken and coworkers expanded on this initial study with the development of 
an enantioselective method.23 In this work, Morken utilizes a palladium phosphoramidite 
catalyst system and a superstoichiometric amount of potassium hydroxide base to induce 
enantioselective cross coupling of one of the boron moieties on substituted diborylalkanes with 
aryl halides. Mechanistic studies revealed that the base does not deprotonate the acidic a-proton 
on the boron reagent, but instead hydrolizes the pinacol group on the reactive boron in order for 
the transmetallation to occur. Additionally, it was shown through isotope labeling experiments 
and mass spectral techniques that the transmetallation occurs through an invertive process.23,27 
This work was further expanded on by Hall and coworkers.27 These mechanistic studies 
illustrate that the a-boryl organopalladium species is generated in high levels of 
















Figure 1.4 Enantioselective cross coupling of 1,1-diborylalkanes by Morken and coworkers 
Initial work in the Meek lab pioneered by Matthew Joannou focused on using these 1,1-
organodiboronate esters in 1,2-addition reactions with aldehydes. Utilizing a catalyst system 
comprised of Cu(NCMe)4PF6 and Monophos with LiOt-Am base as activator, the addition of 
diborylethane (1.19) to various aryl aldehydes was accomplished in high yield, 
enantioselectivity, and diastereoselectivity (Figure 1.5a).24 The syn-hydroxyboronates 
accessible through this methodology can be easily functionalized using known stereospecific 
boron transformations. Joannou also developed a method for the diastereoselective synthesis of 
anti-hydroxboronate esters using a silver catalyst at decreased temperature (Figure 1.5b).28 
Additionally, a broader range of substituted 1,1-diboronate esters could be employed in this 
methodology. Alkyl aldehydes were tolerated by using slightly modified conditions employing 
preactivation of the diboron substrate with nBuLi. This approach prevented the enolization of 
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Figure 1.5 1,1-Diborylalkanes in 1,2-addition to aldehydes 
The mechanism of the copper catalyzed transformation is outlined in Figure 1.6. 
Initially, the 1,1-diboronate ester (1.19) is activated by the lithium alkoxide base (1.27) to 
generate the borate species (1.26) which is then ready for transmetallation. This activation can 
theoretically occur via two different pathways that lead to the same intermediate. The first 
involves free lithium alkoxide in solution interacting with the empty p-orbital on one of the 
boron moieties to generate the desired borate species (1.26) that can then undergo 
transmetallation giving 1.28. The alternative route resembles more of a sigma bond methathesis 
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(a) Cu Catalyzed Enantio- and Diastereoselective 1,2-Addition of Diborylmethane






the boron moieties resulting in transmetallation of the alkyl fragment to the catalyst. Once the 
alkyl copper species (1.28) is generated, it can partake in 1,2-addition to the carbonyl generating 
the chiral secondary alcohol via formation of a new C-C bond (1.30). The product (1.31) can 
then be released from the catalyst by salt exchange with the lithium base in solution to 
regenerate the active catalyst (1.25). Upon aqueous workup, the desired product is obtained 
(1.32).  
 
Figure 1.6 Catalytic cycle of the Cu-catalyzed addition of diborylethane to aldehydes. 
This method proved to be successful for a variety of aryl aldehydes in good yield and 
selectivity.24 The high diastereo- and enantioselectivity observed in this chemistry suggest that, 
like in Morken’s enantioselective cross-coupling reaction, the a-boryl organocopper species 
(1.26) is generated through an enantioselective transmetallation and is configurationally stable 
under the reaction conditions. To confirm this, the secondary alcohol generated from the 
carbonyl of a substrate that resulted in low diastereoselectivity was removed and the 








































unchanged (92:8) at the remaining stereocenter suggesting that the a-boryl organocopper 
species is being formed in high selectivity and the poor diastereoselectivity is a result of poor 
facial selectivity between the catalyst and the aldehyde.  
With this precedent established for the addition of 1,1-organodiboronate esters to 
carbonyls, the expansion to other carbonyl substrates and diboron reagents was undertaken. In 
the original work done in the lab, the 1,2-addition reaction generated secondary alcohols via 
addition to aldehydes. Tertiary alcohols are another useful functional group that can be 
challenging to synthesize selectively.29,30 Additionally, if a method can incorporate additional 
functionality in a single manipulation while setting that tertiary alcohol stereocenter, it will be 
even more useful as it will allow for the rapid buildup of molecular complexity through an 
efficient process. Due to the abundance of stereospecific boron-based functionalizations, the 
development of methods that stereospecifically incorporate boron into molecules is highly 
desirable.  
1.3 Addition of 1,1-diborylalkanes to carbonyls for the generation of tertiary 
1,2-hydroxyboronate esters 
The first step towards developing this methodology was choosing the correct carbonyl 
substrate to generate these tertiary alcohol products. Theoretically the simplest transition would 
be from the aldehydes used previously to ketones. However, this presented many obstacles. The 
potential difficulty with this class of substrates stems from their ability to enolize under basic 
conditions. The stoichiometric alkoxide base that is required for activating the diboron reagent 
can also deprotonate the ketone to generate an enolate which can then undergo a variety of 
different nonproductive decomposition pathways including aldol chemistry. We had previously 
shown through NMR studies that, under our reaction conditions, only 21% of the diboron 
reagent is activated.24 The remaining base is free in solution. As the activated boron reagent is 
consumed in the 1,2-addition reaction, more of the diborylethane is activated to maintain the 
equilibrium between the activated and unactivated species in solution. Since some of the base is 
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always free in solution, it is possible that it will be able to deprotonate the ketone starting 
material and lead to destruction of the substrate before it can be used productively.  
With these potential problems in mind, ketones were explored under reaction conditions 
that were successful for aldehydes to see if the product forming pathway would be fast enough to 
compete with the decomposition of the starting ketone via deprotonation. Using Cu(OMe)2, R-
Monophos, and LiOtBu as activator in THF with a 1:1 stoichiometry between the acetophenone 
and diborylmethane did not yield any of the desired product (Table 1.1, Entry 1). To try to 
encourage reactivity the base was switched to NaOtBu, which is typically a stronger activator 
than the lithium variant. Using an excess of the diborylmethane 14% of the desired product 
(1.34) was obtained (Table 1.1 Entry 2). While observing product was a promising result, the 
enantioselectivity of the reaction was only 59:41 er. In the early reaction screenings for the 
aldehyde chemistry the authors had found that copper methoxide often led to inconsistent 
results in the 1,2-addition reactions. Because of this, a similar reaction to entry 2 but using CuCl 
as the copper source instead of Cu(OMe)2 was attempted, however only 17% conversion to the 
desired product was observed and an even lower level of selectivity at 52:48 er. (Table 1.1, 
Entry 3). A brief solvent screen was then performed to observe solvent effects on conversion 
and enantioselectivity, however better results were not obtained in 1,4-dioxane or DME (Table 
1.1, Entries 4&5). Additionally, all of these reactions showed substantial consumption of the 
starting materials indicating that further optimization in this type of reaction would be quite 
challenging. 
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Table 1.1 Addition of diborylmethane to acetophenone. 
 
Having established that ketones are not viable substrates under the current reaction 
manifold, other carbonyl substrates that would produce the desired tertiary alcohol were 
explored. a-Ketoesters were another class of substrates that seemed promising for 1,2-addition 
with organodiboronate esters. The adjacent ester group in an a-ketoester eliminates the 
possibility for enolization. Additionally, the ester would help to make the ketone more reactive 
towards 1,2-addition than a ketone would be.  
1.3.1 Reaction optimization30 
Initially, the 1,2-addition of diborylmethane to ethyl phenyl glyoxylate was explored 
under the previously optimized conditions for the addition of diborylethane to aldehydes using 
LiOtBu as base (Table 1.2). At 22 ºC, the desired product was observed in 23% yield and 91:9 er 
(Table 1.2, Entry 1) using Cu(MeCN)4PF6 and R-Monophos as the catalyst. No starting 
ketoester was returned in this reaction, however 11% of product 1.38 derived from boron-Wittig 
elimination was observed. The boron Wittig reaction occurs when the alkoxide group generated 
in the 1,2-addition reaction chelates with the adjacent boron which results in the elimination of 





Cu Source (5 mol%)
R-Monophos (10 mol%)
Activator (X eq.)
Solvent, 22 ºC, 24 h
HO Me
B(pin)
Entry Cu Source Activator (X eq) Solvent Eq. of 1.3 1.34 (%) er
1 Cu(OMe)2 LiOtBu (1) 1 0 -
2 Cu(OMe)2 NaOtBu (1.2) 2 14 59:41
3 CuCl NaOtBu (1) 1 17 52:48
4 Cu(OMe)2 NaOtBu (1.2) dioxane 2 18 -






formation so we speculated that if the elimination reaction can be slowed down then the amount 
of desired product formed should increase. 
Table 1.2 Optimization of the addition of diborylmethane to ethyl phenyl glyoxylate 
 
Another important observation made with this first reaction was the identity of the ester. 
The a-ketoester substrate used in the reaction contained an ethyl ester moiety, however the 
primary product observed in the reaction contained a tert-butyl ester obtained from a 
transesterification reaction with some of the lithium tert-butoxide in solution (1.36). This is not 
a surprising result as it was previously shown that only a small amount of the diboron reagent 















THF, Temp, 24 h
Entrya R Base (X eq) Temp (ºC) 1.37 (%)b 1.36 (%)c 1.38 (%) erd
2 Et LiOtBu (2.05 22 <2 43 24 91:9
3 Et LiOtBu (2.05) 4 <2 60 12 92:8
4 Et LiOtBu (2.05) -10 <2 74 <2 96:4
5 Et LiOtBu (2.05) -25 35 51 <2 95:5
6 tBu LiOtBu (1) -10 <2 63 <2 94:6
7 Me LiOtBu (2.05) -10 <2 70 <2 93:7
8 Et LiOtBu (1) -10 18 26 8 91:9






1 Et LiOtBu (1) 22 <2 23 11 91:9
(a) Reactions performed under N2 atm. (b) In all cases >98% conv. of α-ketoester starting material. 
(c) Conversions determined by 1H NMR analysis of unpurified mixtures, with DMF as an internal 
standard, at either 400 or 600 MHz. (d) Determined by NaBO3•H2O oxidation to diol and HPLC 
analysis.
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LiOtBu is available to transesterify the starting ethyl ester to the tert-butyl ester. This process 
also results in the formation of lithium ethoxide as base and consumes the remaining lithium 
tert-butoxide. This means that in order for the desired reaction to proceed under these reaction 
conditions, it would be necessary for the lithium ethoxide to activate the diborylmethane for 
addition to the ketoester. This could be problematic as the less soluble lithium ethoxide might 
not be a good activator of the diboron reagent. Additionally, the enantioselectivity of the 
reaction could be affected by the smaller ethoxide activating group. 
In order to overcome the issue of multiple alkoxide bases present in solution, the 
reaction was repeated using 2.05 equivalents of LiOtBu. Under these reaction conditions, the 
conversion to the desired product increased to 43% and the enantioselectivity remained 
constant at 91:9 er (Table 1.2, Entry 2). The elimination product (1.38) increased to 24%. 
This was a promising result as the elimination product is derived from the desired product, so if 
that pathway can be shut down then the yield of desired product should increase.  
To try to decrease the elimination product, the reaction temperature was lowered to 4 
ºC. This resulted in an increase in conversion to the desired product to 60% and a slight increase 
in enantioselectivity to 92:8 er (Table 1.2, Entry 3). A small amount, 12%, of the undesired 
elimination product was still observed at this temperature. Additional cooling to -10 ºC led to a 
further increase in conversion to 74% and enantioselectivity to 96:4 er (Table 1.2, Entry 4). At 
-10 ºC no elimination product or returned starting material was observed. Further cooling to -25 
ºC did not improve the reaction (Table 1.2, Entry 5). At this temperature only 51% conversion 
to product was observed with an enantioselectivity of 95:5. No elimination product was observed 
at -25 ºC however starting material in the form of the tert-butyl ester (1.37) was observed in 
35% yield. Reactions conducted at -25 ºC for longer periods of time did not result in an increase 
in conversion to product. This also indicates that the transesterification reaction is likely faster 
than the 1,2-addition, and that the starting ketoester is transesterified to the tert-butyl ester 
prior to the addition of the diboron reagent. This is further supported by a control reaction 
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wherein treatment of ethyl phenyl glyoxylate with 2 equivalents of LiOtBu without copper or 
ligand at -10 ºC for 2.5 h resulted in full consumption of the starting ethyl ester and 90% 
conversion to the tert-butyl ester.  
With optimized reaction conditions in hand, the role that the identity of the ester plays in 
the reaction was probed. Starting with the tert-butyl ketoester and using only one equivalent of 
base resulted in a slight decrease in reaction efficiency yielding 63% conversion and 94:6 er 
(Table 1.2, Entry 6). Using the methyl ester, the product was obtained in 70% conversion, 
however only 91:9 er (Table 1.2, Entry 7). Using one equivalent of lithium tert-butoxide at -10 
ºC lead to a complex mixture of all three products in overall low yield (Table 1.2, Entry 8). 
The identity of the base was also explored by switching from the lithium alkoxide base to sodium 
tert-butoxide (Table 1.2, Entry 9). The sodium base resulted in a much more complex product 
distribution even at decreased temperature. At -10 ºC, product was observed in only 37% 
conversion and had a significant decrease in enantioselectivity to an er of only 81:19. The 
starting material was observed as the tert-butyl ester in 32%. These results agree with the 
previous work with aldehydes in which a lithium alkoxide base was necessary to achieve the 
desired reactivity and selectivity.  
Finally, a variety of phosphine ligands were screened to see if an increase in yield or 
conversion could be achieved. Bidentate phosphines such as (R)-BINAP and (R)-dtbm-
SEGPHOS both resulted in <2% conversion. A bidentate (R,S)-Josiphos ligand gave 63% 
conversion to product however the enantioselectivity diminished to only 60:40 er. Other 
phosphoramidite ligands were successful in this reaction, however the conversion and selectivity 
were always comparable to or diminished relative to that of the simple R-Monophos variant. The 
results of the reactions using these ligands are illustrated in Figure 1.7.  
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Figure 1.7 Ligand screen for 1,2-addition of diborylmethane to ethyl phenyl glyoxylate. 
1.3.3 Substrate scope30 
With optimized conditions in hand, the substrate scope of the reaction was explored. 
First, the ketoester was varied. In order to aid in isolation and determination of selectivity, the 
crude reactions were oxidized to the diol for isolation. Figure 1.8 illustrates the many aromatic 
ketoesters were tolerated in this reaction. The p-OMe substrate (1.48), while being a high 
yielding reaction, gave product in significantly lower enantioselectivity than most of the other 
substrates which all tended to be greater than 90:10 e.r. It was postulated that this particularly 
electron-rich aromatic ring could allow for racemization of the product upon purification by 
silica gel chromatography. This was ruled out by taking the isolated product and resubjecting it 




































































(a) Reactions performed under N2 atm. (b) In all cases >98% conv. of α-ketoester starting material. (c) 
Conversions determined by 1H NMR analysis of unpurified mixtures, with DMF as an internal standard, at either 
400 or 600 MHz. (d) Determined by NaBO3•H2O oxidation to diol and HPLC analysis.
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re-isolated product. No change in selectivity was observed meaning that the lower 
enantioselectivity is what is produced in the reaction. A weakly electron withdrawing chloride 
group in the para position resulted in 64% yield and 97:3 er of the desired diol product (1.49). A 
tert-butyl substituent at the para was well tolerated yielding product 1.50 in 70% yield and 92:8 
er. Strongly electron withdrawing nitro group (1.51) was tolerated at the para position in good 
er (94:6) and slightly diminished yield (46%). Trifluoromethyl substitution at the para position 
resulted in 54% isolated yield and 97:3 er (1.52). 
Substitution at the meta position was well tolerated. This was illustrated through methyl 
(1.53, 63% yield, 96:4 er), methoxy (1.54, 62% yield, 96:4 er) and chloro (1.55, 64% yield, 97:3 
er) substitution. Napthyl derived ketoester yielded product 1.56 in 62% yield and 96:4 er. The o-
Me ketoester showed decreased reactivity and selectivity yielding 1.57 in 27% yield and 66:34 
er. This is most likely due to the increase in sterics near the already sterically hindered reactive 
sight on the ketoester. A pyridine heterocyle (1.58) was well tolerated for the initial 1,2-addition 
reaction as illustrated by the 72% conversion to the corresponding 1,2-hydroxyboronate ester, 
however upon oxidation only 36% of the desired diol was isolated in 97:3 er.  
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Figure 1.8 Ketoester substrate scope 
The substrate scope was then explored in relation to the 1,1-organodiboronate ester. 
Initially, 1,1-diborylethane was studied. With an increase in catalyst loading to 10 mol% and an 
increase in temperature to 22 ºC, a 64% yield of the desired product was obtained as a single 
diastereomer and in 98:2 er (Figure 1.9). X-ray crystallographic analysis of the product 
confirmed that the boron unit and the hydroxyl group are on opposite faces (Figure 1.10). 
When the scope was explored further beyond the simple ethyl substituted diboron reagent, the 
yields of the desired product dropped dramatically. Jacob Green took over the further 
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a In all cases >98% conv. of α-ketoester starting material is consumed. b Determined by 1H-NMR analysis of unpurified 
mixtures with dmf as internal standard, at either 400 or 600 MHz. c Yield of the purified diol (average of 2  runs) 
dDetermined by HPLC analysis
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the ligand from R-Monophos to the partially hydrogenated R-H8-Monophos (1.39 in Figure 
1.7) the yields of the desired products rose significantly. As illustrated in Figure 1.9, alkyl, 
alkenyl, benzyl, and ester substituted diboron reagents all give the desired products in high 
yields and diastereo- and enantioselectivity.  
 








































72% Conv.,a,b 51% Yieldc
3.3:1 dr, 98:2 erd
1.60e
75% Conv., 64% Yield
>20:1 dr 98:2 er
1.61
62% Conv., 50% Yield
>20:1 dr, 99:1 er
1.62
70% Conv., 60% Yield
7.3:1 dr, 99:1 er
1.63
45% Conv., 30% Yield
3.5:1 dr, 98:2 er
1.64
40% Conv.
>20:1 dr, 94:6 er
1.65
55% Conv.




a In all cases >98% conv. of α-ketoester starting material is consumed. b Determined by 1H-NMR analysis of unpurified 
mixtures with dmf as internal standard, at either 400 or 600 MHz. c Yield of the purified diol (average of 2  runs). 
dDetermined by HPLC analysis. e 1.35 used as ligand.
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Figure 1.10 X-ray structure of 1.60 
1.3.4 Functionalizations30 
In order to illustrate the utility of the products generated in these reactions, a series of 
functionalizations was carried out on both the alcohol and boron moiety (Figure 1.11). First, to 
show that the products can be isolated with the boron moiety in place, the alcohol was protected 
as the trimethylsilyl ether and the product 1.67 was isolated in 46% overall yield from the 
starting ketoester. The oxidation of 1.59 resulted in the diol product 1.68 in 91% isolated yield. 
To illustrate the versatility of the boron moiety, a homologation reaction was carried out on silyl 
protected 1.69. Product 1.70 was obtained after one carbon homologation in 50% yield.32 Next, 
a cross methathesis reaction was carried out on 1.61 with cis-butenediol as coupling partner.33 
This functionalization results in a 63% yield of 1.71 and a 16:1 E:Z ratio illustrating that 
transformations can be conducted on other parts of the molecule while leaving the boron moiety 
in place. Lastly, an iodoetherification reaction was performed on the prenyl substituted product 
to form tetrahydropyran 1.74 in 56% yield and 3:1 d.r.34  
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Figure 1.11 Product functionalizations 
1.3.5 Mechanism30 
Figure 1.12 illustrates the proposed catalytic cycle for this reaction. Transmetallation of 
diborylethane (1.19) to the copper catalyst occurs via coordination to the bound alkoxide ligand 




































































56% conv., 3:1 d.r.
45% yield, >20:1 d.r.
I2, NaHCO3
MeCN, -35 ºC, 2h
(b) Oxidation












THF, -10 ºC, 24 h (70% conv)
TMSCl, imidazole
DMF, 22 ºC, 12 h
B(pin)(pin)B
1.3 1.67





a 1,2-addition reaction with the ketoester (1.39) followed by turnover of the catalyst via ligand 
exchange with the lithium alkoxide base.  
 
Figure 1.12 Proposed catalytic cycle 
In order to gain insight into the stereochemical determining steps of the reaction, the 
addition of diborylethane to benzophenone was carried out and is illustrated in Scheme 1.3. 
The product of this reaction (1.73) is formed in low conversion (42%) however high 
stereoselectivity (97:4 e.r.). This indicates that the a-boryl copper species 1.76, is formed in high 
selectivity, and that the catalyst controls both the selective formation of the a-boryl copper 






































Scheme 1.3 1,2-Addition of diborylethane to benzophenone as mechanistic probe 
1.4 Conclusions30 
In summary, a new methodology for the stereoselective synthesis of tertiary alcohols 
containing a vicinal boronate ester from 1,1-organodiboronate esters and a-ketoesters using a 
copper phosphoramidite catalyst system was developed. The products are generated in good 
yield, diastero-, and enantioselectivity. The methodology extends to a variety of a-ketoesters and 
substituted 1,1-diboronate esters. The versatility of these products was illustrated through 
multiple functionalizations including oxidation, homologation, and cross coupling. The reaction 
is proposed to occur via an enantioselective transmetallation and evidence of this was presented 
in the high level of enantioselectivity that is achieved when benzophenone is used as the 
carbonyl substrate.  
1.5 Experimental30 
1.5.1 General 
All reactions were carried out in oven-dried (150 ˚C) or flame-dried glassware under an 
inert atmosphere of dried nitrogen unless otherwise noted. Analytical thin-layer 
chromatography was performed on glass plates coated with 0.25 mm of 60 Å mesh silica gel.  
Plates were visualized by exposure to UV light (254 nm) and/or immersion into Seebach’s or 
KMnO4 stain followed by heating. Column chromatography using regular silica gel was 
performed using silica gel P60 (mesh 230-400) supplied by Silicycle. Deactivated silica gel was 

























shaking and stirring until a free-flowing powder was obtained. This was allowed to sit overnight. 
All solvents were sparged with argon and then purified under a positive pressure of argon 
through an SG Water, USA Solvent Purification System. Tetrahydrofuran (OmniSolv) was 
passed successively through two columns of neutral alumina. The ambient temperature in the 
laboratory was approximately 22 °C. Reactions were run at low temperatures using an 
isopropanol filled SP Scientific cryobath. 
1.5.2 Instrumentation 
All 1H NMR spectra were recorded on Bruker Spectrometers (AVANCE-600 and DRX 
400). Chemical shifts are reported in ppm from tetramethylsilane and referenced to the residual 
protio solvent peak (CDCl3: δ 7.26). Data are reported as follows: chemical shift, multiplicity (s = 
singlet, d = doublet, t = triplet, qu = quartet, quint = quintet, br = broad, m = multiplet, app = 
apparent), integration, and coupling constants are given in Hz. 13C NMR spectra were recorded 
on Bruker Spectrometers (AVANCE-600 and DRX-400) with carbon and proton decoupling. 
Chemical shifts are reported in ppm from tetramethylsilane and referenced to the residual 
protio solvent peak (CDCl3: δ 77.16). 13B NMR spectra were recorded on a Bruker model 500 
MHz spectrometer. All IR spectra were recorded on a Jasco 260 Plus Fourier transform infrared 
spectrometer. Mass spectrometry samples were analyzed with a hybrid LTQ FT (ICR 7T) 
(ThermoFisher, Bremen, Germany) mass spectrometer. Samples were introduced via a 
microelectrospray source at a flow rate of 10 µL/min (solvent composition 10:1 MeOH:H2O). 
Xcalibur (ThermoFisher, Breman, Germany) was used to analyze the data. Molecular formula 
assignments were determined with Molecular Formula Calculator (v 1.2.3). Low-resolution mass 
spectrometry (linear ion trap) provided independent verification of molecular weight 
distributions. All observed species were singly charged, as verified by unit m/z separation 
between mass spectral peaks corresponding to the 12C and 13C12Cc-1 isotope for each elemental 
composition. Optical rotations were determined using a Jasco P1010 polarimeter and 
concentrations are reported in g/100mL. Enantiomeric ratios were determined on an Agilent 
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Technologies 1220 Infinity LC using the following columns: Diacel CHIRALPAK IA (4.6 mm x 
250 mmL x 5 µm), Diacel CHIRALPAK IB (4.6 mm x 250 mmL x 5 µm), and Diacel 
CHIRALPAK IC (4.6 mm x 250 mmL x 5 µm). 
1.5.3 Reagents 
Ammonium chloride was purchased from Alfa Aesar and used as received.  
nButyl lithium (1.6M in hexanes) was purchased from Strem Chemicals and titrated using 
sec-butanol and phenanthroline prior to use.  
Calcium hydride was purchased from Strem Chemicals and used without further purification. 
Copper(I) chloride was purchased from Strem Chemicals and kept in a nitrogen filled dry 
box.   
Copper(II) triflate was purchased from Strem Chemicals and kept in a nitrogen filled dry box.   
Copper(I) tetrakisacetonitrile hexafluorophosphate was purchased from Sigma-Aldrich 
and kept in a nitrogen filled dry box.  
Chloroform-d3 was purchased from Cambridge Isotope Laboratories and used without further 
purification.  
Chlorotrimethylsilane was purchased from Acros, dried over calcium hydride, distilled, 
stored under nitrogen at 0° C, and used within 2 weeks of distillation.  
Diborylmethane was synthesized according to literature procedure and matched literature 
spectra.24 It was purified via column chromatography (20:1 hexanes:ethyl acetate) to contain 
<7% B2(pin)2 by 1H-NMR spectroscopy and dried via azeotropic distillation from benzene.  
Dibromomethane was purchased from Alfa Aesar and passed through a short column of 
neutral alumina and then sparged with dry nitrogen before use.  
Dimethylformamide (dry) was purchased from EMD and used as received. 
Ethyl benzoylformate was purchased from Sigma Aldrich and Alfa Aesar, dried via 
azeotropic distillation with benzene, and stored under nitrogen. 
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Ethyl 4-nitrophenylglyoxylate was obtained from Lancaster Synthesis, dried via azeotropic 
distillation with benzene, and stored under nitrogen at -25° C. 
Ethyl mesitylglyoxylate was obtained from Lancaster Synthesis, dried via azeotropic 
distillation with benzene, and stored under nitrogen at -25° C. 
Ethyl-3-methylbenzoyl formate was obtained from Reike Specialty Chemicals, dried via 
azeotropic distillation with benzene, and stored under nitrogen at -25° C.  
Hoveyda-Grubbs Catalyst 2nd Generation was obtained from Sigma Aldrich and used as 
received. 
Imidazole was purchased from Alfa-Aesar and used as received.  
Iodine was purchased from EM Science and used as received. 
Lithium tert-butoxide was purchased from Strem Chemicals, stored in a nitrogen filled dry 
box and used as received.  
(R)-Monophos (1.35), (R)-MorphPhos (1.41), and (R)-H8-Monophos (1.40) were 
synthesized according to published literature procedure and matched literature spectra.35,36 
R)-BINAP was purchased from Strem Chemicals and stored in a nitrogen filled dry box.  
(R,S)-josiphos (1.45) was purchased from Strem Chemicals and stored in a nitrogen filled dry 
box.  
Sodium bicarbonate was purchased from BDH and used as received. 
Sodium perborate tetrahydrate was purchased from Sigma Aldrich and used as received. 
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1.5.4 Preparation of a-ketoesters 
 
Ketoesters 1.82 – 1.89 were prepared according to literature procedure and matched the 
known 1H-NMR and 13C-NMR spectra.37-41 All ketoesters were dried via azeotropic distillation 
with benzene and stored under nitrogen at -25 ºC.  
1.5.5 Preparation of substituted diboryl reagents 
Diboryl reagents used for the synthesis of compounds 1.59 – 1.60 and 1.62 – 1.66 were 
synthesized following a known synthetic procedure and matched literature spectra.24,28 
 
Diboryl reagent 1.90 was prepared according to a literature procedure.24,28 In an N2-filled glove 
box, an oven-dried 50 mL round-bottom flask was charged with diboryl methane (500 mg, 1.9 
mmol) and a magnetic stirbar, capped with a rubber septum, and sealed with electrical tape. A 
separate oven-dried, 25 mL conical flask was charged with lithium 2,2,6,6-
tetramethylpiperidide (288 mg, 1.96 mmol), capped with a rubber septum, and sealed with 
electrical tape. The two flasks were brought out of the glove box, where the diboryl methane 




















































mL of dry THF (0.17 M total). Both flasks were allowed to cool to 0 °C (ice/water baths). The 
LTMP solution was then transferred via cannula to the diboryl methane flask with stirring. After 
the transfer, the reaction mixture was allowed to stir at 0 °C for 10 min. Allyl bromide (0.403 
mL, 4.67 mmol) was added to the reaction via a syringe. The reaction mixture was allowed to 
warm up to 22 °C over 18 h with stirring. The reaction was quenched with 10 mL of a saturated 
aqueous solution of NH4Cl. The biphasic mixture was extracted three times with diethyl ether 
(150 mL total), and the combined organic extracts were dried over MgSO4, filtered, and 
concentrated in vacuo. The crude reaction mixture was purified by silica gel chromatography 
(20:1 hexanes:EtOAc, Rf=0.20) to give the desired product as a clear, viscous oil in 77% isolated 
yield (445 mg). 1H NMR (600 MHz, CDCl3) δ 5.87 (ddt, J = 16.6, 10.1, 6.3 Hz, 1H), 4.99 (ddd, J 
= 17.1, 3.5, 1.7 Hz, 1H), 4.88 – 4.84 (m, 1H), 2.29 (dd, J = 7.8, 6.5 Hz, 2H), 1.22 (s, 12H), 1.21 (s, 
12H), 0.85 (t, J = 8.0 Hz, 1H). 13C NMR (151 MHz, CDCl3) δ 140.70, 113.20, 83.07, 29.62, 
24.88, 24.52. IR (u/cm-1): 2979 (s), 2931 (s), 1359 (m), 1320 (m), 1141 (s). LRMS (ESI+) 
[M+Na] calcd for C16H30B2O4Na 331.22, found 331.27. 
1.5.6 General procedures 
General procedure A: Cu-catalyzed 1,2-addition reaction using diborylmethane  
 
In a nitrogen filled dry box, a stock solution of Cu(MeCN)4PF6 (0.017 M), (R)-Monophos 
(0.033 M) and LiOtBu (0.017 M) in THF was made in an 8-mL vial equipped with a magnetic 
stir bar. This was allowed to stir for 45 min at 22 °C. Diborylmethane (40.2 mg, 0.15 mmol) and 
LiOtBu (16 mg, 0.2 mmol) were weighed into a separate 8-mL vial and dissolved in THF (0.4 
mL). An aliquot of the catalyst solution (0.3 mL) and stir bar was then transferred to the vial 
containing the diborylmethane and LiOt-Bu. The vial was sealed with a septa-lined cap, taped, 
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ketoester was added to the vial via syringe. The reaction was kept at -10 °C for 24 hours and 
agitated periodically. The reaction was quenched with a saturated aqueous solution of NH4Cl 
(1.5 mL), and the aqueous layer extracted three times with diethyl ether. The combined organic 
extracts were dried over MgSO4, filtered, and concentrated in vacuo. Conversion was 
determined by 1H NMR using dimethylformamide as an internal standard. The crude reaction 
mixture was then taken on to Supplementary Procedure A or C without purification. 
General procedure B: Cu-catalyzed 1,2-addition reaction of secondary alkyl 
boronates 
 
In a nitrogen filled dry box, an 8-mL vial equipped with a magnetic stir bar was charged with 
Cu(MeCN)4PF6 (1.9 mg, 0.005 mmol), (R)-Monophos (3.9 mg, 0.010 mmol), and LiOtBu (0.4 
mg, 0.005 mmol) and dissolved in THF (0.30 mL, 0.017M). This was allowed to stir for 45 min. 
Organodiboron reagent (0.15 to 0.20 mmol) and LiOtBu (16 mg, 0.2 mmol) were weighed into a 
separate 8-mL vial and dissolved in THF (0.4 mL). The catalyst solution and stir bar was then 
transferred to the vial containing the organodiboron reagent and LiOtBu. The vial was sealed 
with a septa-lined cap, taped, removed from the glovebox, and placed on a magnetic stir plate at 
22 °C. Ethyl benzoyl formate (18 mg, 0.1 mmol) was added to the vial via syringe. The reaction 
was allowed to stir at room temperature for 24 hours. The reaction was quenched with a 
saturated aqueous solution of NH4Cl (1.5 mL), and the aqueous layer extracted three times with 
diethyl ether. The combined organic extracts were dried over MgSO4, filtered, and concentrated 
in vacuo. Conversion was determined by 1H NMR using dimethylformamide as an internal 
standard. The product was purified via silica gel chromatography.  















In a nitrogen filled dry box, an 8-mL vial equipped with a magnetic stir bar was charged with 
Cu(MeCN)4PF6 (3.8 mg, 0.010 mmol), H8-(R)-Monophos (7.3 mg, 0.020 mmol), and LiOtBu 
(0.8 mg, 0.010 mmol) and dissolved in THF (0.60 mL). This was allowed to stir for 45 min. 
Organodiboron reagent (0.15 to 0.20 mmol) and LiOtBu (16 mg, 0.2 mmol) were weighed into a 
separate 8-mL vial and dissolved in THF (0.1 mL). The catalyst solution and stir bar was then 
transferred to the vial containing the organodiboron reagent and LiOtBu. The vial was sealed 
with a septa-lined cap, taped, removed from the glovebox, and placed on a magnetic stir plate at 
22 °C. Ethyl benzoyl formate (18 mg, 0.1 mmol) was added to the vial via syringe. The reaction 
allowed to stir at room temperature for 24 hours. The reaction was quenched with a saturated 
aqueous solution of NH4Cl (1.5 mL), and the aqueous layer extracted three times with diethyl 
ether. The combined organic extracts were dried over MgSO4, filtered, and concentrated in 
vacuo. Conversion was determined by 1H NMR using dimethylformamide as an internal 
standard. The product was purified via silica gel chromatography. 
1.5.7 Supplementary procedures 
Supplementary procedure A: synthesis of enantioenriched diols 
 
The crude hydroxyboronate was combined with sodium perborate tetrahydrate (77 mg, 0.5 
mmol), dissolved in a 1:1 mixture of THF and water (1 mL, 0.1M) and vigorously stirred for 2 
hours at 22 °C. The reaction was quenched with a saturated aqueous solution of NH4Cl (1.5 mL), 
and the aqueous layer extracted three times with diethyl ether, dried over MgSO4, filtered, and 
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Enantiomeric excess of the diol was determined by HPLC analysis compared to the authentic 
racemic material.   
Supplementary procedure B: synthesis of enantioenriched diols 
The crude hydroxyboronate was passed through a silica gel column. The resulting oil was then 
combined with sodium perborate (77 mg, 0.5 mmol), dissolved in a 1:1 mixture of THF and 
water (1 mL, 0.1M) and vigorously stirred for 2 hours at 22 °C. The reaction was quenched with 
a saturated aqueous solution of NH4Cl (1.5 mL), and the aqueous layer extracted three times 
with diethyl ether, dried over MgSO4, filtered, and concentrated in vacuo. The product was 
purified via silica gel column chromatography. Enantiomeric excess of the diol was determined 
by HPLC analysis compared to the authentic racemic material.   
Supplementary Procedure C: synthesis of TMS-protected β-hydroxyboronates 
 
The crude hydroxyboronate (R=H) or purified hydroxyboronate (R=alkyl) was concentrated in 
an 8 mL vial, capped with a septa-lined cap, and purged with nitrogen for 5 minutes. Imidazole 
(8 mg, 0.12 mmol) and a magnetic stir bar were quickly added to the vial under a stream of 
nitrogen. The vial was purged with nitrogen for an addition 2 minutes and then vial was charged 
with DMF via syringe (0.2 mL, 0.15M). Chlorotrimethylsilane (15 µl, 0.4 mmol) was added via 
syringe to the vial. The vial was placed on a magnetic stir plate at 22 °C and allowed to stir for 18 
hours. The reaction was quenched with saturated NH4Cl (2 mL), extracted with diethyl ether, 
washed with saturated sodium bicarbonate solution, washed with brine, dried over MgSO4 and 
concentrated in vacuo. The crude mixture was purified via silica gel column chromatography. 











Tert-butyl (S)-2,3-dihydroxy-2-phenylpropanoate (1.47). Following General Procedure 
A and Supplementary Procedure A, the crude oxidation mixture was purified by silica gel 
(regular) chromatography (4:1 hexanes:ethyl acetate, gravity) to yield diol 1.47 as a colorless oil 
in 65% isolated yield (15.5 mg). 1H NMR (600 MHz, CDCl3) d 7.65 - 7.59 (m, 2H), 7.39 (t, J = 
7.6 Hz, 2H), 7.34 (m, J = 7.2 Hz, 1H), 4.21 (t, J = 10.8 Hz, 1H), 4.14 (s, 1H), 3.74 (dd, J = 11.4, 
3.0 Hz, 1H), 2.39 (dd, J = 10.4, 3.5 Hz, 1H), 1.52 (s, 9H). 13C NMR (151 MHz, CDCl3) d 172.9, 
138.6, 128.3, 128.1, 125.4, 84.0, 79.4, 68.4, 27.9.  HRMS (ESI+) [2M+Na]+ calcd for 
C26H36O8Na+ 499.2308, found 499.2296. IR (n/cm-1): 3446 (m, br), 2976 (m), 1732 (s), 1558 
(m), 1541 (m), 1369 (s), 1252 (m), 1140 (m).   [a]22D = -25.6° (c = 0.205, CH2Cl2, l = 100 mm).  
[a]22D = -6.8 (c = 0.16, CH2Cl2, l = 100 mm). Absolute stereochemistry was confirmed by 












Enantioenriched Material   
 
Major: 15.2 min; Minor: 19.8 min; 96:4 e.r. 
 
Tert-butyl (S)-2,3-dihydroxy-2-(4-methoxyphenyl)propanoate (1.48). Following 
General Procedure A and Supplementary Procedure A, the crude oxidation mixture was purified 
by silica gel (50:50 regular:deactivated, mixed) chromatography (4:1 hexanes: ethyl acetate) to 
yield diol 1.48 as a colorless oil in 60% yield (16.1 mg). 1H NMR (600 MHz, CDCl3) d 7.49 (d, J 
= 8.8 Hz, 2H), 6.88 (d, J = 8.8 Hz, 2H), 4.15 (t, J = 10.7 Hz, 1H), 4.08 (s, 1H), 3.81 (s, 3H), 3.68 
(dd, J = 11.6, 2.6 Hz, 1H), 2.34 (dd, J = 10.4, 3.5 Hz, 1H), 1.49 (s, 9H). 13C NMR (151 MHz, 
CDCl3) d 173.2, 159.5, 130.8, 126.8, 113.8, 84.0, 79.2, 68.5, 55.4, 28.0. HRMS (ESI+) [2M+Na]+ 
calcd for C28H40O10Na+ 559.2519, found 559.2510. IR (u/cm-1): 3465 (br, m), 2978 (m), 2931 
(m), 1718 (s), 1510 (s), 1251 (s), 1159 (s). [a]22D = -25.6 (c = 0.435, CH2Cl2, l = 100 mm). 











Major: 21.5 min; Minor: 25.5 min; 85:15 e.r. 
 
Tert-butyl (S)-2-(4-chlorophenyl)-2,3-dihydroxypropanoate (1.49). Following 
General Procedure A and Supplementary Procedure A, the crude oxidation mixture was purified 
by silica gel (50:50 regular:deactivated, mixed) chromatography  (6:1 hexanes: ethyl acetate) to 
yield diol 1.49 as a colorless oil in 64% yield (17.6 mg). 1H NMR (600 MHz, CDCl3) d 7.53 (d, J 
= 8.6 Hz, 2H), 7.33 (d, J = 8.6 Hz, 2H), 4.14 (m, J = 4.2 Hz, 2H), 3.68 (dd, J = 11.4, 2.7 Hz, 1H), 
2.33 (dd, J = 9.6, 4.3 Hz, 1H), 1.49 (s, 9H). 13C NMR (151 MHz, CDCl3) d 172.6, 137.2, 134.3, 
128.6, 127.1, 84.5, 79.2, 68.4, 28.0. HRMS (ESI+) [M+Na]+ calcd for C13H17O4ClNa+ 295.0713, 
found 295.0909. IR (u/cm-1): 3449 (m, br), 2978 (m), 1727 (s), 1492 (m), 1370 (m), 1254 (m), 
1156 (s), 1094 (s). [a]22D = -21.3 (c = 0.455, CH2Cl2, l = 100 mm). 














Major: 17.1 min; Minor: 18.4 min; 97:3 e.r. 
 
Tert-butyl (S)-2-(4-(tert-butyl)phenyl)-2,3-dihydroxypropanoate (1.50). Following 
General Procedure A and Supplementary Procedure A, the crude oxidation mixture was purified 
by silica gel (50:50 regular:deactivated, mixed) chromatography (6:1 hexanes: ethyl acetate) to 
yield diol 1.50 as a white solid in 70% yield (20.6 mg). 1H NMR (600 MHz, CDCl3) d 7.55 - 7.47 
(m, 2H), 7.42 - 7.33 (m, 2H), 4.15 (d, J = 10.3 Hz, 1H), 4.06 (s, 1H), 3.70 (d, J = 11.3 Hz, 1H), 
2.37 (s, 1H), 1.51 (s, 9H), 1.31 (s, 9H). 13C NMR (151 MHz, CDCl3) d 173.1, 151.1, 135.8, 125.4, 






611.3560, found 611.3553. IR (u/cm-1): 3472 (m, br), 2964 (s), 1722 (s), 1369 (m), 1274 (m), 
1159 (s), 1112 (m). [a]22D = -25.3 (c = 0.680, CH2Cl2, l = 100 mm). 





Major: 12.4 min; Minor: 14.6 min; 92:8 e.r. 
 
Tert-butyl (S)-2,3-dihydroxy-2-(4-nitrophenyl)propanoate (1.51). Following General 
Procedure A and Supplementary Procedure A, the crude oxidation mixture was purified by silica 
gel (50:50 regular:deactivated, mixed) chromatography (4:1 hexanes: ethyl acetate, gravity) to 
yield diol 1.51 as a yellow oil in 46% yield (13.1 mg). 1H NMR (600 MHz, CDCl3) d 8.22 (d, J = 






1H), 2.38 (s, 1H), 1.50 (s, 9H). 13C NMR (151 MHz, CDCl3) d 171.6, 147.8, 145.6, 126.8, 123.5, 
85.1, 79.3, 68.3, 27.8. HRMS (ESI+) [M+Na]+ calcd for C13H34O12NNa+ 306.0945, found 
306.0945. IR (u/cm-1): 3443 (s), 2979 (w), 1726 (m), 1642 (m), 1522 (s), 1370 (m), 1349 (s), 
1156 (m). [a]22D = -34.9 (c = 0.53, CH2Cl2, l = 100 mm). 





Major: 81.7 min; Minor: 88.8 min; 94: 6 e.r. 
 
Tert-butyl (S)-2,3-dihydroxy-2-(4-(trifluoromethyl)phenyl)propanoate (1.52). 
Following General Procedure A and Supplementary Procedure A, the crude oxidation mixture 






colorless oil in 54% yield (17.1 mg). 1H NMR (600 MHz, CDCl3) δ 7.74 (d, J = 8.2 Hz, 2H), 7.62 
(d, J = 8.3 Hz, 2H), 4.22 (d, J = 0.9 Hz, 1H), 4.17 (t, J = 10.7 Hz, 1H), 3.71 (dd, J = 11.3, 3.8 Hz, 
1H), 2.43 (dd, J = 10.0, 3.9 Hz, 1H), 1.50 (s, 9H). 13C NMR (151 MHz, CDCl3) δ 172.1, 142.5, 
126.1, 125.3, 125.3, 125.3, 125.2, 124.9, 123.1, 84.6, 79.3, 68.4, 27.8. LRMS (ESI+) 
[M+Na]+calcd for C14H17F3O4Na+ 329.10, found 329.18. IR (u/cm-1): 3457 (m, br), 2980 (m), 
2934 (m), 1726 (s), 1328 (s). [a]22D = -9.4 (c = 0.91, CH2Cl2, l = 100 mm). 





Major: 14.2 min; Minor: 15.8 min; 97:3 e.r. 
 
Tert-butyl (S)-2,3-dihydroxy-2-(m-tolyl)propanoate (1.53). Following General 






gel (50:50 regular:deactivated, mixed) chromatography (6:1 hexanes: ethyl acetate) to yield diol 
1.53 as a colorless oil in 63% yield (16.4 mg). 1H NMR (600 MHz, CDCl3) d 7.41 (d, J = 2.0 Hz, 
1H), 7.36 (d, J = 8.4 Hz, 1H), 7.24 (t, J = 7.7 Hz, 1H), 7.12 (d, J = 7.7 Hz, 1H), 4.17 (d, J = 10.5 
Hz, 1H), 4.07 (s, 1H), 3.71 (d, J = 11.3 Hz, 1H), 2.36 (s, 3H), 1.49 (s, 9H). 13C NMR (151 MHz, 
CDCl3) d 173.1, 138.7, 138.1, 129.0, 128.3, 126.3, 122.6, 84.0, 79.5, 68.5, 28.0, 21.8. HRMS 
(ESI+) [2M+Na]+ calcd for C28H40O8Na+ 527.2621, found 527.2611. IR (u/cm-1): 3469 (m, br), 
2978 (m), 1722 (s), 1370 (m), 1275 (m), 1156 (s), 1059 (m). [a]22D = -31.9 (c = 0.625, CH2Cl2, l = 
100mm). 












Tert-butyl (S)-2,3-dihydroxy-2-(3-methoxyphenyl)propanoate (1.54). Following 
General Procedure A and Supplementary Procedure A, the crude oxidation mixture was purified 
by silica gel (50:50 regular:deactivated, mixed) chromatography (4:1 hexanes: ethyl acetate,) to 
yield diol 1.54 as a colorless oil in 62% yield (16.7 mg). 1H NMR (600 MHz, CDCl3) d  7.30 - 
7.24 (m, 1H), 7.19 - 7.13 (m, 2H), 6.85 (ddd, J = 8.1, 2.6, 1.0 Hz, 1H), 4.16 (t, J = 10.3 Hz, 1H), 
4.09 (s, 1H), 3.81 (s, 3H), 3.70 (d, J = 11.3 Hz, 1H), 2.32 (d, J = 9.8 Hz, 1H), 1.50 (s, 9H). 13C 
NMR (151 MHz, CDCl3) d 172.8, 159.6, 140.2, 129.3, 117.8, 113.6, 111.3, 84.0, 79.4, 68.4, 55.2, 
27.9. HRMS (ESI+) [2M+Na]+ calcd for C28H40O10Na+ 559.2512, found 559.2512. IR (u/cm-1): 
3452 (m, br), 2932 (m), 1725 (s), 1602 (m), 1401 (m), 1369 (m), 1255 (s), 1155 (s), 1052 (s).  
[a]22D = -21.4 (c = 0.49, CH2Cl2, l = 100 mm). 





Major: 21.1 min; Minor: 25.9 min; 96:4 e.r. 
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Tert-butyl (S)-2-(3-chlorophenyl)-2,3-dihydroxypropanoate (1.55). Following General 
Procedure A and Supplementary Procedure A, the crude oxidation mixture was purified by silica 
gel (50:50 regular:deactivated, mixed) chromatography (6:1 hexanes: ethyl acetate) to yield diol 
1.55 as a colorless oil in 64% yield (17.6 mg). 1H NMR (600 MHz, CDCl3) d 7.62 (bs, J = 1.3 Hz, 
1H), 7.50 - 7.44 (m, 1H), 7.33 - 7.27 (m, 2H), 4.29 - 4.00 (m, 2H), 3.69 (dd, J = 11.5, 2.9 Hz, 1H), 
2.36 (dd, J = 10.1, 3.8 Hz, 1H), 1.50 (s, 9H). 13C NMR (151 MHz, CDCl3) d 172.2, 140.6, 134.3, 
129.5, 128.2, 125.9, 123.7, 84.4, 79.0, 68.3, 27.8. HRMS (ESI+) [2M+Na]+ calcd for 
C26H34O8Cl2Na+ 567.1528, found 567.1517. IR (u/cm-1): 3464 (s, br), 2979 (m), 2929 (m), 1724 
(s), 1370 (m), 1287 (m), 1258 (m), 1157 (s), 1079 (m). [a]22D = -32.7 (c = 0.725, CH2Cl2, l = 100 
mm). 
















Major: 14.8 min; Minor: 19.6 min; 97:3 e.r. 
 
Tert-butyl (S)-2,3-dihydroxy-2-(napthalen-2-yl)propanoate (1.56). Following General 
Procedure A and Supplementary Procedure A, the crude oxidation mixture was purified by silica 
gel (50:50 regular:deactivated, mixed) chromatography (6:1 hexanes: ethyl acetate, gravity) to 
yield diol 1.56 as a white solid in 62% yield (17.8 mg). 1H NMR (600 MHz, CDCl3) d 8.12 - 8.07 
(m, 1H), 7.90 - 7.81 (m, 3H), 7.68 (dd, J = 8.7, 1.9 Hz, 1H), 7.53 - 7.46 (m, 2H), 4.32 (t, J = 10.2 
Hz, 1H), 4.28 - 4.21 (m, 1H), 3.81 (d, J = 11.3 Hz, 1H), 2.43 (d, J = 6.9 Hz, 1H), 1.50 (s, 9H). 13C 
NMR (151 MHz, CDCl3) d 173.0, 136.2, 133.2, 133.1, 128.5, 128.1, 127.7, 126.5, 126.4, 125.0, 
123.4, 84.3, 79.7, 68.5, 28.0. HRMS (ESI+) [2M+Na] calcd for C34H40O8Na+ 599.2621, found 
599.2614. IR (u/cm-1): 3469 (br, m), 2978 (m), 2929 (m), 1721 (s), 1370 (s), 1283 (s), 1249 (s), 
1156 (s), 1128 (s).   [a]22D = -24.3 (c = 0.740, CH2Cl2, l = 100 mm). 













Major: 32.2 min; Minor: 21.9 min; 96:4 e.r. 
 
Tert-butyl (S)-2,3-dihydroxy-2-(o-tolyl)propanoate (1.57). Following General 
Procedure A and Supplementary Procedure A, the crude oxidation mixture was purified by silica 
gel (regular) chromatography (4:1 hexanes: ethyl acetate) to yield diol 1.57 as a colorless oil in 
27% yield (6.8 mg). 1H NMR (400 MHz, CDCl3) d 7.31 (dd, J = 7.6, 1.6 Hz, 1H), 7.23 - 7.13 (m, 
3H), 4.33 - 4.20 (m, 1H), 4.11 - 4.02 (m, 2H), 2.39 (s, 3H), 1.43 (s, 9H). ). 13C NMR (151 MHz, 
CDCl3) d 173.6, 137.2, 136.7, 132.4, 128.3, 126.3, 125.9, 83.7, 79.1, 67.4, 27.9, 20.8. HRMS 
(ESI+) [2M+Na] calcd for C28H40O8Na+ 527.2611, found 527.2621. IR (u/cm-1): 3446 (m, br), 
2977 (s), 2929 (s), 1725 (s), 1458 (m), 1394 (m), 1369 (s), 1277 (s), 1159 (s), 1114 (s). [a]22D = -











Major: 17.2 min; Minor: 19.5 min; 66:34.r. 
 
Tert-butyl-(S)-2,3-dihydroxy-2-(pyridine-2-yl)propanoate (1.58). Following General 
Procedure A and Supplementary Procedure A, the crude oxidation mixture was purified by silica 
gel (50:50 regular:deactivated, mixed) chromatography (4:1 hexanes: ethyl acetate) to yield diol 
1.58 as a yellow oil in 36% yield (8.6 mg). 1H NMR (600 MHz, CDCl3) d 8.85 (d, J = 2.2 Hz, 
1H), 8.57 (dd, J = 4.9, 1.6 Hz, 1H), 7.94 (dt, J = 8.2, 1.9 Hz, 1H), 7.30 (dd, J = 8.1, 4.8 Hz, 1H), 
4.17 (d, J = 11.4 Hz, 1H), 3.73 (d, J = 11.3 Hz, 1H), 1.50 (s, 9H). 13C NMR (151 MHz, CDCl3) d 






C12H17NO4Na+ 262.1055, found 262.1054. IR (u/cm-1): 3385 (m, br), 2919 (m), 1730 (s), 1370 
(m), 1286 (m), 1251 (m), 1159 (s). [a]22D = -39.2 (c = 0.425, CH2Cl2, l = 100 mm). 





Major: 45.2 min; Minor: 56.6 min; 97:3 e.r. 
 
Tert-butyl (R)-2-phenyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-2 
((trimethylsilyl)oxy)propanoate (1.67). Following General Procedure A and 
Supplementary Procedure C, the crude material was purified by silica gel (regular) 
chromatography (75:1 pentane:diethyl ether) to yield 1.67 as a colorless solid in 46% yield (58 





1H), 1.77 (d, J = 15.3 Hz, 1H), 1.70 (d, J = 15.3 Hz, 1H), 1.44 (s, 9H), 1.16 (s, 6H), 1.15 (s, 6H), 
0.07 (s, 9H). 13C NMR (151 MHz, CDCl3) d 173.0, 145.2, 127.7, 127.0, 125.6, 83.0, 81.3, 80.7, 
27.9, 24.8, 24.7, 2.2. HRMS (ESI+) [M+Na]+ calcd for C22H37BO5SiNa+ 443.2401, found 
443.2389. IR (u/cm-1): 2979 (m), 1738 (s), 1366 (s), 1333 (m), 1248 (m), 1147 (s). [a]22D = +2.8 
(c = 0.17, CH2Cl2, l = 100 mm). 
 
Tert-butyl (2R,3R)-5-((tert-butyldimethylsilyl)oxy)-2-hydroxy-2-phenyl-3-(4,4,5,5-
tetramethyl-1,3,2-dioxaborolan-2-yl)pentanoate (1.59). Following General Procedure C, 
the crude material was purified by silica gel (80:20 regular:deactivated, layered) 
chromatography (benzene, gravity) to yield β-hydroxyboronate 1.59 as a colorless oil in 51% 
isolated yield (25.6 mg). 1H NMR (600 MHz, CDCl3) δ 7.56 (d, J = 7.4 Hz, 2H), 7.30 (t, J = 7.7 
Hz, 2H), 7.22 (t, J = 7.3 Hz, 1H), 3.98 (s, 1H), 3.60 (ddd, J = 9.9, 8.3, 4.2 Hz, 1H), 3.46 – 3.40 
(m, 1H), 2.16 (dd, J = 11.0, 2.9 Hz, 1H), 1.59 – 1.53 (m, 1H), 1.40 (s, 9H), 1.36 – 1.28 (m, 1H), 
1.25 (s, 6H), 1.24 (s, 6H), 0.85 (s, 9H), -0.05 (d, J = 11.2 Hz, 6H). 13C NMR (151 MHz, CDCl3) δ 
174.6, 141.6, 127.9, 127.0, 126.1, 83.4, 82.4, 80.5, 62.7, 28.6, 27.7, 26.0, 25.0, 24.6, 18.3, -5.3, -
5.4. HRMS (ESI+) [M+Na]+ calcd for C27H47BO6SiNa+ 529.3133, found 529.3126. IR (u/cm-1): 
3489 (m, br), 2930 (s), 2857 (s), 1719 (m), 1369 (s). [a]22D = -2.5 (c = 1.04, CH2Cl2, l = 100 mm). 
 
Tert-butyl (2R,3R)-2-hydroxy-2-phenyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-
2-yl)butanoate (1.60). Following General Procedure B, the crude material was purified by 
silica gel (regular) chromatography (15:1 pentane:diethyl ether, gravity) to yield β-










scale (with respect to ketoester), compound 11b was isolated in 60% yield (1.21 g, contains 5% 
diboryl ethane impurity).  1H NMR (600 MHz, CDCl3) d 7.58 - 7.51 (m, 2H), 7.31 (dd, J = 8.4, 
7.0 Hz, 2H), 7.25 - 7.20 (m, 1H), 3.86 (s, 1H), 2.08 (q, J = 7.6 Hz, 1H), 1.41 (s, 9H), 1.25 (s, 6H), 
1.24 (s, 6H), 0.75 (d, J = 7.6 Hz, 3H). 13C NMR (151 MHz, CDCl3) d 174.6, 141.5, 127.8, 126.9, 
125.8, 83.4, 82.3, 80.2, 27.8, 24.9, 24.6, 9.5. HRMS (ESI+) [2M+Na]+ calcd for C40H62B2O10Na+ 
747.4427, found 747.4451. IR (u/cm-1): 3401 (m, br), 2979 (s), 1693 (s), 1475 (m), 1373 (s). 
[a]22D = -1.6 (c = 1.47, CH2Cl2, l = 100 mm). 
 
Tert-butyl (2R,3R)-2-hydroxy-2-phenyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-
2-yl)hex-5-enoate (1.61). Following General Procedure C, the crude mixture was purified by 
silica gel (80:20 regular:deactivated, layered) chromatography (benzene, gravity) to yield β-
hydroxyboronate 1.61 as a colorless oil in 50% isolated yield (19.3 mg). 1H NMR (600 MHz, 
CDCl3) d 7.59 - 7.54 (m, 2H), 7.32 (dd, J = 8.4, 7.0 Hz, 2H), 7.26 - 7.22 (m, 1H), 5.77 (ddt, J = 
17.1, 10.1, 6.7 Hz, 1H), 4.93 - 4.86 (m, 1H), 4.85 (ddt, J = 10.0, 2.1, 1.0 Hz, 1H), 3.92 (s, 1H), 2.17 
- 2.10 (m, 1H), 2.09 (dd, J = 11.3, 2.8 Hz, 1H), 1.41 (s, 9H, 1.25 (s, 6H), 1.24 (s, 6H). 13C NMR 
(151 MHz, CDCl3) d 174.3, 141.3, 138.4, 128.4, 127.9, 127.1, 125.9, 114.8, 83.6, 82.5, 80.1, 30.2, 
27.8, 24.9, 24.8. HRMS (ESI+) [M+Na]+ calcd for C22H33BO5Na+ 411.2319, found 411.2315. 
[a]22D = -4.2 (c = 0.37, CH2Cl2, l = 100 mm) 
 
Tert-butyl (2R,3R)-2-hydroxy-6-methyl-2-phenyl-3-(4,4,5,5-tetramethyl-1,3,2-
dioxaborolan-2-yl)hept-5-enoate (1.62). Following General Procedure C, the crude 










(benzene, gravity) to yield β-hydroxyboronate 1.62 as a white solid in 60% isolated yield (24.9 
mg). 1H NMR (600 MHz, CDCl3) d 7.61 - 7.55 (m, 2H), 7.31 (dd, J = 8.4, 7.1 Hz, 2H), 7.25 - 7.21 
(m, 1H), 5.06 (dddd, J = 6.8, 5.4, 2.8, 1.4 Hz, 1H), 3.91 (s, 1H), 2.07 (dd, J = 13.1, 7.8 Hz, 1H), 
2.01 (dd, J = 11.6, 3.7 Hz, 1H), 1.60 (s, 3H), 1.42 (d, J = 1.3 Hz, 3H), 1.40 (s, 9H), 1.24 (s, 6H), 
1.23 (s, 6H). 13C NMR (151 MHz, CDCl3) d 174.4, 141.3, 131.6, 127.8, 127.0, 126.0, 124.0, 83.5, 
82.5, 80.0, 27.8, 25.8, 24.9, 24.7, 24.3, 17.7. HRMS (ESI+) [2M+Na]+ calcd for C48H74B2O10Na+ 
855.5366, found 855.5387. IR (u/cm-1): 3489 (m, br), 2978 (s), 2926 (s), 1716 (s), 1370 (m). ). 
[a]22D = +8.3 (c = 0.65, CH2Cl2, l = 100 mm). 
 
Tert-butyl (2R,3R)-2-hydroxy-2-phenyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-
2-yl)hexanoate (1.63). Following General Procedure C, the crude mixture was purified by 
silica gel (80:20 regular:deactivated, layered) chromatography (benzene, gravity) to yield β-
hydroxyboronate 1.63 as a colorless oil in 30% isolated yield (11.8 mg).) 1H NMR (600 MHz, 
CDCl3) δ 7.56 – 7.52 (m, 2H), 7.31 (dd, J = 10.5, 4.8 Hz, 2H), 7.25 – 7.21 (m, 1H), 3.90 (s, 1H), 
1.97 (dd, J = 11.2, 3.6 Hz, 1H), 1.39 (s, 9H), 1.38 – 1.32 (m, 2H), 1.26 (s, 6H) 1.26 (s, 6H), 1.14 – 
1.05 (m, 1H), 1.00 – 0.92 (m, 1H), 0.74 (t, J = 7.3 Hz, 3H). 12C NMR (151 MHz, CDCl3) δ 174.63, 
141.68, 127.79, 126.89, 125.83, 83.42, 82.28, 80.49, 27.76, 27.64, 24.88, 24.78, 22.52, 14.36. 
HRMS (ESI+) [2M+Na]+ calcd for C44H70B2O10Na+ 803.5053, found 803.5065. IR (u/cm-1): 











dioxaborolan-2-yl)pentanedioate (1.64). Following General Procedure C, the crude 
mixture was purified by silica gel (80:20 regular:deactivated, layered) chromatography 
(benzene, gravity) to yield β-hydroxyboronate 1.64 as a colorless oil in 14% isolated yield (6.6 
mg). 1H NMR (600 MHz, CDCl3) δ 7.61 – 7.56 (m, 2H), 7.31 (dd, J = 10.5, 4.8 Hz, 2H), 7.26 – 
7.21 (m, 1H), 3.95 (s, 1H), 2.46 (dd, J = 11.7, 4.3 Hz, 1H), 2.34 (dd, J = 17.2, 11.8 Hz, 1H), 1.89 
(dd, J = 17.2, 4.3 Hz, 1H), 1.44 (s, J = 7.0 Hz, 9H), 1.36 (s, 9H), 1.25 (s, 6H), 1.21 (s, 6H). 13C 
NMR (151 MHz, CDCl3) δ 174.17, 173.76, 141.11, 128.00, 127.19, 126.06, 83.61, 83.07, 79.87, 
79.14, 32.04, 28.04, 27.75, 25.01, 24.54. HRMS (ESI+) [M+Na]+ calcd for C25H39BO7Na+ 
485.2687, found 485.2683. IR (u/cm-1): 3482 (m, br), 2979 (s), 1724 (s), 1369 (m), 1141 (m). 
[a]22D = -5.7 (c = 0.38, CH2Cl2, l = 100 mm). 
 
Tert-butyl (2R,3R)-2-hydroxy-2,5-diphenyl-3-(4,4,5,5-tetramethyl-1,3,2-
dioxaborolan-2-yl)pentanoate (1.65). Following General Procedure C, the crude mixture 
was purified by silica gel (80:20 regular:deactivated, layered) chromatography (benzene, 
gravity) to yield β-hydroxyboronate 1.65 as a colorless oil in 33% isolated yield (14.8 mg). 1H 
NMR (600 MHz, CDCl3) d 7.48 - 7.42 (m, 2H), 7.30 - 7.25 (m, 2H), 7.24 - 7.20 (m, 1H), 7.18 (d, 
J = 7.6 Hz, 2H), 7.14 - 7.09 (m, 1H), 7.04 - 6.99 (m, 2H), 3.93 (s, 1H), 2.72 (ddd, J = 13.6, 10.6, 
4.6 Hz, 1H), 2.37 (ddd, J = 13.7, 10.2, 7.0 Hz, 1H), 2.03 (dd, J = 11.1, 3.4 Hz, 1H), 1.71 (dtd, J = 
13.2, 10.6, 4.6 Hz, 1H), 1.39 (s, 9H), 1.34 (ddt, J = 13.7, 6.6, 3.4 Hz, 1H), 1.29 (s, 6H), 1.28 (s, 









125.5, 83.5, 82.4, 80.5, 35.4, 27.7, 27.2, 25.0, 24.8. HRMS (ESI+) [M+Na]+ calcd for 
C27H37BO5Na+ 475.2632, found 475.2627. IR (u/cm-1): 3524 (m, br), 2979 (s), 2931 (s), 1722 
(s), 1369 (m). [a]22D = +11.1 (c = 0.44, CH2Cl2, l = 100 mm). 
 
Tert-butyl (2S,3R)-5-((tert-butyldimethylsilyl)oxy)-2,3-dihydroxy-2-
phenylpentanoate  (1.68) Following General Procedure C and Supplementary Procedure A, 
the crude oxidation mixture was purified by silica gel (regular) chromatography (15:1 
hexanes:ethyl acetate, gravity) to yield diol 1.68 as a colorless oil in 91% isolated yield (15.2 mg). 
1H NMR (600 MHz, CDCl3) d 7.63 (dd, J = 7.9, 1.4 Hz, 2H), 7.37 - 7.30 (m, 2H), 7.30 - 7.26 (m, 
1H), 4.55 (ddd, J = 9.6, 7.0, 1.9 Hz, 1H), 4.00 (s, 1H), 3.78 (ddd, J = 10.2, 7.2, 4.4 Hz, 1H), 3.68 
(ddd, J = 10.6, 6.7, 4.8 Hz, 1H), 2.95 (d, J = 7.0 Hz, 1H), 1.47 (s, 9H), 0.88 (s, 9H), 0.02 (d, J = 
14.9 Hz, 6H). 13C NMR (151 MHz, CDCl3) d 173.4, 138.8, 128.1, 127.6, 125.8, 83.4, 81.1, 75.0, 
61.2, 32.6, 27.8, 25.9, 18.2, -5.5, -5.5. HRMS (ESI+) [2M+Na]+ calcd for C42H72O10Si2Na+ 
815.4562, found 815.4546. IR (u/cm-1): 3482 (m, br), 2955 (s), 2857 (m), 1723 (s), 1370 (m). 
[a]22D = -16.7 (c = 1.03, CH2Cl2, l = 100 mm). 











Major: 10.8 min; Minor: 11.8 min; 98:2 e.r. 
 
Tert-butyl (2S,3R)-2,3-dihydroxy-2-phenylbutanoate (1.91). Following General 
Procedure B and Supplementary Procedure A, the crude oxidation mixture was purified by silica 
gel (regular) chromatography (4:1 hexanes:ethyl acetate, gravity) to yield diol 1.91 as a white 
solid in 40% isolated yield (10.2 mg) over two steps. 1H NMR (600 MHz, CDCl3) d 7.61 (dd, J = 
8.4, 1.3 Hz, 2H), 7.34 (dd, J = 8.3, 6.7 Hz, 2H), 7.30 - 7.26 (m, 1H), 4.48 (q, J = 6.4 Hz, 1H), 4.03 
(s, 1H), 1.48 (s, 9H), 0.95 (d, J = 6.5 Hz, 3H). 13C NMR (151 MHz, CDCl3) d 173.6, 139.1, 128.2, 
127.7, 125.6, 83.8, 81.2, 72.3, 27.8, 17.0. HRMS (ESI+) [2M+Na]+ calcd for C28H40O8Na+ 
527.2621, found 527.2609. IR (u/cm-1): 3460 (m, br), 2925 (s), 1716 (s), 1449 (m), 1278 (s). 
[a]22D = -37.2 (c = 0.51, CH2Cl2, l = 100 mm). 










Major: 13.3 min; Minor: 19.9 min; 98:2 e.r. 
 
Tert-butyl (2S,3R)-2,3-dihydroxy-2-phenylhex-5-enoate (1.92). Following General 
Procedure C and Supplementary Procedure A, the crude oxidation mixture was purified by silica 
gel (regular) chromatography (8:1 hexanes:ethyl acetate, pressure) to yield diol 1.92 as a 
colorless oil in 34% isolated yield (9.6 mg) over two steps. 1H NMR (600 MHz, CDCl3) d 7.67 - 
7.61 (m, 2H), 7.39 - 7.33 (m, 2H), 7.32 - 7.28 (m, 1H), 5.79 (dddd, J = 16.9, 10.2, 7.6, 6.5 Hz, 1H), 
5.06 - 5.03 (m, 1H), 5.03 - 4.99 (m, 1H), 4.36 - 4.30 (m, 1H), 4.06 (d, J = 0.7 Hz, 1H), 2.11 - 2.02 
(m, 2H), 1.92 (dddd, J = 13.3, 6.6, 2.8, 1.4 Hz, 1H), 1.48 (s, 9H). 13C NMR (151 MHz, CDCl3) d 
173.3, 138.6, 135.0, 128.3, 127.9, 125.7, 117.6, 83.9, 81.0, 75.4, 35.4, 27.8. HRMS (ESI+) 
[2M+Na]+ calcd for C32H44O8Na+ 579.2934, found 579.2928. IR (u/cm-1):  3485 (m, br), 2926 
(s), 1721 (s), 1278 (s). [a]22D = -20.7 (c = 0.44, CH2Cl2, l = 100 mm). 














Major: 11.8 min; Minor: 28.1 min; 99:1 e.r. 
 
Tert-butyl (2S,3R)-2,3-dihydroxy-6-methyl-2-phenylhept-5-enoate (1.93). Following 
General Procedure C and Supplementary Procedure A, the crude oxidation mixture was purified 
by silica gel (regular) chromatography (15:1 hexanes:ethyl acetate, gravity) to yield diol 1.93 as a 
colorless oil in 39% isolated yield (11.8 mg) over two steps. 1H NMR (600 MHz, CDCl3) d  7.67 - 
7.61 (m, 2H), 7.38 - 7.32 (m, 2H), 7.32 - 7.26 (m, 1H), 5.14 (dddd, J = 8.1, 6.8, 2.9, 1.4 Hz, 1H), 
4.28 (dd, J = 10.2, 2.8 Hz, 1H), 4.06 (s, 1H), 2.09 - 2.01 (m, 1H), 1.86 - 1.79 (m, 1H), 1.66 (d, J = 
1.5 Hz, 3H), 1.47 (s, 12H). 13C NMR (151 MHz, CDCl3) d 173.4, 138.9, 134.6, 128.2, 127.7, 125.7, 
120.5, 83.8, 81.1, 76.4, 29.6, 27.8, 25.9, 17.8. HRMS (ESI+) [2M+Na]+ calcd for C36H52O8Na+ 
635.3560, found 635.3554. IR (u/cm-1): 3475 (m, br), 2977 (s), 2927 (s), 1721 (s), 1159 (s). 












Major: 8.8 min; Minor: 21.4 min; 99:1 e.r 
 
Tert-butyl (2S,3R)-2,3-dihydroxy-2-phenylhexanoate (1.94). Following General 
Procedure C and Supplementary Procedure A, the crude oxidation mixture was purified by silica 
gel (regular) chromatography (4:1 hexanes:ethyl acetate, gravity) to yield diol 1.94 as a white 
solid. 1H NMR (600 MHz, CDCl3) δ 7.61 (dd, J = 5.3, 3.4 Hz, 2H), 7.38 – 7.32 (m, 2H), 7.31 – 
7.27 (m, 1H), 4.29 – 4.22 (m, 1H), 4.05 (s, 1H), 1.91 (d, J = 11.1 Hz, 1H), 1.56 – 1.49 (m, 1H), 1.48 
(s, 9H), 1.31 – 1.22 (m, 2H), 1.09 – 1.03 (m, 1H), 0.81 (t, J = 7.2 Hz, 3H). 13C NMR (151 MHz, 
CDCl3) δ 173.7, 139.0, 128.2, 127.7, 125.6, 83.9, 81.4, 75.9, 32.7, 27.8, 19.1, 13.9. HRMS (ESI+) 






2960 (m), 1869 (s), 1716 (m), 1541 (m), 1507 (m), 1457 (s), 1395 (s), 1371 (s), 1278 (s), 1141 (s), 
1069 (s).  [a]16D = -5.1 (c = 0.19, CH2Cl2, l = 100 mm). 





Major: 11.8 min; Minor: 23.9 min; 98:2 e.r. 
 
Di-tert-butyl (2S,3R)-2,3-dihydroxy-2-phenylpentanedioate (1.95). Following General 
Procedure C and Supplementary Procedure A, the crude oxidation mixture was purified by silica 
gel (regular) chromatography (4:1 hexanes:ethyl acetate, gravity) to yield diol 1.95 as a colorless 
oil in 21% isolated yield (7.5 mg) over two steps. 1H NMR (600 MHz, CDCl3) d 7.68 - 7.62 (m, 
2H), 7.39 - 7.32 (m, 2H), 7.32 - 7.27 (m, 1H), 4.73 (dd, J = 10.0, 2.7 Hz, 1H), 4.05 - 3.93 (m, 1H), 
2.35 (dd, J = 16.5, 10.0 Hz, 1H), 2.02 (dd, J = 16.6, 2.7 Hz, 1H), 1.48 (s, 9H), 1.41 (s, 9H). 13C 






28.1, 27.8. HRMS (ESI+) [2M+Na]+ calcd for C38H66O12Na+ 727.3669, found 727.3658. IR 
(u/cm-1): 3486 (m, br), 2978 (s), 2927 (m), 1727 (s), 1154 (s). [a]22D = -23.7 (c = 0.38, CH2Cl2, l 
= 100 mm). 





Major: 10.4 min; Minor: 15.8 min; 94:6 e.r. 
 
Tert-butyl (2S,3R)-2,3-dihydroxy-2,5-diphenylpentanoate (1.96). Following General 
Procedure C and Supplementary Procedure A, the crude oxidation mixture was purified by silica 
gel (regular) chromatography (8:1 hexanes:ethyl acetate) to yield diol 1.96 as a colorless oil in 
22% isolated yield (7.5 mg) over two steps. 1H NMR (600 MHz, CDCl3) d 7.55 - 7.51 (m, 2H), 
7.34 - 7.29 (m, 2H), 7.29 - 7.26 (m, 1H), 7.21 (t, J = 7.5 Hz, 2H), 7.16 - 7.12 (m, 1H), 7.08 - 7.03 





Hz, 1H), 2.53 (ddd, J = 13.9, 10.1, 6.9 Hz, 1H), 2.06 (d, J = 11.2 Hz, 1H), 1.67 - 1.58 (m, 1H), 1.47 
(s, 9H), 1.44 (ddt, J = 10.4, 3.4, 1.7 Hz, 1H). 13C NMR (151 MHz, CDCl3) d 173.5, 141.9, 138.7, 
128.4, 128.2, 128.2, 127.8, 125.7, 125.6, 83.9, 81.3, 75.5, 32.4, 32.2, 27.8. HRMS (ESI+) 
[2M+Na]+ calcd for C42H52O8Na+ 707.3560, found 707.3558. IR (u/cm-1): 3460 (m, br), 2926 
(m), 1721 (s), 1278 (s). [a]22D = +11.6 (c = 0.14, CH2Cl2, l = 100 mm). 





Major: 15.0 min; Minor: 28.4 min; 98:2 e.r. 
 
Tert-butyl (2R,3R)-6-methyl-2-phenyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-
2-yl)-2-((trimethylsilyl)oxy)hept-5-enoate (1.69).  Following General Procedure C and 
Supplementary Procedure C, the crude material was purified by silica gel chromatography (50:1 





MHz, CDCl3) d  7.45 (dd, J = 8.5, 1.3 Hz, 2H), 7.28 (t, J = 7.4 Hz, 2H), 7.22 - 7.18 (m, 1H), 5.04 
(ddd, J = 8.2, 4.0, 2.4 Hz, 1H), 2.11 - 1.94 (m, 1H), 1.83 - 1.71 (m, 2H), 1.56 (s, 3H), 1.47 (s, 9H) 
1.40 (s 3H), 1.19 (s, 6H), 1.18 (s, 6H), 0.17 (s, 9H). 13C NMR (151 MHz, CDCl3) d 172.9, 143.9, 
130.9, 127.6, 126.9, 126.0, 124.8, 84.2, 82.9, 82.1, 28.1, 25.9, 25.1, 24.9, 24.8, 17.7, 2.9. HRMS 
(ESI+) [M+Na]+ calcd for C27H45BO5SiNa+ 511.3027, found 511.3013. IR (u/cm-1): 2979 (m), 
1735 (s), 1370 (s), 1248 (s), 1146 (s). [a]16D = +35.8 (c = 0.2, CH2Cl2, l = 100 mm).  
 
Tert-butyl (2R,3R)-6-methyl-2-phenyl-3-((4,4,5,5-tetramethyl-1,3,2-dioxaborolan-
2-yl)methyl)-2-((trimethylsilyl)oxy)hept-5-enoate (1.70). Following a literature 
procedure,43 protected hydroxyboronate 1.70 (23.9 mg, 0.05 mmol) was added to an oven dried 
8 mL vial containing a stir bar. The vial was purged with nitrogen for 3 minutes. A solution of 
dibromomethane in THF was made (0.125 mmol, 0.25M) and an aliquot (0.5 mL) was added to 
the vial via syringe. The vial was cooled to -78 °C (dry ice/acetone bath). A solution of nBuLi 
(0.066 mL, 0.11 mmol, 1.67M) in hexanes was added dropwise via syringe. The reaction was 
allowed to stir at -78 °C for 20 minutes and then allowed to warm to room temperature and 
stirred for an additional two hours. The reaction was quenched with a saturated solution of 
ammonium chloride (1.5 mL), extracted with diethyl ether (3x), dried over MgSO4 and 
concentrated. The crude material was purified via silica gel (regular) chromatography (100:1 
pentane:ether, gravity) to yield the desired homologated product 1.70 in 50% yield (12.5 mg). 
1H NMR (400 MHz, CDCl3) d   7.63 - 7.55 (m, 2H), 7.29 (dd, J = 8.4, 6.7 Hz, 2H), 7.25 - 7.16 (m, 
1H), 4.99 - 4.88 (m, 1H), 2.64 (td, J = 9.7, 4.2 Hz, 1H), 1.77 - 1.59 (m, 2H), 1.56 (s, 3H), 1.48 (s, 
9H), 1.41 (s, 3H), 1.24 (s, 12H), 0.21 (s, 9H). 13C NMR (151 MHz, CDCl3) d 172.8, 142.7, 131.8, 













(ESI+)[M+Na]+ calcd for C28H47BO5SiNa+ 525.3184, found 525.26. IR (u/cm-1): 2978 (m), 
1734 (s), 1457 (m), 1369 (s), 1324 (m), 1248 (s), 1201 (s), 1079 (m), 1055 (m).  [a]16D = +3.3 (c = 
0.42, CH2Cl2, l = 100 mm). 
 
Tert-butyl (E)-2,7-dihydroxy-2-phenyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-
2-yl)hept-5-enoate (1.72). An 8 mL vial containing a magnetic stir bar was charged with allyl 
hydroxyboronate 1.61 (10.4 mg, 0.027 mmol) and cis-2-butene-1,4-diol 1.71 (4.7 mg, 0.054 
mmol, 4.4 µL). The vial was sealed, evacuated, and placed under an inert atmosphere of N2 gas. 
To a separate, oven-dried 8 mL vial, (1,3-Bis-(2,4,6-trimethylphenyl)-2-
imidazolidinylidene)dichloro(o-isopropoxyphenylmethylene)ruthenium (1.7 mg, 0.0027 mmol) 
was added. The vial was sealed, evacuated and purged with N2. The vial containing the catalyst 
was then charged with dry THF (200 µL) and purged with N2 gas. The catalyst solution was 
cannula transferred to the reaction vial containing hydroxyboronate and alkene at room 
temperature. The green reaction mixture was warmed to 40 °C and allowed to stir for 6 hours. 
After, the reaction was diluted with wet diethyl ether and concentrated in vacuo. Analysis of the 
crude mixture revealed formation of desired product in a 6.5:1 E/Z ratio. The resulting brown oil 
was purified by silica gel chromatography (4:1 hexanes:ethyl acetate) to afford 1.72 (7.1 mg, 
0.017 mmol, 63% yield) as a white solid in 94:6 E/Z ratio. 1H NMR (600 MHz, CDCl3) δ 7.60 – 
7.55 (m, 2H), 7.34 (t, J = 7.7 Hz, 2H), 7.28 – 7.24 (m, 1H), 5.61 (dt, J = 15.0, 6.8 Hz, 1H), 5.52 – 
5.46 (m, 1H), 3.98 (d, J = 1.9 Hz, 2H), 3.95 (d, J = 5.1 Hz, 1H), 2.19 – 2.08 (m, 2H), 1.87 – 1.81 
(m, 1H), 1.43 (s, 9H), 1.27 (s, 12H), 1.09 (t, J = 5.7 Hz, 1H). 13C NMR (151 MHz, CDCl3) δ 174.3, 















THF, 40 ºC, 4 h
1.71
1.73 (10 mol%) OH
 61 
(ESI+) [M+Na]+ calcd for C23H35BO6Na+ 441.24, found 441.36. IR (u/cm-1): 3482 (m, br), 2979 
(s), 2929 (m), 1716 (s), 1370 (m), 1163 (s). [a]16D = +4.4 (c = 0.26, CH2Cl2, l = 100 mm). 
 
Tert-butyl (2R,3R,5S)-5-iodo-6,6-dimethyl-2-phenyl-3-(4,4,5,5-tetramethyl-1,3,2-
dioxaborolan-2-yl)tetrahydro-2H-pyran-2-carboxylate (1.74). Following a modified 
literature procedure,34 prenyl-substituted hydroxyboronate 1.62 (16.8 mg, 0.040 mmol) was 
added to an 8 mL amber vial containing a stir bar. The vial was placed under vacuum for ten 
minutes, then back-filled with nitrogen. The vial was charged with dry acetonitrile (0.4 mL) and 
cooled to 0 °C in an ice water bath. Sodium bicarbonate (10.1 mg, 0.121 mmol) was added to the 
vial, the vial was capped, and the resulting suspension was allowed to stir at 0 °C for 15 minutes. 
The reaction was then transferred to a -35 °C bath, where it was allowed to cool for ten minutes. 
Iodine (30.7 mg, 0.121 mmol) was added to the vial, and the reaction was kept at -35 °C for 1.5 
hours. The reaction mixture was diluted with water and extracted with ethyl acetate (4x). The 
combined organics were washed with saturated sodium thiosulfate solution, dried over MgSO4, 
filtered and concentrated in vacuo. The crude material was purified via silica gel (regular) 
chromatography (20:1 hexanes:diethyl ether) to yield the desired cyclized product 1.74 in 45% 
yield (9.5 mg). 1H NMR (600 MHz, CDCl3) δ 7.41 (dd, J = 5.3, 3.4 Hz, 2H), 7.27 (d, J = 7.7 Hz, 
2H), 7.25 – 7.21 (m, 1H), 4.37 (dd, J = 13.2, 3.8 Hz, 1H), 2.70 (dd, J = 27.5, 13.4 Hz, 1H), 2.43 
(dt, J = 14.4, 3.9 Hz, 1H), 1.60 (s, 3H), 1.57 (s, 3H), 1.53 (s, 9H), 1.18 (s, 6H), 1.17 (s, 6H). 13C 
NMR (151 MHz, CDCl3) δ 173.7, 143.2, 127.3, 127.1, 126.7, 84.0, 82.8, 82.8, 39.8, 34.0, 31.8, 
31.6, 27.8, 25.3, 24.2, 22.7, 22.2, 14.2. LRMS (ESI+) [M+Na]+ calcd for C24H36BIO5Na+ 565.16, 
found 565.18. IR (u/cm-1): 2979 (m), 2929 (m), 1715 (s), 1369 (s), 1149 (s). [a]16D = +13.2 (c = 














Following General Procedure B, the crude material (42% NMR conversion) was purified by silica 
gel (regular) chromatography (20:1 hexanes:diethyl ether) to yield β-hydroxyboronate 20 which 
was taken directly on to oxidation (see below). 1H NMR (600 MHz, CDCl3) δ 7.57 (dd, J = 8.4, 
1.1 Hz, 2H), 7.46 (dd, J = 8.4, 1.1 Hz, 2H), 7.28 – 7.23 (m, 6H), 7.13 (ddd, J = 11.9, 6.0, 2.9 Hz, 
2H), 3.61 (s, 1H), 2.40 (q, J = 7.4 Hz, 1H), 1.08 (s, 6H), 0.95 (s, 6H), 0.92 (d, J = 7.4 Hz, 3H). 13C 
NMR (151 MHz, CDCl3) δ 149.9, 145.9, 128.2, 128.0, 126.6, 126.1, 125.8, 125.7, 83.7, 78.8, 24.6, 
24.2, 10.1. 
 
(R)-(+)-1,1-Diphenyl-1,2-propanediol. (R)-(+)-1,1-Diphenyl-1,2-propanediol (1.97). 
Following General Procedure B and Supplementary Procedure A, the crude oxidation mixture 
was purified by silica gel (regular) chromatography (4:1 hexanes:ethyl acetate, gravity) to yield 
diol 20 as a white solid in 12% isolated yield (2.7 mg) over two steps. Spectral data aligns with 
previously reported results.44 [a]22D = +9.7  (c = 0.14, MeOH, l = 100mm).  

























































































































































































































































































































































































































































































Hb Hc Hd 
 98 
Selective gradient 1D NOESY at 4.365 ppm (Ha) 
 





























 13C NMR (151 MHz, CDCl3)
 100 
1.5.10 Crystal structure data for 1.60 
 
Identification Code: jcg_ii_300a 
Empirical Formula: C40H58B2O10 
Formula Weight: 720.43 
Measurement Temperature: 100(2) K 
Radiation Type: CuK\a 
Wavelength: 1.54178 
Crystal System: triclinic 
Space Group: P-1 
Unit Cell Dimensions: a = 6.2365(3) Å; α = 101.486(3)° 
              b = 9.4178(4) Å; β = 93.584(3)° 
              c = 18.1506(9) Å; γ = 100.833(3)° 
Volume: 1020.55(8) Å3 
Z: 2 
Density (calculated): 1.172 g/cm3 
Absorption Correction Coefficient: 0.622 (mm-1)  
F(000): 388 
Crystal size: 0.035 mm x 0.053 mm x 0.202 mm 
 101 
Theta Max: 66.61° 
Index Ranges: hmax = 7; kmax = 11; lmax = 21 
Reflections Collected: 6875 
Independent Reflections: 5753 
Completeness of Theta: 98 
Min:Max Transmission Ratio: 0.8977 
Refinement Method: XL 
Goodness-of-fit on F2 0: 0.822 
R Indicies:  R1 = 0.0415; wR2 = 0.0564 
Bond lengths for 1.60 (Å) 
Number Atom1 Atom2 Length 
1 O1 C17 1.469(3) 
2 O1 B1 1.363(3) 
3 O2 C16 1.473(3) 
4 O2 B1 1.369(3) 
5 O5 C9 1.330(3) 
6 O5 C22 1.495(3) 
7 O3 C7 1.420(3) 
8 O3 H3 0.88(4) 
9 O4 C9 1.212(3) 
10 C17 C19 1.513(4) 
11 C17 C16 1.552(3) 
12 C17 C20 1.530(4) 
13 C7 C9 1.535(4) 
14 C7 C1 1.542(4) 
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15 C7 C12 1.543(3) 
16 C19 H19A 0.98 
17 C19 H19B 0.979 
18 C19 H19C 0.98 
19 C16 C21 1.513(4) 
20 C16 C18 1.518(4) 
21 C1 C2 1.387(4) 
22 C1 C6 1.399(4) 
23 C12 H12 1 
24 C12 C26 1.539(4) 
25 C12 B1 1.581(4) 
26 C21 H21A 0.98 
27 C21 H21B 0.98 
28 C21 H21C 0.98 
29 C22 C23 1.520(4) 
30 C22 C25 1.510(4) 
31 C22 C24 1.513(4) 
32 C2 H2 0.95 
33 C2 C3 1.393(4) 
34 C23 H23A 0.981 
35 C23 H23B 0.98 
36 C23 H23C 0.979 
37 C4 H4 0.95 
38 C4 C5 1.380(5) 
39 C4 C3 1.377(4) 
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40 C20 H20A 0.979 
41 C20 H20B 0.98 
42 C20 H20C 0.98 
43 C6 H6A 0.95 
44 C6 C5 1.383(4) 
45 C25 H25A 0.98 
46 C25 H25B 0.981 
47 C25 H25C 0.98 
48 C5 H5 0.949 
49 C26 H26A 0.98 
50 C26 H26B 0.98 
51 C26 H26C 0.98 
52 C3 H3A 0.95 
53 C18 H18A 0.98 
54 C18 H18B 0.979 
55 C18 H18C 0.98 
56 C24 H24A 0.98 
57 C24 H24B 0.98 
58 C24 H24C 0.98 
59 C34 H34 0.95 
60 C34 C37 1.400(4) 
61 C34 C41 1.374(4) 
62 C38 H38 0.95 
63 C38 C37 1.388(4) 
64 C38 C39 1.394(4) 
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65 C37 C42 1.543(4) 
66 C40 H40 0.949 
67 C40 C41 1.396(4) 
68 C40 C39 1.377(5) 
69 C41 H41 0.95 
70 C39 H39 0.951 
71 O6 C42 1.422(3) 
72 O6 H6 0.95(4) 
73 O7 C50 1.207(3) 
74 O8 C49 1.491(3) 
75 O8 C50 1.326(3) 
76 C49 C54 1.521(4) 
77 C49 C53 1.509(4) 
78 C49 C52 1.520(4) 
79 C43 H43 1 
80 C43 C42 1.546(4) 
81 C43 C55 1.540(4) 
82 C43 B2 1.579(4) 
83 C50 C42 1.539(4) 
84 C55 H55A 0.981 
85 C55 H55B 0.98 
86 C55 H55C 0.98 
87 C54 H54A 0.98 
88 C54 H54B 0.979 
89 C54 H54C 0.98 
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90 C53 H53A 0.98 
91 C53 H53B 0.98 
92 C53 H53C 0.98 
93 C52 H52A 0.98 
94 C52 H52B 0.98 
95 C52 H52C 0.98 
96 O9 B2 1.370(3) 
97 O9 C58 1.457(4) 
98 O10 B2 1.374(5) 
99 O10 C59 1.461(4) 
100 C58 C59 1.548(5) 
101 C58 C61 1.512(6) 
102 C58 C63 1.518(5) 
103 C59 C64 1.534(7) 
104 C59 C62 1.502(8) 
105 C61 H61A 0.98 
106 C61 H61B 0.981 
107 C61 H61C 0.98 
108 C63 H63A 0.98 
109 C63 H63B 0.98 
110 C63 H63C 0.98 
111 C64 H64A 0.98 
112 C64 H64B 0.981 
113 C64 H64C 0.98 
114 C62 H62A 0.98 
 106 
115 C62 H62B 0.981 
116 C62 H62C 0.98 
Bond angles for 1.60 (º) 
Number Atom1 Atom2 Atom3 Angle 
1 C17 O1 B1 106.4(2) 
2 C16 O2 B1 106.5(2) 
3 C9 O5 C22 121.3(2) 
4 C7 O3 H3 110(2) 
5 O1 C17 C19 109.5(2) 
6 O1 C17 C16 101.9(2) 
7 O1 C17 C20 107.0(2) 
8 C19 C17 C16 115.1(2) 
9 C19 C17 C20 109.9(2) 
10 C16 C17 C20 112.8(2) 
11 O3 C7 C9 108.4(2) 
12 O3 C7 C1 110.0(2) 
13 O3 C7 C12 107.6(2) 
14 C9 C7 C1 103.8(2) 
15 C9 C7 C12 113.9(2) 
16 C1 C7 C12 113.0(2) 
17 C17 C19 H19A 109.5 
18 C17 C19 H19B 109.5 
19 C17 C19 H19C 109.5 
20 H19A C19 H19B 109.4 
21 H19A C19 H19C 109.5 
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22 H19B C19 H19C 109.5 
23 O2 C16 C17 101.8(2) 
24 O2 C16 C21 108.7(2) 
25 O2 C16 C18 106.5(2) 
26 C17 C16 C21 115.1(2) 
27 C17 C16 C18 113.0(2) 
28 C21 C16 C18 110.9(2) 
29 O5 C9 O4 126.2(2) 
30 O5 C9 C7 112.0(2) 
31 O4 C9 C7 121.7(2) 
32 C7 C1 C2 120.2(2) 
33 C7 C1 C6 121.7(2) 
34 C2 C1 C6 118.0(3) 
35 C7 C12 H12 106.6 
36 C7 C12 C26 110.6(2) 
37 C7 C12 B1 114.1(2) 
38 H12 C12 C26 106.5 
39 H12 C12 B1 106.6 
40 C26 C12 B1 111.9(2) 
41 C16 C21 H21A 109.5 
42 C16 C21 H21B 109.5 
43 C16 C21 H21C 109.5 
44 H21A C21 H21B 109.4 
45 H21A C21 H21C 109.5 
46 H21B C21 H21C 109.5 
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47 O5 C22 C23 111.3(2) 
48 O5 C22 C25 108.0(2) 
49 O5 C22 C24 101.5(2) 
50 C23 C22 C25 112.9(2) 
51 C23 C22 C24 110.9(2) 
52 C25 C22 C24 111.6(2) 
53 C1 C2 H2 119.6 
54 C1 C2 C3 120.9(3) 
55 H2 C2 C3 119.5 
56 C22 C23 H23A 109.5 
57 C22 C23 H23B 109.5 
58 C22 C23 H23C 109.4 
59 H23A C23 H23B 109.4 
60 H23A C23 H23C 109.5 
61 H23B C23 H23C 109.5 
62 H4 C4 C5 120.4 
63 H4 C4 C3 120.4 
64 C5 C4 C3 119.2(3) 
65 C17 C20 H20A 109.5 
66 C17 C20 H20B 109.4 
67 C17 C20 H20C 109.4 
68 H20A C20 H20B 109.6 
69 H20A C20 H20C 109.5 
70 H20B C20 H20C 109.4 
71 C1 C6 H6A 119.7 
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72 C1 C6 C5 120.7(3) 
73 H6A C6 C5 119.6 
74 C22 C25 H25A 109.4 
75 C22 C25 H25B 109.5 
76 C22 C25 H25C 109.5 
77 H25A C25 H25B 109.4 
78 H25A C25 H25C 109.5 
79 H25B C25 H25C 109.5 
80 C4 C5 C6 120.8(3) 
81 C4 C5 H5 119.6 
82 C6 C5 H5 119.6 
83 C12 C26 H26A 109.4 
84 C12 C26 H26B 109.5 
85 C12 C26 H26C 109.4 
86 H26A C26 H26B 109.6 
87 H26A C26 H26C 109.5 
88 H26B C26 H26C 109.4 
89 C2 C3 C4 120.5(3) 
90 C2 C3 H3A 119.8 
91 C4 C3 H3A 119.7 
92 C16 C18 H18A 109.5 
93 C16 C18 H18B 109.5 
94 C16 C18 H18C 109.5 
95 H18A C18 H18B 109.5 
96 H18A C18 H18C 109.5 
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97 H18B C18 H18C 109.5 
98 C22 C24 H24A 109.5 
99 C22 C24 H24B 109.5 
100 C22 C24 H24C 109.5 
101 H24A C24 H24B 109.5 
102 H24A C24 H24C 109.4 
103 H24B C24 H24C 109.5 
104 O1 B1 O2 113.6(2) 
105 O1 B1 C12 126.4(2) 
106 O2 B1 C12 119.9(2) 
107 H34 C34 C37 119.8 
108 H34 C34 C41 119.9 
109 C37 C34 C41 120.4(2) 
110 H38 C38 C37 119.7 
111 H38 C38 C39 119.8 
112 C37 C38 C39 120.5(3) 
113 C34 C37 C38 118.7(2) 
114 C34 C37 C42 120.5(2) 
115 C38 C37 C42 120.8(2) 
116 H40 C40 C41 120.5 
117 H40 C40 C39 120.5 
118 C41 C40 C39 119.1(3) 
119 C34 C41 C40 120.8(3) 
120 C34 C41 H41 119.6 
121 C40 C41 H41 119.6 
 111 
122 C38 C39 C40 120.5(3) 
123 C38 C39 H39 119.7 
124 C40 C39 H39 119.7 
125 C42 O6 H6 107(2) 
126 C49 O8 C50 121.8(2) 
127 O8 C49 C54 109.8(2) 
128 O8 C49 C53 109.4(2) 
129 O8 C49 C52 101.7(2) 
130 C54 C49 C53 112.6(2) 
131 C54 C49 C52 111.1(2) 
132 C53 C49 C52 111.6(2) 
133 H43 C43 C42 107.7 
134 H43 C43 C55 107.7 
135 H43 C43 B2 107.6 
136 C42 C43 C55 111.2(2) 
137 C42 C43 B2 109.8(2) 
138 C55 C43 B2 112.6(2) 
139 O7 C50 O8 126.3(2) 
140 O7 C50 C42 121.9(2) 
141 O8 C50 C42 111.8(2) 
142 C37 C42 O6 110.9(2) 
143 C37 C42 C43 111.6(2) 
144 C37 C42 C50 107.4(2) 
145 O6 C42 C43 106.8(2) 
146 O6 C42 C50 107.5(2) 
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147 C43 C42 C50 112.6(2) 
148 C43 C55 H55A 109.5 
149 C43 C55 H55B 109.5 
150 C43 C55 H55C 109.5 
151 H55A C55 H55B 109.5 
152 H55A C55 H55C 109.5 
153 H55B C55 H55C 109.4 
154 C49 C54 H54A 109.4 
155 C49 C54 H54B 109.4 
156 C49 C54 H54C 109.5 
157 H54A C54 H54B 109.5 
158 H54A C54 H54C 109.5 
159 H54B C54 H54C 109.5 
160 C49 C53 H53A 109.5 
161 C49 C53 H53B 109.5 
162 C49 C53 H53C 109.4 
163 H53A C53 H53B 109.5 
164 H53A C53 H53C 109.5 
165 H53B C53 H53C 109.5 
166 C49 C52 H52A 109.5 
167 C49 C52 H52B 109.4 
168 C49 C52 H52C 109.5 
169 H52A C52 H52B 109.5 
170 H52A C52 H52C 109.5 
171 H52B C52 H52C 109.5 
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172 B2 O9 C58 108.0(2) 
173 B2 O10 C59 107.7(3) 
174 C43 B2 O9 122.3(2) 
175 C43 B2 O10 125.5(3) 
176 O9 B2 O10 112.1(3) 
177 O9 C58 C59 102.4(3) 
178 O9 C58 C61 106.2(3) 
179 O9 C58 C63 109.3(3) 
180 C59 C58 C61 113.6(3) 
181 C59 C58 C63 114.6(3) 
182 C61 C58 C63 110.0(3) 
183 O10 C59 C58 102.9(3) 
184 O10 C59 C64 105.8(3) 
185 O10 C59 C62 110.4(3) 
186 C58 C59 C64 112.9(3) 
187 C58 C59 C62 115.4(3) 
188 C64 C59 C62 109.0(4) 
189 C58 C61 H61A 109.5 
190 C58 C61 H61B 109.5 
191 C58 C61 H61C 109.5 
192 H61A C61 H61B 109.5 
193 H61A C61 H61C 109.4 
194 H61B C61 H61C 109.5 
195 C58 C63 H63A 109.4 
196 C58 C63 H63B 109.4 
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197 C58 C63 H63C 109.5 
198 H63A C63 H63B 109.5 
199 H63A C63 H63C 109.5 
200 H63B C63 H63C 109.5 
201 C59 C64 H64A 109.5 
202 C59 C64 H64B 109.5 
203 C59 C64 H64C 109.5 
204 H64A C64 H64B 109.4 
205 H64A C64 H64C 109.5 
206 H64B C64 H64C 109.4 
207 C59 C62 H62A 109.5 
208 C59 C62 H62B 109.4 
209 C59 C62 H62C 109.5 
210 H62A C62 H62B 109.4 
211 H62A C62 H62C 109.5 
212 H62B C62 H62C 109.5 
Torsion angles for 1.60 (º) 
Number Atom1 Atom2 Atom3 Atom4 Torsion 
1 B1 O1 C17 C19 148.6(2) 
2 B1 O1 C17 C16 26.2(2) 
3 B1 O1 C17 C20 -92.3(2) 
4 C17 O1 B1 O2 -11.8(3) 
5 C17 O1 B1 C12 164.7(2) 
6 B1 O2 C16 C17 24.6(2) 
7 B1 O2 C16 C21 146.6(2) 
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8 B1 O2 C16 C18 -93.9(2) 
9 C16 O2 B1 O1 -9.2(3) 
10 C16 O2 B1 C12 174.1(2) 
11 C22 O5 C9 O4 0.8(4) 
12 C22 O5 C9 C7 
-
175.8(2) 
13 C9 O5 C22 C23 -54.3(3) 
14 C9 O5 C22 C25 70.1(3) 
15 C9 O5 C22 C24 
-
172.4(2) 
16 H3 O3 C7 C9 -8(3) 
17 H3 O3 C7 C1 105(3) 
18 H3 O3 C7 C12 -131(3) 
19 O1 C17 C19 H19A -54.8 
20 O1 C17 C19 H19B -174.8 
21 O1 C17 C19 H19C 65.2 
22 C16 C17 C19 H19A 59.3 
23 C16 C17 C19 H19B -60.7 
24 C16 C17 C19 H19C 179.3 
25 C20 C17 C19 H19A -172.1 
26 C20 C17 C19 H19B 68 
27 C20 C17 C19 H19C -52.1 
28 O1 C17 C16 O2 -30.5(2) 




30 O1 C17 C16 C18 83.2(2) 
31 C19 C17 C16 O2 
-
149.0(2) 
32 C19 C17 C16 C21 93.6(3) 
33 C19 C17 C16 C18 -35.2(3) 
34 C20 C17 C16 O2 83.8(2) 
35 C20 C17 C16 C21 -33.6(3) 
36 C20 C17 C16 C18 
-
162.4(2) 
37 O1 C17 C20 H20A -62.9 
38 O1 C17 C20 H20B 177 
39 O1 C17 C20 H20C 57.1 
40 C19 C17 C20 H20A 55.9 
41 C19 C17 C20 H20B -64.2 
42 C19 C17 C20 H20C 175.9 
43 C16 C17 C20 H20A -174.2 
44 C16 C17 C20 H20B 65.7 
45 C16 C17 C20 H20C -54.2 
46 O3 C7 C9 O5 
-
158.0(2) 
47 O3 C7 C9 O4 25.3(3) 
48 C1 C7 C9 O5 85.1(3) 
49 C1 C7 C9 O4 -91.7(3) 
50 C12 C7 C9 O5 -38.2(3) 
51 C12 C7 C9 O4 145.0(3) 
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52 O3 C7 C1 C2 -18.7(3) 
53 O3 C7 C1 C6 164.7(2) 
54 C9 C7 C1 C2 97.1(3) 
55 C9 C7 C1 C6 -79.5(3) 
56 C12 C7 C1 C2 
-
139.0(3) 
57 C12 C7 C1 C6 44.4(3) 
58 O3 C7 C12 H12 -174.2 
59 O3 C7 C12 C26 -58.8(3) 
60 O3 C7 C12 B1 68.4(3) 
61 C9 C7 C12 H12 65.6 
62 C9 C7 C12 C26 
-
179.0(2) 
63 C9 C7 C12 B1 -51.8(3) 
64 C1 C7 C12 H12 -52.5 
65 C1 C7 C12 C26 62.9(3) 
66 C1 C7 C12 B1 
-
169.9(2) 
67 O2 C16 C21 H21A -50.1 
68 O2 C16 C21 H21B -170 
69 O2 C16 C21 H21C 70 
70 C17 C16 C21 H21A 63.4 
71 C17 C16 C21 H21B -56.6 
72 C17 C16 C21 H21C -176.6 
73 C18 C16 C21 H21A -166.8 
 118 
74 C18 C16 C21 H21B 73.3 
75 C18 C16 C21 H21C -46.8 
76 O2 C16 C18 H18A -53.2 
77 O2 C16 C18 H18B -173.2 
78 O2 C16 C18 H18C 66.8 
79 C17 C16 C18 H18A -164.1 
80 C17 C16 C18 H18B 75.9 
81 C17 C16 C18 H18C -44.1 
82 C21 C16 C18 H18A 65 
83 C21 C16 C18 H18B -55 
84 C21 C16 C18 H18C -175 
85 C7 C1 C2 H2 3.5 
86 C7 C1 C2 C3 
-
176.5(2) 
87 C6 C1 C2 H2 -179.7 
88 C6 C1 C2 C3 0.3(4) 
89 C7 C1 C6 H6A -3.5 
90 C7 C1 C6 C5 176.5(3) 
91 C2 C1 C6 H6A 179.8 
92 C2 C1 C6 C5 -0.2(4) 
93 C7 C12 C26 H26A -61.4 
94 C7 C12 C26 H26B 178.5 
95 C7 C12 C26 H26C 58.6 
96 H12 C12 C26 H26A 54 
97 H12 C12 C26 H26B -66.1 
 119 
98 H12 C12 C26 H26C 174 
99 B1 C12 C26 H26A 170.2 
100 B1 C12 C26 H26B 50.1 
101 B1 C12 C26 H26C -69.8 
102 C7 C12 B1 O1 22.0(4) 
103 C7 C12 B1 O2 
-
161.7(2) 
104 H12 C12 B1 O1 -95.3 
105 H12 C12 B1 O2 81 
106 C26 C12 B1 O1 148.5(3) 
107 C26 C12 B1 O2 -35.1(3) 
108 O5 C22 C23 H23A -38.4 
109 O5 C22 C23 H23B -158.4 
110 O5 C22 C23 H23C 81.5 
111 C25 C22 C23 H23A -160.1 
112 C25 C22 C23 H23B 79.9 
113 C25 C22 C23 H23C -40.1 
114 C24 C22 C23 H23A 73.8 
115 C24 C22 C23 H23B -46.2 
116 C24 C22 C23 H23C -166.2 
117 O5 C22 C25 H25A -64.6 
118 O5 C22 C25 H25B 175.5 
119 O5 C22 C25 H25C 55.4 
120 C23 C22 C25 H25A 58.9 
121 C23 C22 C25 H25B -61.1 
 120 
122 C23 C22 C25 H25C 178.9 
123 C24 C22 C25 H25A -175.4 
124 C24 C22 C25 H25B 64.7 
125 C24 C22 C25 H25C -55.3 
126 O5 C22 C24 H24A -55.9 
127 O5 C22 C24 H24B -175.9 
128 O5 C22 C24 H24C 64.1 
129 C23 C22 C24 H24A -174.2 
130 C23 C22 C24 H24B 65.8 
131 C23 C22 C24 H24C -54.2 
132 C25 C22 C24 H24A 59 
133 C25 C22 C24 H24B -61 
134 C25 C22 C24 H24C 179 
135 C1 C2 C3 C4 -0.1(4) 
136 C1 C2 C3 H3A 179.9 
137 H2 C2 C3 C4 179.9 
138 H2 C2 C3 H3A -0.1 
139 H4 C4 C5 C6 -179.8 
140 H4 C4 C5 H5 0.2 
141 C3 C4 C5 C6 0.1(4) 
142 C3 C4 C5 H5 -179.9 
143 H4 C4 C3 C2 179.9 
144 H4 C4 C3 H3A -0.1 
145 C5 C4 C3 C2 -0.1(4) 
146 C5 C4 C3 H3A 179.9 
 121 
147 C1 C6 C5 C4 0.1(4) 
148 C1 C6 C5 H5 -180 
149 H6A C6 C5 C4 180 
150 H6A C6 C5 H5 0 
151 H34 C34 C37 C38 -178.6 
152 H34 C34 C37 C42 2.6 
153 C41 C34 C37 C38 1.5(4) 
154 C41 C34 C37 C42 
-
177.4(2) 
155 H34 C34 C41 C40 179.3 
156 H34 C34 C41 H41 -0.8 
157 C37 C34 C41 C40 -0.7(4) 
158 C37 C34 C41 H41 179.2 
159 H38 C38 C37 C34 178.8 
160 H38 C38 C37 C42 -2.3 
161 C39 C38 C37 C34 -1.2(4) 
162 C39 C38 C37 C42 177.7(3) 
163 H38 C38 C39 C40 -179.8 
164 H38 C38 C39 H39 0.2 
165 C37 C38 C39 C40 0.2(4) 
166 C37 C38 C39 H39 -179.8 
167 C34 C37 C42 O6 175.4(2) 
168 C34 C37 C42 C43 56.4(3) 
169 C34 C37 C42 C50 -67.4(3) 
170 C38 C37 C42 O6 -3.4(3) 
 122 
171 C38 C37 C42 C43 
-
122.4(3) 
172 C38 C37 C42 C50 113.7(3) 
173 H40 C40 C41 C34 179.7 
174 H40 C40 C41 H41 -0.2 
175 C39 C40 C41 C34 -0.3(4) 
176 C39 C40 C41 H41 179.8 
177 H40 C40 C39 C38 -179.5 
178 H40 C40 C39 H39 0.6 
179 C41 C40 C39 C38 0.5(4) 
180 C41 C40 C39 H39 -179.4 
181 H6 O6 C42 C37 96(2) 
182 H6 O6 C42 C43 -142(2) 
183 H6 O6 C42 C50 -21(2) 
184 C50 O8 C49 C54 63.5(3) 
185 C50 O8 C49 C53 -60.6(3) 
186 C50 O8 C49 C52 
-
178.7(2) 
187 C49 O8 C50 O7 -2.7(4) 
188 C49 O8 C50 C42 178.9(2) 
189 O8 C49 C54 H54A -68.1 
190 O8 C49 C54 H54B 172 
191 O8 C49 C54 H54C 51.9 
192 C53 C49 C54 H54A 54.2 
193 C53 C49 C54 H54B -65.8 
 123 
194 C53 C49 C54 H54C 174.1 
195 C52 C49 C54 H54A -179.8 
196 C52 C49 C54 H54B 60.3 
197 C52 C49 C54 H54C -59.8 
198 O8 C49 C53 H53A -54.1 
199 O8 C49 C53 H53B -174.2 
200 O8 C49 C53 H53C 65.9 
201 C54 C49 C53 H53A -176.6 
202 C54 C49 C53 H53B 63.4 
203 C54 C49 C53 H53C -56.5 
204 C52 C49 C53 H53A 57.6 
205 C52 C49 C53 H53B -62.4 
206 C52 C49 C53 H53C 177.7 
207 O8 C49 C52 H52A -59.5 
208 O8 C49 C52 H52B -179.4 
209 O8 C49 C52 H52C 60.6 
210 C54 C49 C52 H52A 57.3 
211 C54 C49 C52 H52B -62.6 
212 C54 C49 C52 H52C 177.4 
213 C53 C49 C52 H52A -176 
214 C53 C49 C52 H52B 64 
215 C53 C49 C52 H52C -56 
216 H43 C43 C42 C37 -62.3 
217 H43 C43 C42 O6 176.3 
218 H43 C43 C42 C50 58.6 
 124 
219 C55 C43 C42 C37 55.5(3) 
220 C55 C43 C42 O6 -65.9(3) 
221 C55 C43 C42 C50 176.4(2) 
222 B2 C43 C42 C37 
-
179.2(2) 
223 B2 C43 C42 O6 59.4(3) 
224 B2 C43 C42 C50 -58.3(3) 
225 H43 C43 C55 H55A 53.9 
226 H43 C43 C55 H55B -66.1 
227 H43 C43 C55 H55C 173.9 
228 C42 C43 C55 H55A -63.9 
229 C42 C43 C55 H55B 176 
230 C42 C43 C55 H55C 56.1 
231 B2 C43 C55 H55A 172.3 
232 B2 C43 C55 H55B 52.3 
233 B2 C43 C55 H55C -67.6 
234 H43 C43 B2 O9 -46.8 
235 H43 C43 B2 O10 130.7 
236 C42 C43 B2 O9 70.2(3) 
237 C42 C43 B2 O10 
-
112.3(3) 
238 C55 C43 B2 O9 
-
165.3(3) 
239 C55 C43 B2 O10 12.2(4) 
 125 
240 O7 C50 C42 C37 
-
101.7(3) 
241 O7 C50 C42 O6 17.7(3) 
242 O7 C50 C42 C43 135.0(3) 
243 O8 C50 C42 C37 76.8(3) 
244 O8 C50 C42 O6 
-
163.8(2) 
245 O8 C50 C42 C43 -46.5(3) 
246 C58 O9 B2 C43 
-
171.0(3) 
247 C58 O9 B2 O10 11.2(3) 
248 B2 O9 C58 C59 -22.8(3) 
249 B2 O9 C58 C61 96.6(3) 
250 B2 O9 C58 C63 
-
144.8(3) 
251 C59 O10 B2 C43 -171.1(3) 
252 C59 O10 B2 O9 6.6(4) 
253 B2 O10 C59 C58 -20.2(3) 
254 B2 O10 C59 C64 98.4(4) 
255 B2 O10 C59 C62 
-
143.8(3) 
256 O9 C58 C59 O10 25.7(3) 
257 O9 C58 C59 C64 -87.8(4) 
258 O9 C58 C59 C62 146.0(3) 
259 C61 C58 C59 O10 -88.3(4) 
 126 
260 C61 C58 C59 C64 158.1(4) 
261 C61 C58 C59 C62 31.9(5) 
262 C63 C58 C59 O10 144.0(3) 
263 C63 C58 C59 C64 30.4(5) 
264 C63 C58 C59 C62 -95.8(4) 
265 O9 C58 C61 H61A -61.1 
266 O9 C58 C61 H61B 178.8 
267 O9 C58 C61 H61C 58.8 
268 C59 C58 C61 H61A 50.6 
269 C59 C58 C61 H61B -69.4 
270 C59 C58 C61 H61C 170.6 
271 C63 C58 C61 H61A -179.3 
272 C63 C58 C61 H61B 60.7 
273 C63 C58 C61 H61C -59.4 
274 O9 C58 C63 H63A -66.6 
275 O9 C58 C63 H63B 173.4 
276 O9 C58 C63 H63C 53.3 
277 C59 C58 C63 H63A 179.1 
278 C59 C58 C63 H63B 59.1 
279 C59 C58 C63 H63C -60.9 
280 C61 C58 C63 H63A 49.6 
281 C61 C58 C63 H63B -70.4 
282 C61 C58 C63 H63C 169.5 
283 O10 C59 C64 H64A -69.3 
284 O10 C59 C64 H64B 170.8 
 127 
285 O10 C59 C64 H64C 50.8 
286 C58 C59 C64 H64A 42.5 
287 C58 C59 C64 H64B -77.5 
288 C58 C59 C64 H64C 162.6 
289 C62 C59 C64 H64A 172 
290 C62 C59 C64 H64B 52 
291 C62 C59 C64 H64C -67.9 
292 O10 C59 C62 H62A -67.7 
293 O10 C59 C62 H62B 172.4 
294 O10 C59 C62 H62C 52.4 
295 C58 C59 C62 H62A 176.2 
296 C58 C59 C62 H62B 56.3 
297 C58 C59 C62 H62C -63.7 
298 C64 C59 C62 H62A 48.1 
299 C64 C59 C62 H62B -71.8 
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The development of efficient methodologies that quickly and selectively build up 
complexity within a molecular scaffold is critical for the synthesis of existing pharmaceuticals 
and potential new bioactive molecules. This is best accomplished using methods that 
simultaneously generate new carbon-carbon bonds, which make up the backbone of organic 
molecules, introduce new functional groups that can serve as handles for further 
functionalization, and install stereocenters in high selectivity resulting in single enantiomer 
products. Tandem reactions have the potential to incorporate each of these desirable reaction 
features into a single transformation. In a tandem reaction, initial reactivity between two 
reaction components generates a new molecule, with inherently different reactivity than the 
starting materials, which can then participate in further reactions.1–4 This type of reaction is 
attractive for use with 1,1-diboronate ester reagents as they have two different modes of 
reactivity that could be selectively employed at different points of a reaction sequence. This 
would allow for the formation of a new carbon-carbon bond, installation of a boronate ester as a 
functional group, and generation of at least one new stereocenter. 
																																																						
1 A portion of this work appeared as a communication in the Journal of the American Chemical 
Society. The full reference is as follows: Murray, S. A.; Liang, M. Z.; Meek, S. J. J. Am. Chem. 
Soc. 2017, 139, 14061-14064. 
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Figure 2.1 General concept for proposed tandem reaction 
2.2 Background 
2.2.1 Previous work 
Tandem methodologies which set a new carbon-carbon bond and incorporate new 
functionality have been widely developed.1–5 A subsection of this methodology that is even more 
attractive are methodologies that construct two carbon-carbon bonds at the same carbon center 
through a single synthetic operation.6–19 A prototypical example is dithiane anion relay 
chemistry pioneered by Smith and coworkers. In this work, a dithiane unit can serve as a bis-
carbanion surrogate which allows two electrophiles to be coupled at the same carbon center 
(Figure 2.2).7–10,16–19 While this linchpin methodology is efficient for bond formation, as it 
generates two new carbon-carbon bonds in a single step, it typically does not introduce new 
stereocenters into the molecule. Other examples of dianion relay chemistry have been developed 
by Schaumann and coworkers and Utimoto and coworkers, which utilize silicon-induced 
multicomponent processes for the synthesis of cyclopentanols6 and dihalomethylene units in 
biselectrophile coupling reactions, respectively.11  
Dual cation/anion methodologies also exist. For example, Johnson and co-workers 
employ silyl glyoxylates for multicomponent reactions.12–15 In this approach, the silylglyoxylate 
reacts first as an electrophile through addition to the carbonyl. This then generates a tetrahedral 
intermediate poised to undergo a Brook rearrangement and produce a carbanion at the 
previously electrophilic carbon (2.14 to 2.15 in Figure 2.2). This carbanion then acts as a 
nucleophile and reacts with electrophiles such as carbonyls to complete the tandem process. 
This ultimately generates two new carbon-carbon bonds at the same carbon center and 












generates a new stereocenter in the process which is controlled by the chair-like transition states 
invoked in the second carbon-carbon bond forming event. 
 
Figure 2.2 Examples of dithiane anion relay chemistry 
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a. t-BuLi, Et2O, -78 to -45 ºC
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a. t-BuLi, Et2O, -78 to -45 ºC
b. -78 to -25 ºC
c. HMPA/Et2O, 












Figure 2.3 Silyl glyoxylates in multicomponent reactions 
2.2.2 Reaction design 
There are two different approaches to activating 1,1-diborylakanes: Lewis base activation 
and deprotonation. For Lewis base activation, a nucleophilic base adds into an empty p-orbital 
generating a negatively charged borate (left side of Figure 2.4). Some examples of bases 
typically used for boron activation include potassium hydroxide, lithium tert-butoxide, n-butyl 
lithium, and cesium fluoride. As the C-B bond of the activated boron unit is polarized towards 
carbon it can react as a nucleophile and results in loss of the boron-alkoxy group (a net 
deborylative pathway).  
The second method utilizes the increased acidity of the methylene protons of the gem-
diborylalkane which are markedly more acidic (pKa ~30)20,21 than those on an all carbon alkyl 
chain (right side of Figure 2.4). This allows for deprotonation of the methylene position 
followed by addition to an electrophile. In theory, these two modes of reactivity could be 
employed sequentially in a controlled manner, resulting in the formation of two different 











































Figure 2.4 Modes of activation of 1,1-diborylalkanes 
Epoxides are an attractive electrophile class for this reaction for a variety of reasons. 
First, epoxides are known to undergo ring opening when treated with organometallic reagents22–
24 such as organolithiums,25–28 organoborons,29 organocoppers,30,31 and Grignard reagents.32 
While some reactivity has also been shown between epoxides and diborylmethane in a 
deborylative process, this method has many limitations including a very specific substrate scope 
and selectivity issues.33  
In the proposed reaction, diborylmethane will be deprotonated with LTMP and the 
resulting boron stabilized carbanion will be used to open an epoxide (Figure 2.5). After the 
lithiated diboron reagent opens the epoxide, an alkoxide is generated at the 3-position relative 
to the new carbon-carbon bond that was formed (A in Figure 2.5). As previously mentioned, 
the second mode of reactivity of 1,1-diboronate esters is activation of a boryl group through 
coordination of an alkoxide or hydroxide base to the empty p-orbital on the boron generating a 
negatively charged borate species. The newly generated alkoxide can intramolecularly activate 
one of the boronate esters to form the chelated borate intermediate (B in Figure 2.5). This 
borate is then nucleophilic at carbon and can directly add to an electrophile or transmetallate to 
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Figure 2.5 Proposed epoxide opening utilizing deprotonated diborylmethane 
Precedent for using boron stabilized carbanions to open epoxides can be found in the 
work of Pelter and coworkers. As illustrated in Scheme 2.1, styrene oxide was efficiently 
opened by the boron stabilized carbanion 2.19 to give the 1,3-hydroxy boron compound 2.20 in 
81% yield and 4:3 syn:anti selectivity as determined by oxidation to the corresponding diol.29 
This illustrates that boron stabilized carbanions are sufficient nucleophiles for opening epoxides 
and therefore that deprotonated diborylmethane should be able to participate in a similar 
reaction. 
 
Scheme 2.1 Styrene oxide ring opening with boron stabilized carbanions 
Lewis base activation of boronate esters typically occurs through an intermolecular 
interaction between the p-orbital on the boron and an external base such as lithium tert-
butoxide or potassium hydroxide like what is seen in a Suzuki-Miyaura cross-coupling reaction34 
or our group’s 1,2-addition chemistry with aldehydes35 and ketoesters36. The need for an 
external strong base is often a limitation for this chemistry as any substrate used in the reaction 










































labile functional groups. There are also examples of intramolecular activation of boryl moieties 
as nucleophiles in which an amide serves as the activating group.37–39 Since the activation will 
occur through an intramolecular process, this methodology will not have the same limitations 
present in processes that require stoichiometric strong base.  
In addition to facilitating the second carbon-carbon bond forming event, the five 
membered chelate intermediate (B in Figure 2.5) formed through the opening of the epoxide 
has the potential to control stereochemistry in the second step and lead to a diastereoselective 
process. Stereodefined epoxides are readily available substrates that are easily made through 
stereoselective oxidation of alkenes40–43 or resolution of racemic epoxides.44 Using an 
enantioenriched epoxide for the ring opening step could theoretically lead to the formation of 
two diastereomers of the chelated intermediate (A and B in Figure 2.6). By developing 
reaction conditions that either preferentially formed one diastereomer (selective synthesis of A 
or B) over the other or that allowed for interconversion between them (equilibrium between A 
and B) with one preferentially reacting to give product over the other, a highly diastereoselective 
reaction could be achieved. The identity of the diastereomer of the product that is formed would 
be dependent on both the reactive chelate intermediate and the reaction pathway followed 
(invertive or retentive). Additionally, if the mechanism of the second reaction (inversion vs 
retention) could be controlled, potentially through changing the metal catalyst or reaction 
conditions,45 then all potential stereoisomers of the product could easily be obtained which is 




Figure 2.6 Potential reaction pathways to yield product from chelated intermediate 
2.3 Allylation of chelated borates derived from ring opening of epoxides by 
diborylmethane46 
In order to make use of this potential tandem bis-electrophile coupling reaction, an 
appropriate secondary reaction must be chosen to pair with the ring opening step. In theory, this 
reaction can be any of the well-studied, boron-based functionalizations that proceeds via an 
activated borate intermediate such as allylation, cross-coupling, or 1,2-addition. A reaction 
sequence consisting of an epoxide ring opening step followed by an allylation reaction was 
explored first. The goal was to establish a procedure for effectively opening the epoxide with the 
lithiated diborylmethane as well as conditions for an in situ allylation of the resulting chelated 
borate intermediate. 
2.3.1 Reaction development 
The initial reaction being studied is illustrated in Table 2.1. Treatment of 1,1-
diborylmethane with LTMP at 0 ºC for 10 minutes results in the formation of the lithiated 
intermediate 2.17. This is the same procedure as is used in the formation of the substituted 
diboron reagents outlined in Chapter 1. After 10 minutes at 0 ºC, styrene oxide (2.18) was 
added and the reaction was allowed to stir at 22 ºC for fifteen minutes. The solution of the ring 
opened intermediate was then treated with copper chloride and allyl chloride and allowed to stir 
































and 3:1 d.r. favoring the anti-product as illustrated in Table 2.1, Entry 1. This was a promising 
first result as it illustrated that the epoxide can in fact be opened by the carbanion of 
diborylmethane and that the chelated intermediate is reactive towards copper catalyzed 
allylation. Increasing the temperature to 45 ºC did not result in an increase in conversion to 
product and produced a lower dr of 2:1 (Table 2.1, Entry 2). While the decrease in 
diastereoselectivity was not desired, the change in the dr did indicate that there was potential to 
control the diastereoselectivity of the reaction by tuning the reaction conditions. Further heating 
the reaction to 60 ºC increased the conversion to product slightly to 58% and did not affect the 
dr (Table 2.1, entry 3).  
In an attempt to increase the conversion and diastereoselectivity of the reaction, the 
identity of the allyl coupling partner was explored. The use of an allyl phosphate was tolerated in 
the reaction and gave 45% conversion to product, however the diastereoselectivity further 
decreased from the allyl chloride result giving a 1:1 mixture of diastereomers (Table 2.1, Entry 
4). Allyl acetate was completely inactive in the reaction (Table 2.1, Entry 5). With allyl 
bromide as the allylating reagent, the product was formed in 77% conversion to product and 8:1 
dr (Table 2.1, Entry 6).  
With the optimal allylation reagent in hand, the optimization of the catalyst was 
undertaken. Copper (I) acetate resulted in a slight increase in diastereoselectivity to 10:1 
however, a more substantial decrease in conversion to 57% (Table 2.1, Entry 7). A similar 
decrease in yield was observed for copper (I) bromide (8:1 d.r. and 55% conversion) and copper 
(I) iodide (9:1 d.r. and 62% conversion) (Table 2.1, Entries 8 & 9).  
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Table 2.1 Tandem epoxide opening and allylation optimization studies 
 
The effect of a ligand on the conversion and diastereoselectivity of the reaction was 
explored next and is illustrated in Figure 2.7. While the use of BINAP as a ligand led to the 
desired product, other bidentate ligands such as Xantphos, dppb, and bdpp shut down 
reactivity. Interestingly, while the conversion is comparable between rac-BINAP and R-BINAP, 
a significant difference in diastereoselectivity was observed between the racemic and 
enantioenriched forms of the ligand. This suggests that there could be an important 
matched/mismatched relationship between the chiral intermediates generated in this reaction 
and the chirality on the ligand. While monodentate phosphines such as R-Monophos, 
triphenylphosphine, and tricyclohexylphosphine yielded product in decent to good yield, the 
diastereoselectivity decreased with all of these ligands to either 2:1 or 3:1. Lastly, NHC ligands 





a. THF, 22 ºC, 15 min
b. Cu salt (15 mol%)





entry X Cu salt temp (ºC) conv. (%)a drb
1 Cl CuCl 22 52 3:1
2 Cl CuCl 45 58 2:1
3 Cl CuCl 60 45 2:1
4 OP(OEt)3 CuCl 60 45 1:1
5 OAc CuCl 60 <2 -
6 Br CuCl 60 77 8:1
7 Br CuOAc 60 57 10:1
8 Br CuBr.dms 60 55 8:1
9 Br CuI 60 62 9:1
 Reactions performed under N2 atm. a Conversion to 2.19; values determined by 
analysis of 400, 500 or 600 MHZ 1H NMR spectra of unpurified mixtures with 
DMF as internal standard. b dr determined by oxidation to the corresponding diol 
and analysis of 1H NMR spectra
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achieved by changing the catalyst, the conditions in entry 6 of Table 2.1 that resulted in 77% 
conversion and 8:1 d.r. favoring the anti-product were deemed the best conditions and further 
optimization was not undertaken.  
 
Figure 2.7 Ligand optimization 
2.3.2 Substrate scope 
Having determined the optimized conditions for this reaction, the scope of the reaction 
was explored, first with respect to the epoxide. For ease of purification, the crude reaction 
material was subjected to silyl ether protection conditions to yield the resulting OTBS-B(pin) 
derivatives which were isolated via silica gel chromatography. A series of aryl epoxides was tried 





a. THF, 22 ºC, 15 min
b. Cu salt (15 mol%)
Ligand (15 mol%)
































































2.24) of the ring were all tolerated. While a slight decrease in yield was observed for the para 
substituted epoxides (2.23 and 2.24) an increase in diastereoselectivity was observed at 10:1 
and 13:1 respectively. Meta and ortho methyl substituted styrene oxide substrates both gave 
good yield and diastereoselectivity to the desired products. Di-substituted product 2.27, derived 
from a-methyl styrene oxide, was also tolerated in moderate yield, albeit lower 
diastereoselectivity, likely due the larger methyl group (relative to hydrogen) allowing for less 
differentiation than can occur when R2 is H. b-methylstyrene derived epoxide was also explored 
in this reaction, however this substrate resulted a low yield of a mixture of products with ring 
opening occurring at both the terminal and internal positions.  
 
Figure 2.8 Substrate scope - aryl epoxides 
One of the benefits of this reaction over previous 1,1-diboronate ester chemistry is the 
lack of stoichiometric strong alkoxide base in the reaction. In previous work, the presence of 
external alkoxide base has limited the substrates to aryl and other non-enolizable groups, such 





a. THF, 22 ºC, 15 min
b. CuCl (15 mol%)





































a Reactions performed under N2 atm. bYield represents isolated yield of purified material and is an average of two 





internal chelate and no strong base (after initial deprotonation of diborylmethane during which 
the epoxide is not present) is necessary for the reaction to proceed, a wider array of substrates 
was available for this transformation. Terminal alkyl epoxides (compounds 2.28 – 2.31) were 
tolerated in the reaction giving high yields however, slightly diminished diastereoselectivity was 
observed. This decrease in diastereoselectivity was expected based on the origin of stereocontrol 
in the reaction. The diastereoselectivity of this reaction is under complete substrate control. The 
observed selectivity is based on the steric interactions at play in the chelated intermediate and 
how it proceeds through the allylation step. Because of this, it is reasonable that the smaller 
alkyl substituted epoxides would give a lower level of diastereoselectivity than the larger, aryl 
substituted substrates. Simple alkyl substituents such as dodecyl (2.28) and cyclohexyl (2.29) 
both gave good yield however low diastereoselectivity. An epoxide containing a silyl protected 
alcohol yielded product in 80% yield and 3:1 diastereoselectivity (2.30).  
Cyclohexeneoxide (2.32) was the best alkyl derived substrate giving 74% yield as a single 
diastereomer. The rigid cyclic conformation of the ring likely contributed to the high level of 
diastereoselectivity observed with this substrate. High diastereoselectivity was found with 
limonene oxide however the product was only obtained in 42% yield (2.33). This is probably 
partially due to the fact that limonene oxide is sold as a mixture of isomers and one likely reacts 
faster than the other. Finally, b-pinene (2.34) derived epoxide gave a modest 60% yield and 
only 2:1 dr. 
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Figure 2.9 Substrate scope - alkyl epoxides 
The scope of the allyl bromide was then explored and is illustrated in Figure 2.10. It 
was observed through this study that the diastereoselectivity was also dependent on the allyl 
bromide used. Terminal substituted crotyl bromide yielded product 2.35 in modest yield and 
low diastereoselectivity. The decreased efficiency and selectivity of this reaction is most likely 
due to competing SN2 and SN2’ mechanisms which yield different products (both of which were 
observed). Allyl bromides substituted at the 2-position (2.36 and 2.40) gave good to excellent 
yield and high diastereoselectivity. The same product is achieved when these allyl bromides 
react through an SN2 or SN2’ mechanism which most likely helps increase the yield and 
selectivity. Terminally substituted geranyl and prenyl bromides yielded products 2.37 and 2.39 
in moderate yield and diastereoselectivity. The highest selectivity was observed with the internal 
cyclohexene derived bromide which gave 2.38 in 86% yield as a single diastereomer. 
Repositioning the olefin one carbon over inside the cyclohexene ring yielded product 2.42 in 





a. THF, 22 ºC, 15 min
b. CuCl (15 mol%)















































a Reactions performed under N2 atm. bYield represents isolated yield of purified material and is an average of two 











substrate for this reaction and no conversion to 2.41 was observed. Compound 2.43 which is 
derived from the corresponding bromodiene is obtained in 45% yield and 7:1 dr.  
 
Figure 2.10 Substrate scope - allyl bromides 
The last component of this reaction that can be changed to expand the scope of possible 
products is the diboron reagent. Substituted diboron reagents can be made simply by 
deprotonating diborylmethane with LTMP and quenching the resulting carbanion with the 
desired alkyl bromide or iodide.21,47 Following this protocol, diborylethane 2.42 can be easily 
synthesized by treatment of the diborylmethane derived carbanion with iodomethane.20  
The reactivity of diborylethane towards ring opening and allylation was then explored. 
Dodecene oxide was treated with 2.44 at 45 ºC for 24 h followed by addition of allylbromide 





a. THF, 22 ºC, 15 min
b. CuCl (15 mol%)








































































thf, 0 to 22 ºC
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mixture was subjected to hydrogen peroxide oxidation conditions which would result in the diol 
product if the reaction was successful. As shown in Scheme 2.2, b-hydroxyketone 2.46 was 
obtained instead of the desired diol. This product is the result of the efficient ring opening of the 
epoxide however a failed allylation step. The ketone is generated when the ring opened diboryl 
intermediate does not react further with the copper and allylbromide but is stable enough to 
survive the reaction conditions and then undergo oxidation upon the addition of hydrogen 
peroxide and sodium hydroxide. 
 
Scheme 2.2 Application of diborylethane in tandem epoxide opening and allylation reaciton 
2.3.3 Mechanistic studies 
Mechanistic studies were performed by following the progress of the reaction using NMR 
spectroscopy. Following the normal reaction conditions, diborylmethane was treated with LTMP 
at 0 ºC in deuterated THF. After stirring at 0 ºC for 10 minutes, styrene oxide was added and 
the reaction mixture was transferred to an NMR tube under N2. The NMR spectra presented in 
Figure 2.11 was obtained 10 minutes after addition of the epoxide to the deprotonated 
diborylmethane (in this time the reaction went from being a heterogeneous mixture to a 
homogeneous solution). The styrene oxide was completely consumed and the conversion to the 
chelated species was 73% as determined by comparison to an internal standard.  As is shown in 
Figure 2.11 and Figure 2.12, the dr between the chelated intermediates (labeled 2.47 and 
2.48 in Figure 2.11) is 56:44.  
O
2.44
a. THF, 45 ºC, 24 min
b. CuCl (15 mol%)
allylbromide














Figure 2.11 NMR reaction of styrene oxide with deprotonated diborylmethane. 
 
 
Figure 2.12 NMR spectrum of the reaction shown in Figure 2.11 
As illustrated in Figure 2.11, this chelated intermediate can take on two different 
diastereomeric forms depending on which boron forms the chelate with the alkoxy group. In 
theory, the observed high diastereoselectivity of this reaction can result from one of three 
reaction pathways. In the first path, one of the two diastereomers of the chelated intermediate 
will be formed selectively over the other and will react to give a single diastereomer of the 
product. Since both of the diastereomers are formed, as is seen in the NMR experiment, this is 






































Figure 2.13 Possible mechanistic pathways to achieve high diastereoselectivity 
In the second path, both diastereomers are formed but only one of them is reactive to 
give the desired product. Due to the high yield observed in many of the examples in the 
substrate scope, in order for this to be the case there would also need to be a pathway for 
interconversion between the two chelated intermediates. This interconversion would allow for 
the high yield and diastereoselectivity to be achieved. It was theorized that interconversion 
between the intermediates could be possible at the elevated temperature (60 ºC) that the 
reaction is conducted at. This was tested by heating the reaction to 60 ºC in the NMR 
spectrometer. The ratio did not change upon heating the sample to 60 ºC in the spectrometer or 
after 14 hours at 60 ºC (Figure 2.14). This data suggests that, under the reaction conditions, 
















Pathway 1: Selective formation of single diastereomeric intermediate






















































Figure 2.14 NMR spectra of epoxide opening reaction at 60 ºC 
Considering all of the NMR data, the observed selectivity must be related to the copper 
species and not the diboron intermediate. The first possibility is that the selectivity can come 
from the selective formation of one of the two possible copper chelated intermediates (only 
forms 2.51 or 2.52) which then results in the selective formation of the product. The second is 
that the copper intermediate is not formed selectively and that a Curtin-Hammett situation 
arises where the selective reaction of one of the intermediate diastereomers leads to product and 
there is a pathway for interconversion between these two intermediates (interconversion 
between 2.51 and 2.52).  
 
An attempt was made to follow the reaction via NMR after the addition of the copper 
catalyst. It was observed that both diastereomers of the borate intermediate were consumed at 
similar rates. This further confirmed the hypothesis that the diastereoselectivity was achieved 
through a copper species. In addition to seeing the disappearance of the two boron 
intermediates, once the copper was added to the reaction, a multitude of new peaks appeared 
between 4.6 and 5.2 ppm. This indicated that, upon addition of the copper and allyl chloride, 
multiple new species were observed. These new species most likely include both diastereomers 
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peaks and their overlapping nature, further mechanistic insights about the transmetallation and 
allylation steps could not be garnered from the NMR data.  
 
Figure 2.15 NMR spectra after the addition of CuCl and allyl chloride 
2.3.4 Product functionalizations 
In order to illustrate the versatility of the products obtained via this methodology, a 
variety of product functionalizations were undertaken. First, using conditions developed by 
Morken and coworkers,48 the boronate ester group in compound 2.22 was transformed into an 
amine via treatment with a solution of methoxy amine and n-butyl lithium. This afforded 
compound 2.53 in 85% yield. Compound 2.53 is a known intermediate in the synthesis of the 
natural product (+)-allo-sedamine which can be used to treat a variety of respiratory problems.49  
 
Scheme 2.3 Amination of protected 1,3-hydroxyboronate ester 
Next, two carbon-carbon bond forming functionalizations were carried out. The first was 
an alkene isomerization/allylation reaction. When compound 2.54 was treated with 
benzaldehyde in the presence of a palladium (I) catalyst, the olefin in 2.54 undergoes 
isomerization to generate the allyl boronate ester in situ.50 This species then undergoes a 1,2-













Scheme 2.4 Alkene isomerization and allylation of protected 1,3-hydroxyboronate ester 
The ability of these products to participate in Suzuki cross-coupling reactions was also 
explored. For the previous functionalization, the reactions were carried out on the isolated, TBS-
protected derivative of the product obtained from the allylation reactions. A different approach 
was taken for the cross-coupling reactions. Cross-coupling reactions were carried out on the free 
alcohols obtained as the product of the allylation reaction to show how useful this methodology 
could be for rapid installation of multiple functional groups in a complex molecule. Following an 
established cross-coupling procedure,51 compound 2.22 was treated with an aryl bromide and 
aqueous potassium hydroxide in the presence of a Pd-RuPhos catalyst system. Products 2.50, 
and 2.51 were obtained in 40% and 54% overall yield respectively from the starting epoxide. 
This sequence makes 3 new carbon-carbon bonds and sets one new stereocenter. 
 















a. THF, 22 ºC, 15 min
b. CuCl (15 mol%)





























70 ºC, 12 h
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Lastly, my co-worker Michael Liang carried out a series of sequential tandem coupling 
reactions in order to illustrate the iterative nature that these reactions can take on for the 
synthesis of 1,3-polyol motifs. As illustrated in Figure 2.17, following the standard ring 
opening/allylation reaction sequence previously discussed, compound 2.58 was synthesized in 
99% yield on a 5 mmol (1.03 g of product) scale. It was found that increasing the scale that the 
reaction was conducted on led to an increase in the yield of the reaction. This is most likely due 
to the reaction setup. Since the deprotonation must occur at 0 ºC, a cooled solution of LTMP in 
THF is cannula transferred to a cooled solution of diborylmethane. After 10 minutes, the 
epoxide is added to this reaction mixture via syringe. After the reaction has stirred at 22 ºC for a 
sufficient amount of time to allow for the epoxide to be fully opened by the diborylmethane, the 
solution is then cannula transferred to a separate vial containing the copper catalyst. The 
allylbromide is then added via syringe. Increasing the scale of the reaction likely increases the 
efficiency of these cannula transfers; a small amount being left behind in a transfer will not have 
as detrimental of an effect on the yield of a 5 mmol scale reaction as it will on a 0.1 mmol scale 
reaction (the scale at which all reaction optimization and substrates were tested at).  
After the isolation of the product from the first ring opening/allylation sequence, a 
vanadium catalyzed directed epoxidation followed by ketal protection was carried out to yield 
the terminal epoxide 2.59 in 55% yield and 25:3.5:1 dr. The second ring opening/allylation 
sequence was then carried out on the ketal epoxide to give the desired product, 2.60, in 75% 
yield and 4.5:1 dr as the diol after oxidation. This results in an overall yield of 41% for the 
formation of 4 carbon-carbon bonds and three stereocenters. 
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Figure 2.17 Sequential tandem reactions for the synthesis of 1,3-polyol motifs 
2.4 Enantioselective tandem allylation of ethylene oxide 
The allylation reaction presented thus far relies on substrate control to set the 
stereochemistry in the final product. This means that steric interactions within the molecule 
determine which diastereomer will be favored and to what degree. As is visible in the substrate 
scope, examples with more sterically demanding substituents or rigid ring systems tend to yield 
products in higher levels of selectivity than those with less sterically demanding substitution (ie 
2.22 vs 2.31). Another approach to setting stereochemistry is catalyst control. In this case, the 
selectivity is dependent upon the interactions between the catalyst and the bound substrate. 
This gives the potential for more control over the key interactions that lead to high levels of 
selectivity since the catalyst can be altered as needed without changing the identity of the 
product obtained from the reaction. Similar modifications to steric interactions present in a 
substrate-controlled reaction would typically lead to a different product being formed as the 





a. THF, 22 ºC, 15 min
b. CuCl (15 mol%)













a. V(O)(acac)2 (5 mol%)
t-BuOOH
b. 2,2-DMP, PPTS (10 mol%)
THF, 22 ºC, 24 h
2.59
55% Yield










a. THF, 45 ºC, 24 h
b. CuCl (15 mol%)








As shown in Figure 2.7, the identity of the catalyst had a profound effect on the 
diastereoselectivity of the allylation reaction. For example, using a catalyst system comprised of 
CuCl and rac-BINAP, a decrease in conversion and diastereoselectivity to 42% and 5:1 was 
observed and when a CuCl and triphenylphosphine catalyst system was employed the 
conversion remained higher at 65% but a substantial decrease in diastereoselectivity to 2:1 was 
observed (compared to 77% and 8:1 dr with just CuCl). While the decrease in yield and 
selectivity observed with these catalysts is undesired, the fact that the catalyst changed the 
selectivity at all was encouraging as it signified that there was the potential for a catalyst 
controlled system.  
One of the challenges with attempting an enantioselective variant of this reaction 
through a catalyst-controlled method is controlling the many stereoisomers that can be formed 
throughout the reaction. For example, using a racemic styrene oxide and a chiral catalyst to 
conduct an enatio- and diastereoselective tandem allylation reaction would be very challenging. 
The chiral catalyst would introduce another stereochemical component to the reaction therefore 
leading to four possible diastereomers (and their enantiomers) being formed. Selective 
formation or reaction through one specific diastereomer would be very difficult to control.  
Ethylene oxide was chosen as a model substrate for the development of a catalyst-
controlled enantioselective allylation reaction. Starting with ethylene oxide had many benefits. 
First, as an unsubstituted epoxide, the reaction will simply be an enantioselective reaction as 
opposed to both an enantio- and diastereoselective reaction. This simplification also decreases 
the number of possible diastereomers of intermediates in the reaction making it much more 
manageable as a starting point for a catalyst-controlled reaction. Lastly, the seemingly simple 
products that would be obtained from the ring opening and enantioselective allylation of 
ethylene oxide are not easy to make via other methodologies so developing a synthesis of them 
from simple building blocks such as ethylene oxide, diborylmethane, and allyl bromide is very 
attractive.  
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Using ethylene oxide as the model epoxide also presents some challenges. Since it is 
completely unsubstituted, achieving high levels of enantioselectivity could be quite difficult. A 
catalyst-controlled reaction relies on interactions between the catalyst and substrate that lead to 
preferential binding of the substrate in a specific orientation. An unsubstituted epoxide might 
not be sterically demanding enough to favor a specific binding orientation with the catalyst.  
The initial round of screening was conducted to determine the feasibility of the reaction 
from a reactivity standpoint without focusing on enantioselectivity. A series of chiral phosphine 
ligands were screened under conditions similar to those disclosed for the diastereoselective 
allylation reaction and the results are illustrated in Table 2.2. The primary modification, other 
than the catalyst identity, from the previously optimized conditions is the change in the identity 
of the limiting reagent. In the previous work, the epoxide always served as the limiting reagent 
with a slight excess (1.5 equivalents) of the diboron reagent. It was found through early reaction 
screening that this ratio led to the most efficient epoxide ring opening. Ethylene oxide is a gas 
but can also be used as a solution in a variety of solvents, including THF which is the solvent 
used for these tandem reactions. While using the solution of ethylene oxide makes the reaction 
far more user friendly than using the epoxide in its gaseous state, it is still not a perfect solution. 
Solutions of ethylene oxide in THF are sold under a concentration range as opposed to at a 
specific concentration. For example, the solution used in this chemistry had a molarity between 
2.5 and 3.3M. Because of this, it was difficult to use the ethylene oxide as the limiting reagent 
because the exact amount present in the reaction was unknown. Additionally, the highly volatile 
nature of ethylene oxide meant that the solution could easily change concentration from one day 
to the next. To avoid having to quantify the concentration of ethylene oxide in the solution prior 
to each reaction the epoxide was used in excess with the diborylmethane serving as the limiting 
reagent.  
 156 
Table 2.2 Catalyst screening for ethylene oxide allylation reaction 
 
As illustrated in Table 2.2, a variety of chiral phosphine ligands were initially screened 
for reactivity in this system. For ease of characterization, the initially formed crude 
hydroxyboronate ester 2.62 was oxidized in-situ to the corresponding diol 2.63. The highest 
conversion obtained in this screen was 47% utilizing a Josiphos ligand. Other ligands that gave 
promising results included BINAP, SegPhos, Me-DuPhos and OMe-biphep. One problem with 
this reaction that was observed early during reaction optimization was reproducibility. For 
example, using the same Josiphos ligand across three reactions led to conversions of 47%, 9%, 
and 7% and OMe-biphep gave 42%, 45% ad 26% over three reactions. This proved to be a 
problem present with other ligands as well and is most likely due to inconsistent formation of 
the cyclic borate intermediate.  
As mentioned previously, one of the main concerns associated with this reaction was the 
efficient formation of the chelated intermediate. In previous work, it had been observed that the 
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attempt was made to make and isolate the cyclic borate derived from ethylene oxide and 
diborylmethane (Scheme 2.5). A cooled solution of LTMP in THF was added to a solution of 
diborylmethane in THF at 0 ºC. After stirring at 0 ºC for 10 minutes, a solution of ethylene 
oxide in THF was added and the reaction was allowed to warm to room temperature and stir for 
15 minutes. The solvent was then removed under a stream of dry nitrogen gas and then the 
reaction vial was brought into the glovebox.  
 
Scheme 2.5 Isolation of chelated intermediate 
Inside the glovebox, the resulting solid residue was washed three times with hexanes and 
dried under vacuum. The 1H-NMR spectrum was obtained in d8-THF and matched what was 
expected for the cyclic borate intermediate. Two multiplets centered at 3.5 ppm were indicative 
of the protons at the base of the oxygen. Two multiplets centered at 1.5 and 1.7 ppm indicated 
the methylene protons on the carbon between the alcohol and the boron (see experimental for 
spectrum). The proton at the base of the two borons was found to be a multiplet centered at 0.1 
ppm which is in agreement with previous NMR studies conducted for the allylation chemistry. It 
appeared that the borate had been formed very cleanly on small scale. However, when the 
reaction was scaled up in an attempt to make enough to use directly in a reaction, it was no 
longer a clean reaction. Many new peaks were observed by NMR indicating either that the 
reaction did not go to completion or that other species were also being formed. While further 
attempts at isolating this species were not undertaken, the initial result shows promise that 
further optimization could lead to isolation of the cyclic borate intermediate in high yield and 
purity. 
Attempts to separate the enantiomers of the diol via chiral gas chromatography were 
unsuccessful and the lack of a strong chromophore in the molecule made separation on chiral 









crude hydroxyboronate ester was subjected to TBDPS protection conditions to result in the silyl 
protected hydroxyboronate ester. This approach had two main benefits. The first is that it 
allowed for easier visualization using the UV detector on an HPLC or SFC for quantification of 
the level of enantioselectivity of the reaction. Second, the silyl protected products tended to be 
more stable and easier to handle than the hydroxyboronate esters. While the tert-
butyldiphenylsilyl group made the product easy to track during chiral separations, it also made 
the product extremely nonpolar and therefore difficult to separate via HPLC or SFC methods. 
Oxidation of the silyl-protected 1,3-hydroxyboronate ester to the monoprotected 1,3-diol also 
did not result in a useful chiral assay. 
Due to the difficulties associated with developing an appropriate stereochemical assay 
for this reaction and the success of other projects at the time further exploration of a catalyst 
controlled, enantioselective allylation reaction was not undertaken. The work here illustrates 
that this reaction is feasible and further work to develop a good method for quantifying 
selectivity and further screening of ligands and reaction conditions could lead to improved 
results.  
2.5 Tandem palladium catalyzed cross-coupling reaction 
The Suzuki-Miyaura cross coupling reaction is one of the most well-known boron-based 
transformations in organic chemistry. In 2010 Suzuki shared the Nobel Prize in chemistry for 
developing the palladium catalyzed cross coupling reaction along with Richard Heck and Ei-ichi 
Negishi. The Suzuki reaction couples organoboron compounds with aryl halides using a 
palladium catalyst and a base. The palladium catalyst first undergoes oxidative addition into the 
aryl or vinyl halide. The base then serves to activate the boron species generating a four-
coordinate borate which can undergo transmetallation with the palladium complex to generate 
an organopalladium intermediate. Reductive elimination then occurs to yield the desired 
product. Over the years, the scope of this reaction has been expanded dramatically with regards 
to both the boron reagents and halides that can be used.34  
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Since the Suzuki reaction is facilitated by the formation of a borate species followed by 
transmetallation to a metal catalyst, it was theorized that the chelated intermediate generated 
upon addition of the deprotonated diborylmethane 2.17 to an epoxide could participate in a 
Suzuki cross-coupling reaction. Precedent was set for transmetallation to a metal catalyst 
through the copper catalyzed allylation work so it was possible that transmetallation to 
palladium would also be feasible.  
Initially, this reaction was explored using common conditions for Suzuki cross coupling 
reactions (Scheme 2.6). Ligands such as RuPhos, XPhos, and SPhos which are known to work 
well for Suzuki cross coupling reactions were employed with Pd(dba)2 as the metal source. 
Initial catalyst screening without additives did not result in conversion to the desired cross-
coupled product. Inclusion of a base additive such as cesium carbonate or potassium phosphate 
was explored but did not result in the desired product.  
 
Scheme 2.6 Initial tandem cross-couping reaction 
The results up to this point suggest that transmetallation to palladium was more difficult 
than the previously studied transmetallation to copper. Both Semba/Nakao52 and Brown45,53 
independently showed in 2014 that palladium catalyzed cross coupling reactions could be 
facilitated by the addition of a copper co-catalyst to the reaction.54 Since it is already known 
from the allylation chemistry that the cyclic borate is capable of transmetallating efficiently to 
copper, and there is precedent for copper and palladium co-catalyzed Suzuki reactions, a copper 
and palladium dual catalyst system was explored as a secondary reaction in this tandem process.  
Treating the in-situ generated borate intermediate derived from styrene oxide and 
diborylmethane with copper chloride, Buchwald’s Pd-RuPhos complex, and 4-bromotoluene at 
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and 4:1 dr after oxidation to the corresponding diol. A small catalyst screen focusing on the 
identity of the copper catalyst was then conducted to try to increase both the conversion and the 
diastereoselectivity of the reaction. It was found that while copper-NHC complexes were capable 
of catalyzing the reaction, the dr tended to decrease relative to when unligated copper was used. 
An increase in dr to 8:1 was observed when the loading was decreased to 2.5 mol%. Additionally, 
the temperature was increased from 60 ºC to 80 ºC to try and increase the conversion. While 
this did result in a slight increase in conversion, the dr decreased to 2:1.  
 
Scheme 2.7 Cu/Pd co-catalyst system for tandem cross-coupling 
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entry Copper Complex Palladiumb Ligand conv. (%)c drd
1 CuCl Pd precat RuPhos 57 4:1
2 CuCle Pd(dba)2 RuPhos 40 4:1
3 CuClf Pd(dba)2 RuPhos 35 8:1
4 CuIMesCl Pd precat RuPhos 37 2:1
5 CuSiAdCl RuPhos 47 2:1
6 CuSiMesCl RuPhos 39 2:1
aReactions performed under N2 atm. bPd precat refers to the palladcycle complex 
in Figure X. cConversion to 2.58; values determined by analysis of 400, 500 or 
600 MHZ 1H NMR spectra of unpurified mixtures with DMF as internal standard. 





While further optimization of the reaction was not undertaken at this time, these results 
illustrate that cross coupling of the cyclic borate intermediate is a viable process. To explore 
whether this process would also be applicable to alkyl epoxides, propylene oxide was subjected 
to the reaction conditions and the desired product 2.59 was obtained in 57% conversion and 4:1 
dr. While the yield and diastereoselectivity are low for both of these examples, the fact that both 
alkyl and aryl epoxides are tolerated under these unoptimized reaction conditions is promising 
for future work on this project.  
 
Scheme 2.8 Tandem cross-coupling with propylene oxide 
2.6 Diastereoselective protonation of substituted cyclic borate species 
As previously mentioned in section 2.3.2 on the copper-catalyzed tandem allylation 
reaction, substituted gem-diborylalkanes, such as diborylethane, are capable of participating in 
the ring opening reaction with epoxides at elevated temperatures, however they are incapable of 
undergoing a subsequent copper catalyzed allylation reaction (Scheme 2.2). This does not 
mean that there are no other reactions that these substituted intermediates can participate in. 
The addition of the methyl group in diborylethane appears to bring enough additional steric 
hindrance to the system to prevent reactivity with the copper allyl species. Because of this, in 
order for a secondary reaction to be feasible on these substituted intermediates, it must utilize a 
very small, unhindered electrophile. The best reaction to begin with for these systems is 
therefore a simple diastereoselective protodeboration reaction.  
In 2010, Aggarwal and coworkers showed that enantioenriched tertiary boronate esters 
could participate in a stereospecific protodeboronation reaction to give enantioenriched tertiary 
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hours to give high yields and enantiospecificity of the desired products as illustrated in Scheme 
2.9. If this reaction could be employed as a secondary reaction in the tandem epoxide opening 
chemistry it would result in the diastereoselective synthesis of 1,3-hydroxyboronate esters.  
 
Scheme 2.9 Aggarwal's stereospecific protodeporation 
To test this protodeboronation reaction in the tandem system, R-styrene oxide was 
treated with deprotonated diborylethane and heated to 45 ºC for 24 hours to facilitate the ring 
opening reaction (Scheme 2.10). This mixture was then transferred to a vial containing cesium 
fluoride followed by the addition of water. The reaction was again heated to 45 ºC for 24 hours. 
After oxidation, the desired diol product was obtained in 43% conversion and 8:1 dr favoring the 
anti-product (2.59) with 28% returned styrene oxide indicating that the reaction could become 
higher yielding if the ring opening was more efficient. These results illustrated a promising proof 
of concept for this reaction.  
 
Scheme 2.10 Protodeboration reaction utilizing diborylethane and styrene oxide 
Using gem-diborylalkane 2.70, which contains an allyl substituent, in this methodology 
would yield the same products obtained in the copper catalyzed allylation reaction when 
diborylmethane was utilized to open the epoxide. It was theorized that using this protonation 
approach could result in a higher level of diastereoselectivity for some of the alkyl substrates 
that yielded products in low dr with the copper allylation methodology. To test this, dodecene 
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1. THF, 45 ºC, 24 h
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mixture was then transferred to a vial containing CsF and water was added to the reaction. After 
24 hours at 45 ºC, the product was observed in 60% conversion and 2:1 dr. This is both a 
decrease in conversion and diastereoselectivity relative to the copper catalyzed methodology 
(73% yield, 3:1 dr). The size difference between the dodecyl substituent and the allyl group must 
not be significant enough to favor one diastereomer of the chelated intermediate over the other. 
Further optimization of the reaction conditions and exploration of the substrate scope will 
further develop this initial study into a useful reaction. 
 
Scheme 2.11 Protodeboration reaction utilizing an allyl substituted 1,1-diboronate ester and 
dodecene oxide 
2.7 Conclusions46 
A method for the stereoselective linchpin coupling of 1,1-diborylmethane with epoxides 
and allyl electrophiles was developed. This method takes advantage of the acidity of 1,1-
organodiboronates to generate a reactive boron stabilized carbanion which can undergo a ring 
opening reaction with an epoxide. The alkoxy group generated from the ring opening can then 
chelate to one of the boronate esters thereby activating it for further reactivity. Introduction of a 
copper catalyst and allyl electrophile generated the allylation products in good yield and 
diastereoselectivity. The mechanism was studied via NMR spectroscopy and it was determined 
that interconversion between the two diastereomers of the boron chelated intermediate does not 
occur and that copper plays a role in the high levels of diastereoselectivity observed. The 
versatility of the products was illustrated via amination, isomerization/allylation, and cross-
coupling functionalizations. The usefulness of this transformation for iterative processes was 
illustrated through the synthesis of a 1,3-polyol motif via sequential ring opening and allylation 
reactions. Initial development of an enantioselective, catalyst-controlled tandem ring opening 
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borate intermediate to other borate based reactions were also studied. The borate species was 
found to participate in cross-coupling and protodeboronation reactions. 
2.8 Experimental46 
2.8.1 General 
All reactions were carried out in oven-dried (150 ºC) or flame dried glassware under 
inert atmosphere of dried nitrogen unless otherwise noted. Analytical thin-layer 
chromatography was performed on glass plates coated with 0.25 mm of 60 Å mesh silica gel. 
Plates were visualized by exposure to UV light (254 nm) and/or immersion into Seebach’s or 
KMnO4 stain followed by heating. Column chromatography using silica gel was performed using 
P60 (mesh 230-400) supplied by Silicycle. All solvents were sparged with argon and then 
purified under a positive pressure of argon through an SG Water, USA Solvent Purification 
System. Tetrahydrofuran (Omnisolv) was passed successively through two columns of neutral 
alumina. The ambient temperature in the laboratory was approximately 22 ºC. 
2.8.2 Instrumentation 
All 1H NMR spectra were recorded on Bruker Spectrometers (AVANCE-600, Bruker 500, 
and DRX 400).  Chemical shifts are reported in ppm from tetramethylsilane and referenced to 
the residual protio solvent peak (CDCl3: δ 7.26; C6D6: δ 7.16; THF-d8 δ 3.58). Data are reported 
as follows: chemical shift, multiplicity (s = singlet, d = doublet, t = triplet, qu = quartet, quint = 
quintet, br = broad, m = multiplet, app = apparent), integration, and coupling constants are 
given in Hz. 13C NMR spectra were recorded on Bruker Spectrometers (AVANCE-600 and 
Bruker 500) with carbon and proton decoupling. Chemical shifts are reported in ppm from 
tetramethylsilane and referenced to the residual protio solvent peak (CDCl3: δ 77.16; C6D6: δ 
128.06).  11B NMR spectra were recorded on a Bruker model 500 MHz spectrometer. All IR 
spectra were recorded on a Jasco 260 Plus Fourier transform infrared spectrometer.  Low-
resolution mass spectrometry samples were analyzed with a hybrid LTQ FT (ICR 7T) 
(ThermoFisher, Bremen, Germany) mass spectrometer. Samples were introduced via a 
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microelectrospray source at a flow rate of 10 µL/min in methanol. Xcalibur (ThermoFisher, 
Breman, Germany) was used to analyze the data. Molecular formula assignments were 
determined with Molecular Formula Calculator (v 1.2.3). All observed species were singly 
charged, as verified by unit m/z separation between mass spectral peaks corresponding to the 
12C and 13C12Cc-1 isotope for each elemental composition. High-resolution mass spectrometry 
samples were analyzed using an HPLC system that consisted of an Agilent 1200 (Agilent, 
Waldbronn, Germany) binary pump (G1312A) operating at a flow-rate of 0.3 mL min−1. The 
solvents were degassed using an on-line membrane system (Agilent G1379A). The column was 
maintained in a thermostated compartment at 40 °C (Agilent G1316A). The diode array detector 
was an Agilent G1315D operating at three wavelengths of 250, 254 and 280 nm. Separation was 
performed on a Waters Acquity UPLC BEH C18 column (2.1 x 50 mm, 1.7 um particle size). The 
injection (5 µL) was performed using an autosampler (Agilent G1329A). LC conditions were set 
at water with 0.1% formic acid (A) for 1 min before ramping linearly over 5 mins to 100% 
acetonitrile with 0.1% formic acid (B) and then switched back to 100% A and allowed to re-
equilibrate until 10 min. The HPLC system was coupled to the Q-TOF via a dual ESI interface 
operating in positive ion mode using a capillary voltage of +3.5 kV. The other optimum values of 
the ESI-TOF parameters were drying gas temperature, 325 °C; drying gas flow, 5 L min−1 and 
nebulizing gas pressure, 15 psi. The detection was carried out considering a mass range of 100–
1500 m/z. Prior to acquiring samples, an external instrument calibration was performed using 
Agilent ESI-L Low Concentration Tuning Mix. MassHunter Quantitative Analysis (Agilent, 
Waldbronn, Germany) was used to analyze the data. Solutions were dissolved in MeOH at 0.1 
mg/mL or less and diluted appropriately based on responsiveness to the ESI mechanism. 
Molecular formula assignments were determined with Molecular Formula Calculator (v 1.2.3). 
The success of mass data for molecular ions was considered based on the widely-accepted 
accuracy threshold for confirmation of elemental compositions established at 5 ppm. All 
observed species were singly charged, as verified by unit m/z separation between mass spectral 
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peaks corresponding to the 12C and 13C12Cc-1 isotope for each elemental composition. Optical 
rotations were determined using a Jasco P1010 polarimeter and concentrations are reported in 
g/100mL.  Enantiomeric ratios were determined on a Waters Acquity UPC2 instrument at 22 ºC 
using ACQUITY UPC2 Trefoil CEL2 (2.1mm x 50 mm x 2.5µm) column and Waters PDA detector 
set to 210 nm. 
2.8.3 Reagents 
Allylbenzene was purchased from Alfa Aesar and used as received. 
Allylbromide was purchased from Sigma Aldrich, plugged through neutral alumina before use 
and stored under nitrogen in the refrigerator.  
Alpha-methylstyrene was purchased from Alfa Aesar and used as received.  
Ammonium chloride was purchased from Alfa Aesar and used as received. 
Benzene-d6 was purchased from Cambridge Isotope Laboratories and used as received. 
(-)-Beta-pinene was purchased from TCI America and used as received. 
Bis(dibenzylideneacetone)palladium (0) (Pd(dba)2) was purchased from Strem, stored 
in a nitrogen filled glovebox, and used as received.  
2-bromonapthalene was purchased from Alfa Aesar and used as received. 
3-bromo-2-bromomethyl-1-propene was purchased from Sigma Aldrich, plugged through 
neutral alumina before use, and stored under nitrogen in the refrigerator. 
3-bromocyclohexene was purchased from Acros, plugged through neutral alumina before 
use, and stored under nitrogen in the refrigerator.  
3-bromo-2-methylpropene was purchased from Sigma Aldrich, plugged through neutral 
alumina before use, and stored under nitrogen in the refrigerator.  
4-bromotoluene was purchased from Alfa Aesar, recrystallized from ethanol, dried via 
azeotropic distillation from benzene, and stored in a nitrogen filled dry box.   
Bromo(tri-tert-butylphosphine)palladium(I) dimer was purchased from Strem, stored 
in a -20 ºC freezer in a nitrogen filled glovebox, and used as received. 
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Chloroform-d (CDCl3) was purchased from Cambridge Isotope Laboratories and used as 
received.  
Copper (I) chloride was purchased from Strem Chemicals and kept in a nitrogen filled dry 
box. 
Copper (I) tetrakisacetonitrile hexafluorophosphate was purchased from Sigma Aldrich 
and kept in a nitrogen filled dry box. 
Cyclohexene oxide was purchased from Alfa Aesar and used as received. 
2-Dicyclohexylphosphino-2ʹ,6ʹ-diisopropoxybiphenyl (RuPhos) was purchased from 
Sigma Aldrich, stored in a nitrogen filled glovebox, and used as received.  
Trans-crotylbromide was purchased from Acros, plugged through neutral alumina before 
use, and stored under nitrogen in the refrigerator. 
1,2-dichloroethane (DCE) was purchased from Sigma Aldrich, dried over calcium hydride, 
distilled onto 3Å molecular sieves, and stored in a nitrogen filled glovebox.  
1-dodecene was purchased from Alfa Aesar and used as received.  
3,3-dimethylallyl bromide was purchased from Sigma Aldrich and plugged through neutral 
alumina before use.  
Dimethylformamide (DMF) (Anhydrous) was purchased from EMD and used as received. 
Diborylmethane was prepared according to literature procedures35 and matched literature 
spectra. It was purified via silica gel chromatography, dried via azeotropic distillation from 
benzene, and stored in a nitrogen filled glovebox. 
Diborylethane was prepared according to literature procedure35 and matched literature 
spectra. It was purified via silica gel chromatography, dried via azeotropic distillation from 
benzene and stored in a nitrogen filled glovebox. 
4-fluorostyrene was purchased from Alfa Aesar and used as received  
Geranylbromide was purchased from Sigma Aldrich, plugged through neutral alumina before 
use, and stored under nitrogen in the refrigerator.  
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Hydrogen peroxide (30%) was purchased from Fisher Scientific, stored in the freezer, and 
used as received.  
Imidazole was purchased from Alfa Aesar and used as received.  
(+)-Limonene oxide, mixture of cis and trans was purchased from Sigma Aldrich and 
dried via azeotropic distillation from benzene. 
Lithium 2,2,6,6-tetramethylpiperidide (LTMP) was purchased from Sigma Aldrich and 
kept in a nitrogen filled dry box.  
2-methylstyrene was purchased from Alfa Aesar and used as received.  
3-methylstyrene was purchased from Alfa Aesar and used as received.  
4-methylstyrene was purchased from Alfa Aesar and used as received.  
Palladium 10% wt on activated carbon (wet) was purchased from Aldrich and used as 
received. 
Pd-RuPhos precataylst was synthesized according to known literature procedure and 
matched literature spectra.56 
(R)-BINAP was purchased from Strem Chemicals and stored in a nitrogen filled dry box.  
(R)-Styrene oxide was purchased from Sigma Aldrich and dried via azeotropic distillation 
before use.  
Styrene was purchased from Alfa Aesar and used as received.  
Tert-butyldimethylchlorosilane was purchased from Alfa Aesar and used as received.  
tert-Butyldimethylsilyl (R)-(-)-glycidyl ether was purchased from Sigma Aldrich and used 
as received.   
Vinylcyclohexane was purchased from Alfa Aesar and used as received. 
2.8.4 General procedures 
General procedure for the synthesis of epoxides  
Epoxides yielding products 2.22-2.34 were synthesized according to the following general 
procedure. All epoxides matched known literature spectra.   
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2-methylstyrene (2.2 mL, 17 mmol) was dissolved in DCM (100 mL) in a 250 mL single neck 
round bottom flask containing a stirbar. Solid NaHCO3 was added to the flask and the reaction 
was cooled to 0 ºC in an ice bath. The flask was then fitted with an addition funnel containing 
mCPBA (6.5g, 18.7 mmol) dissolved in DCM (70 mL). The mCPBA solution was added dropwise 
through the addition funnel over 15 minutes. The reaction was then stirred at 0 ºC for an 
additional 15 minutes and then allowed to warm to room temperature and stirred overnight. The 
mixture was then transferred to a separatory funnel and the organics were washed twice with a 
saturated solution of sodium carbonate and twice with saturated sodium thiosulfate. The 
organics were then dried over sodium sulfate, concentrated, and purified via silica gel 
chromatography to give the desired epoxide as a clear oil (1.76 g, 77%). The epoxide was dried 
via azeotropic distillation from benzene prior to use.  
General procedure for the copper catalyzed three-component allylation reaction 
 
In a nitrogen filled glovebox, diborylmethane (40.2 mg, 0.15 mmol) was weighed into an 8-mL 
vial equipped with a magnetic stir bar. The diborylmethane was dissolved in THF (0.4 ml) and 
the vial was sealed with a septa-lined cap and taped. Lithium 2,2,6,6-tetramethylpiperidide 
(LTMP) (22.8 mg, 0.155 mmol) was weighed into a separate 8-mL vial, dissolved in THF (0.8 
mL) and sealed with a septum lined cap and tape. Copper (I) chloride (1.5 mg, 0.015 mmol) was 
weighed into a third 8-mL vial with a magnetic stir bar and sealed with a septum lined cap and 
mCPBA, NaHCO3
DCM
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tape. The vials were removed from the glovebox and the diborylmethane and LTMP solutions 
were cooled to 0 ºC in an ice water bath. The LTMP solution was transferred via cannula to the 
diborylmethane solution at 0 ºC, and this was solution was allowed to stir at 0 ºC for 10 
minutes. The epoxide (0.1 mmol) was then added via syringe and the solution was brought to 
the correct temperature for the epoxide used and stirred for the necessary time. 
(Monosubstitued epoxides: 15 min at 22 ºC; Di- or ortho-substituted epoxides: 24 hr at 22 ºC; 
trisubstituted epoxides: 24 hr at 45 ºC). The reaction was then returned to room temperature 
and transferred via cannula to the vial containing the copper chloride. Allyl bromide (26 µl, 0.3 
mmol) was then added to the reaction via syringe. The reaction was then sealed with tape and 
allowed to stir at 60 ºC for 24 h. The mixture was then cooled to room temperature and 
quenched with a saturated solution of aqueous ammonium chloride, extracted with diethyl ether 
(x3), dried over magnesium sulfate, filtered, and concentrated in vacuo. For unsubtituted 
allyl bromides: Imidazole (20 mg, 0.3 mmol) and a magnetic stir bar were then added to the 
vial. The vial was sealed with a septum cap and flushed with dry N2. Tert-
butyldimethylchlorosilane (45 mg, 0.3 mmol) was quickly added to the vial and the vial was 
again purged with N2. Dry dimethylformamide (0.6 mL) was then added through the septum 
cap via syringe. The reaction was stirred at 22 ºC for 24 h. The reaction was then quenched with 
a saturated solution of ammonium chloride, extracted with diethyl ether, dried over magnesium 
sulfate, filtered, and concentrated in vacuo. The residue was purified via silica gel 
chromatography (50:1 Hexanes:Et2O, gravity) to yield the desired product. For substituted 
allyl bromides: The crude mixture was dissolved in THF (0.25 mL), a stir bar was added, and 
the reaction was cooled to 0 ºC in an ice water bath. NaOH (3 M, 0.25 mL) and H2O2 (30%, 0.16 
mL) were added. The reaction was sealed with a septum lined cap that was pierced with a vent 
needle and allowed to warm to room temperature and stir for 3 hours. The reaction was then 
cooled to 0 ºC in an ice water bath. The reaction was quenched with a saturated solution of 
sodium thiosulfate, extracted with diethyl ether (x3), dried over magnesium sulfate and 
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concentrated in vacuo. The resulting crude mixture was purified via silica gel chromatography 
(4:1 hexanes:ethyl acetate to 1:1 hexanes:ethyl acetate). Excess pinacol was then removed via 
azeotropic distillation on a rotary evaporator using a 1:1 mixture of water and methanol with a 
55 ºC water bath.  
Note: For Table 2.1 and Figure, yields and diastereomeric ratios were determined using DMF 
as an NMR internal standard. In cases where diastereomeric ratio could not be clearly 
determined in the crude NMR of the hydroxy boronate ester product, oxidation with sodium 
hydroxide and hydrogen peroxide was carried out and the ratio was determined using the crude 
diol obtained.   
2.8.5 Product characterization 
 
Tert-butyldimethyl(((1S,3R)-1-phenyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-
yl)hex-5-en-1-yl)oxy)silane (2.22). Following the general procedure, protected 1,3-
hydroxyboronate ester 2.22 was isolated in 56% yield and 8:1 dr (23.4 mg) as a clear oil.  
1H NMR (600 MHz, C6D6) d 7.46 (dd, J = 8.1, 1.4 Hz, 2H), 7.19 (t, J = 7.7 Hz, 2H), 7.11 - 7.05 
(m, 1H), 5.97 (ddt, J = 17.0, 10.2, 6.8 Hz, 1H), 5.12 (dq, J = 17.0, 1.5 Hz, 1H), 5.04 - 4.98 (m, 1H), 
4.94 (dd, J = 7.2, 5.8 Hz, 1H), 2.46 - 2.29 (m, 2H), 2.02 (dd, J = 8.3, 5.8 Hz, 2H), 1.71 (m, 1H), 
1.07 (s, 6H), 1.07 (s, 6H), 1.02 (s, 8H), 0.20 (s, 3H), -0.05 (s, 3H). 13C NMR (151 MHz, C6D6) d 
146.9, 138.8, 128.5, 127.3, 126.3, 115.3, 83.0, 75.7, 43.3, 36.4, 26.3, 25.2, 24.9, 18.5, -4.1, -4.5. IR 
(n/cm-1): 2928(m), 2857 (m), 1381 (m), 1144 (s), 1059 (m), 700 (m). MS (ESI+): [M+Na]+ 
calcd for C24H41BO3SiNa+ 439.28, found 439.45. [a]22D = -25.4 (c =0.295, CH2Cl2, l = 100 mm). 
Relative stereochemistry of 2.22 was determined via conversion of crude hydroxy boronate 





(1S,3R)-1-phenylhex-5-ene-1,3-diol (2.75). The reaction was performed following the 
general procedure using (R)-styerene oxide (60.1 mg, 0.5 mmol). The crude mixture was 
dissolved in THF (0.25 mL), a stir bar was added, and the reaction was cooled to 0 ºC in an ice 
water bath. NaOH (3M, 0.25 mL) and H2O2 (30%, 0.16 mL) were added. The reaction was sealed 
with a septum lined cap that was pierced with a vent needle and allowed to warm to room 
temperature and stir for 3 hours. The reaction was then cooled down to 0 ºC in an ice water 
bath. The reaction was quenched with a saturated solution of sodium thiosulfate, extracted with 
diethyl ether (x3), dried over magnesium sulfate and concentrated in vacuo. The resulting crude 
mixture was purified via silica gel chromatography (2:1 hexanes:ethyl acetate). Excess pinacol 
was then removed via azeotropic distillation on the rotary evaporator using a 1:1 mixture of 
water and methanol with a 55 ºC water bath to give diol 2.75 in 56% yield (10.7 mg) and 8:1 dr 
as a white solid. 1H-NMR spectra matched the literature spectra for the anti-diol.57  
Major Diastereomer: 
1H NMR (600 MHz, CDCl3) δ 7.50 – 7.34 (m, 4H), 7.34 – 7.29 (m, 1H), 5.87 – 5.69 (m, 1H), 
5.26 – 5.13 (m, 2H), 5.09 (dd, J = 8.1, 3.4 Hz, 1H), 3.95 (tdd, J = 8.0, 4.9, 3.0 Hz, 1H), 3.06 (s, 
1H), 2.40 (s, 1H), 2.36 – 2.21 (m, 2H), 2.04 – 1.84 (m, 2H). [a]22D = -35.9 (c =0.03, CH2Cl2, l = 
100 mm). 
To prove that stereochemistry of the epoxide is maintained throughout the reaction, diol 2.75 
was synthesized from both racemic styrene oxide and R-styrene oxide. As illustrated by the SFC 
traces, no erosion of stereochemistry occurs in this reaction. 









Anti Diastereomer: Major enantiomer: 2.259 min; Minor enantiomer: 2.881 min; 99.5:0.5 
er. 




5-en-1-yl)oxy)silane (2.23). Following the general procedure, protected 1,3-hydroxyboronate 
ester 2.23 was isolated in 53% yield and 10:1 dr (22.7 mg) as a clear oil. 1H NMR (600 MHz, 
CDCl3) d 7.17 (d, J = 8.0 Hz, 2H), 7.08 (d, J = 7.8 Hz, 2H), 5.77 (ddt, J = 17.0, 10.1, 6.9 Hz, 1H), 
4.99 (dt, J = 17.1, 1.7 Hz, 1H), 4.92 (ddd, J = 9.0, 2.3, 1.1 Hz, 1H), 4.62 (t, J = 6.4 Hz, 1H), 2.32 
(s, 3H), 2.15 (ddd, J = 5.4, 4.2, 2.4 Hz, 2H), 1.67 (dd, J = 7.8, 6.2 Hz, 2H), 1.24 (s, 12H), 0.86 (s, 
9H), 0.01 (s, 3H), -0.20 (s, 3H). 13C NMR (151 MHz, CDCl3) d 143.6, 138.5, 136.3, 128.8, 125.9, 
115.2, 83.1, 83.1, 75.0, 42.7, 36.0, 26.1, 26.1, 25.2, 24.9, 21.3, 18.4, -4.3, -4.7. IR (n/cm-1): 2928 
(m), 1381 (s), 1251 (m), 1145 (s), 836 (s). MS (ESI+): [M+Na]+ calcd for C25H43BO3SiNa+ 
453.30, found 453.45. 
  
Tert-butyl((1-(4-fluorophenyl)-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)hex-
5-en-1-yl)oxy)dimethylsilane (2.24). Following the general procedure, protected 1,3-
hydroxyboronate ester 2.24 was isolated in 45% yield and 14:1 dr (19.6 mg) as a clear oil.  
1H NMR (600 MHz, CDCl3) d 7.24 (dd, J = 8.6, 5.6 Hz, 2H), 6.97 (t, J = 8.7 Hz, 2H), 5.76 (ddt, 
J = 17.0, 10.1, 6.9 Hz, 1H), 4.99 (dd, J = 17.0, 1.8 Hz, 1H), 4.96 - 4.92 (m, 1H), 4.64 (t, J = 6.5 
Hz, 1H), 2.23 - 2.08 (m, 2H), 1.65 (dd, J = 8.0, 5.9 Hz, 2H), 1.38 - 1.27 (m, 1H), 1.24 (s, 12H), 
0.86 (s, 9H), 0.01 (s, 3H), -0.21 (s, 3H). 13C NMR (151 MHz, CDCl3) δ 161.9 (d, J = 243.8 Hz), 
142.3 (d, J = 2.9 Hz), 138.4, 127.5 (d, J = 7.8 Hz), 115.3, 114.9 (d, J = 21.2 Hz), 83.2, 74.5, 42.6, 












tolyl)hex-5-en-1-yl)oxy)silane (2.25). Following the general procedure, protected 1,3-
hydroxyboronate ester 2.25 was isolated in 70% yield and 10:1 dr (30 mg) as a clear oil.  
1H NMR (600 MHz, CDCl3) δ 7.16 (t, J = 7.5 Hz, 1H), 7.11 – 7.06 (m, 2H), 7.04 – 6.99 (m, 1H), 
5.78 (ddt, J = 17.0, 10.1, 6.9 Hz, 1H), 4.99 (dd, J = 17.1, 1.9 Hz, 1H), 4.96 – 4.89 (m, 1H), 4.62 
(dd, J = 7.6, 5.2 Hz, 1H), 2.33 (s, 3H), 2.17 (dddd, J = 6.8, 5.3, 4.1, 1.3 Hz, 2H), 1.68 (ddd, J = 
7.2, 5.3, 1.7 Hz, 2H), 1.37 (dq, J = 9.0, 6.8 Hz, 1H), 1.25 (s, 12H), 0.87 (s, 9H), 0.02 (s, 3H), -0.20 
(s, 3H). 13C NMR (151 MHz, CDCl3) δ 146.5, 138.5, 137.5, 127.9, 127.6, 126.7, 123.1, 115.2, 83.1, 
75.2, 42.7, 36.1, 26.1, 25.3, 24.9, 21.7, 18.4, -4.3, -4.7. IR (n/cm-1): 2928 (b, m), 1471 (m), 1380 
(s), 1319 (m), 1254 (s). MS (ESI+) [M+Na]+ calcd for C25H43BO3SiNa+ 453.30, found 453.45. 
  
Tert-butyldimethyl((3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1-(o-tolyl)hex-
5-en-1-yl)oxy)silane (2.26). Following the general procedure, protected 1,3-hydroxyboronate 
ester 2.26 was isolated in 61% yield and >20:1 dr (26.4 mg) as a clear oil. 1H NMR (600 MHz, 
CDCl3) δ 7.45 (d, J = 7.8 Hz, 1H), 7.19 – 7.13 (m, 1H), 7.10 (td, J = 7.4, 1.5 Hz, 1H), 7.08 – 6.99 
(m, 1H), 5.78 (ddt, J = 17.0, 10.1, 6.9 Hz, 1H), 4.98 (dd, J = 17.1, 1.9 Hz, 1H), 4.95 – 4.90 (m, 
1H), 4.88 (dd, J = 10.1, 2.3 Hz, 1H), 2.34 (s, 3H), 2.23 – 2.12 (m, 2H), 1.70 – 1.59 (m, 1H), 1.53 
(m, 2H), 1.27 (s, 6H), 1.26 (s, 6H) 0.87 (s, 9H), 0.01 (s, 3H), -0.23 (s, 3H). 13C NMR (151 MHz, 







18.4, -4.3, -4.8. IR (n/cm-1): 2977 (s), 2956 (s), 1380 (s), 1372 (s), 1254 (s), 1144 (s), 1106 (m), 
1086 (s), 1057 (m). MS (ESI+) [M+Na]+ calcd for C25H43BO3SiNa+ 453.30, found 453.45.  
 
2-phenyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)hept-6-en-2-ol 
 (2.27). Following the general procedure, 1,3-diol 2.27 was isolated in 58% yield and 5:1 dr (11.9 
mg) as a clear oil. 1H NMR (600 MHz, CDCl3) δ 7.43 (dd, J = 8.3, 1.3 Hz, 2H), 7.35 (t, J = 7.7 
Hz, 3H), 5.64 (dddd, J = 16.9, 10.3, 7.9, 6.6 Hz, 1H), 5.12 – 5.01 (m, 2H), 4.24 (s, 1H), 3.55 – 
3.36 (m, 1H), 2.22 – 2.11 (m, 2H), 2.07 (dd, J = 14.6, 1.9 Hz, 1H), 1.95 (dd, J = 14.6, 10.7 Hz, 1H), 
1.52 (s, 3H). 13C NMR (151 MHz, CDCl3) δ 147.5, 133.9, 128.3, 126.5, 125.0, 118.9, 75.5, 69.0, 
48.0, 42.8, 32.7. IR (n/cm-1): 3348 (s, br), 2975 (m), 2927 (m), 2360 (m), 1445 (s), 1267 (m). 
HRMS (ESI+) [2M+Na]+ calcd for C26H36O4Na+ 435.2512, found 435.2487. 
 
tert-butyldimethyl(((4R,6R)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-
yl)hexadec-1-en-6-yl)oxy)silane (2.28). Following the general procedure, 1,3-
hydroxyboronate ester 2.28 was isolated in 73% yield and 3:1 dr (35.0 mg) as a clear oil.  
Major Diastereomer 
 1H NMR (600 MHz, CDCl3) d 5.84 - 5.73 (m, 1H), 5.01 (dd, J = 17.1, 1.9 Hz, 1H), 4.97 - 4.91 (m, 
1H), 3.61 (m, 1H), 2.22 - 2.07 (m, 2H), 1.56 (m, 1H), 1.45 - 1.38 (m, 3H), 1.25 – 1.22 (m, 39H), 
0.87 (s, 12H), 0.05 (s, 3H), 0.03 (s, 3H). 13C NMR (151 MHz, CDCl3) d 138.7, 115.1, 83.1, 72.5, 
38.5, 37.9, 36.2, 32.1, 30.0, 29.8, 29.8, 29.8, 29.5, 26.2, 25.8, 25.3, 25.1, 25.0, 24.9, 22.9, 14.3, -








 1H NMR (600 MHz, CDCl3) d 5.84 - 5.73 (m, 1H), 5.01 (dd, J = 17.1, 1.9 Hz, 1H), 4.97 - 4.91 (m, 
1H), 3.66 (qd, J = 6.7, 6.0, 4.7 Hz, 1H), 2.22 - 2.07 (m, 2H), 1.56 (m, 1H), 1.45 - 1.38 (m, 3H), 
1.25 – 1.22 (m, 39H), 0.87 (s, 12H), 0.05 (s, 3H), 0.03 (s, 3H). 13C NMR (151 MHz, CDCl3) d 
138.5, 115.2, 83.1, 71.3, 38.6, 36.8, 36.0, 29.9, 29.8, 26.1, 25.8, 25.3, 25.0, 23.0, 18.3, -4.1, -4.3.  
IR (n/cm-1): 2955 (s), 1385 (m), 1321 (m), 1254 (s), 1145 (s), 835 (s). MS (ESI+) [M+Na]+ calcd 
for C28H57BO3SiNa+ 503.41, found 503.54. 
  
tert-butyl((-1-cyclohexyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)hex-5-en-
1-yl)oxy)dimethylsilane (2.29). Following the general procedure, 1,3-hydroxyboronate ester 
2.29 was isolated in 61% yield and 3:1 d.r. (25.7 mg) as a clear oil.  
Major Diastereomer  
1H NMR (600 MHz, CDCl3) δ 5.78 (ddq, J = 16.9, 10.1, 6.8 Hz, 1H), 5.01 (dq, J = 17.0, 1.5 Hz, 
1H), 4.93 (ddd, J = 10.1, 2.2, 1.1 Hz, 1H), 3.53 –3.44 (dt, J = 8.3, 3.6 Hz, 1H), 2.20 – 2.04 (m, 
2H), 1.80 – 1.69 (m, 2H), 1.68 – 1.61 (m, 2H), 1.57 – 1.48 (m, 2H), 1.39 – 1.30 (m, 2H), 1.22 (s, 
6H), 1.22 (s, 6H), 1.19 – 1.12 (m, 1H), 1.08 (m, 2H), 0.88 (s, 9H), 0.04 (s, 3H), 0.04 (s, 3H). 13C 
NMR (151 MHz, CDCl3) δ 138.7, 115.0, 83.0, 76.5, 44.3, 36.4, 34.6, 28.2, 28.0, 27.0, 26.9, 26.9, 
26.2, 25.8, 25.1, 25.0. 
 Minor Diastereomer  
1H NMR (600 MHz, CDCl3) δ 5.78 (ddq, J = 16.9, 10.1, 6.8 Hz, 1H), 5.01 (dq, J = 17.0, 1.5 Hz, 
1H), 4.93 (ddd, J = 10.1, 2.2, 1.1 Hz, 1H), 3.41 – 3.31 (m, 1H), 2.20 – 2.04 (m, 2H), 1.80 – 1.69 
(m, 2H), 1.68 – 1.61 (m, 2H), 1.57 – 1.48 (m, 2H), 1.39 – 1.30 (m, 2H), 1.22 (s, 6H), 1.22 (s, 6H), 
1.19 – 1.12 (m, 2H), 1.08 (m, 3H), 0.88 (s, 9H), 0.04 (s, 3H), 0.04 (s, 3H). 13C NMR (151 MHz, 





IR (n/cm-1): 2928 (s), 2855 (m), 1381 (m), 1254 (m), 1145 (s), 1067 (m). MS (ESI+) [M+Na]+ 
calcd for C24H47BO3SiNa+ 445.33, found 445.54. 
  
2,2,3,3,8,8,9,9-octamethyl-5-(2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pent-
4-en-1-yl)-4,7-dioxa-3,8-disiladecane (2.30). Following the general procedure, 1,3-
hydroxyboronate ester 2.30 was isolated in 80% yield and 1.7:1 dr (39.0 mg) as a clear oil.  
Major Diastereomer  
1H NMR (600 MHz, CDCl3) d 5.85 - 5.72 (m, 1H), 5.00 (dd, J = 17.1, 1.8 Hz, 1H), 4.97 - 4.90 (m, 
1H), 3.69 - 3.63 (m, 1H), 3.54 - 3.46 (m, 2H), 2.25 - 2.09 (m, 2H), 1.53 (m, 1H), 1.35 - 1.27 (m, 
1H), 1.22 (s, 12H), 0.90 (s, 9H), 0.87 (s, 9H), 0.07 (s, 3H), 0.06 (s, 3 H) 0.04 (s, 3H), 0.03 (s, 
3H). 13C NMR (151 MHz, CDCl3) d 138.7, 115.1, 83.0, 73.5, 68.3, 36.4, 35.9, 26.2, 26.2, 25.1, 
25.0, 18.6, 18.3, -3.9, -4.5, -5.1, -5.2.  
Minor Diastereomer 
 1H NMR (600 MHz, CDCl3) d 5.85 - 5.72 (m, 1H), 5.00 (dd, J = 17.1, 1.8 Hz, 1H), 4.97 - 4.90 
(m, 1H), 3.74 - 3.69 (m, 1H), 3.39 (dd, J = 10.1, 5.8 Hz, 2H), 2.25 - 2.09 (m, 2H), 1.74 - 1.66 (m, 
1H), 1.35 - 1.27 (m, 1H), 1.22 (s, 12H), 0.88 (s, 9H), 0.88 (s, 9H),  0.03- 0.07 (m, 6H). 13C NMR 
(151 MHz, CDCl3) d 138.4, 115.3, 83.1, 72.4, 67.9, 35.4, 35.2, 26.1, 26.1, 25.1, 25.0,18.6, 18.4, -4.0, 
-4.5, -5.1, -5.1.  
IR (n/cm-1): 2927 (s), 2855 (s), 1380 (m), 1371 (m), 1254 (m), 1146 (s), 1067 (m), 836 (m). MS 








   
Tert-butyldimethyl((1-phenyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)hept-
6-en-2-yl)oxy)silane (2.31). Following the general procedure, 1,3-hydroxyboronate ester 
2.31 was isolated in 70% yield and 1:1 dr (30.4 mg) as a clear oil.  
Major Diastereomer 
 1H NMR (600 MHz, CDCl3) δ 7.24 (dd, J = 7.4, 3.2 Hz, 2H), 7.20 – 7.15 (m, 3H), 5.78 (tdd, J = 
10.0, 6.5, 3.0 Hz, 1H), 5.06 – 4.98 (m, 1H), 4.97 – 4.86 (m, 1H), 3.89 – 3.77 (m, 1H), 2.71 (qd, J 
= 13.4, 6.2 Hz, 2H), 2.53 (dd, J = 13.3, 8.2 Hz, 1H), 2.15 (m, 2H), 1.54 (m 1H), 1.48 – 1.39 (m, 
2H), 1.18 (s, 6H), 1.18 (s, 6H), 0.84 (s, 9H), -0.02 (s, 3H), -0.19 (s, 3H). 13C NMR (151 MHz, 
CDCl3) d139.6, 138.3, 129.9, 128.1, 126.0, 115.2, 83.1, 73.8, 44.6, 38.4, 36.1, 26.1, 25.8, 25.0, 
24.9, 18.2, -4.4, -4.6. 
Minor Diastereomer 
 1H NMR (600 MHz, CDCl3) δ 7.24 (dd, J = 7.4, 3.2 Hz, 2H), 7.20 – 7.15 (m, 3H), 5.78 (tdd, J = 
10.0, 6.5, 3.0 Hz, 1H), 5.06 – 4.98 (m, 1H), 4.97 – 4.86 (m, 1H), 3.89 – 3.77 (m, 1H), 2.86 (dd, J 
= 13.3, 3.7 Hz, 1H), 2.15 (m, 2H), 1.70 – 1.63 (m, 1H), 1.64 – 1.54 (m, 2H), 1.26 (s, 6H), 1.26 (s, 
6H), 0.80 (s, 9H), -0.12 (s, 3H), -0.35 (s, 3H). 13C NMR (151 MHz, CDCl3) d 139.6, 138.3,130.1, 
128.0, 125.9, 83.3, 73.4, 43.4, 39.2, 36.2, 25.8, 25.0, 25.0, 18.2, -4.6, -5.1. 
IR (n/cm-1): 2955 (s), 2928 (s), 1380 (s), 1254 (s), 1144 (s), 1081 (s), 836 (s). MS (ESI+) 
[M+Na]+ calcd for C25H43BO3SiNa+ 453.30, found 453.45. 
  
tert-butyldimethyl((2-(1-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)but-3-en-1-
yl)cyclohexyl)oxy)silane (2.32). Following the general procedure, 1,3-hydroxyboronate 








CDCl3) d 5.86 - 5.75 (m, 1H), 5.00 (dd, J = 17.1, 1.9 Hz, 1H), 4.94 - 4.88 (m, 1H), 3.54 (td, J = 9.5, 
4.3 Hz, 1H), 2.36 - 2.27 (m, 1H), 2.05 - 1.95 (m, 1H), 1.88 - 1.82 (m, 1H), 1.82 - 1.75 (m, 1H), 1.71 
(m, 1H), 1.66 (ddd, J = 9.2, 3.7, 1.9 Hz, 1H), 1.60 - 1.55 (m, 1H), 1.41 - 1.30 (m, 1H), 1.22 (m, 2H) 
1.22 (s, 6H), 1.21 (s, 6H), 1.14 - 1.05 (m, 1H), 1.02 - 0.95 (m, 1H), 0.88 (m, 9H), 0.09 (s, 3H), 
0.06 (s, 3H). 13C NMR (151 MHz, CDCl3) d 139.8, 114.4, 82.8, 74.0, 47.2, 36.4, 33.9, 28.4, 26.2, 
25.9, 25.3, 25.1, 25.0, 18.3, -3.8, -4.6. IR (n/cm-1): 2929 (s), 2856 (s), 1471 (w), 1387 (m), 1371 
(m), 1255 (m), 1144 (m), 1089 (m). MS (ESI+) [M+Na]+ calcd for C22H43BO3SiNa+ 417.47, found 
417.45. 
 
Stereochemistry of 2.32 was determined via transformation to the corresponding acetonide 
2.76 according to the following procedure:58 Following the general procedure, the crude 
hydroxy boronate was dissolved in THF (0.25 mL) in an 8 mL vial with a stir bar and septum 
cap. The vial was cooled to 0 ºC in an ice bath. NaOH (3M, 0.25 mL) and H2O2 (30%, 0.16 mL) 
were added to the reaction at 0 ºC. The septa cap was vented with a needle, allowed to warm to 
room temperature, and stirred for 3 hours. The reaction was then cooled back to 0 ºC and 
quenched with saturated sodium thiosulfate, extracted with diethyl ether, dried over magnesium 
sulfate, and concentrated in vacuo. The crude mixture was then plugged through silica (2:1 
hexanes:ethyl acetate) and concentrated in vacuo. Pinacol was removed via azeotropic 
distillation from a 1:1 mixture of methanol and water. The product was then dissolved in DMF 
(0.6 mL) in an 8 mL vial containing a stir bar and sealed with a septum cap. The vial was purged 
with nitrogen and 2,2-dimethoxypropane was added (0.069 mL, 10 eq) to the vial. The cap was 
then quickly removed and pyridinium p-toluenesulfonate (0.7 mg, 5 mol%) was added. The vial 







temperature for one hour. One drop of triethylamine was added to the reaction followed by a 
saturated solution of sodium bicarbonate. The mixture was extracted with diethyl ether, dried 
over magnesium sulfate, and concentrated in vacuo. The crude mixture was purified via column 
chromatography (10:1 hexanes: diethyl ether) to yield the product in 56% yield and >20:1 dr 
(12.2 mg) as a clear oil. 1H NMR (600 MHz, C6D6) δ 5.99 (ddt, J = 17.1, 10.6, 6.7 Hz, 1H), 5.23 – 
4.95 (m, 2H), 3.96 (ddd, J = 11.1, 7.3, 4.5 Hz, 1H), 3.51 (td, J = 10.6, 4.2 Hz, 1H), 2.52 – 2.22 (m, 
1H), 2.17 – 1.99 (m, 1H), 1.98 – 1.82 (m, 1H), 1.65 (m, 1H), 1.54 (m, 1H), 1.48 (s, 3H), 1.45 (m, 
4H), 1.37 (m, 2H), 1.24 – 1.15 (m, 1H), 1.07 (m, 1H), 0.99 – 0.91 (m, 1H), 0.90 – 0.73 (m, 1H). 
13C NMR (151 MHz, C6D6) δ 137.1, 128.4, 116.0, 99.2, 72.2, 69.4, 45.0, 36.2, 33.2, 28.3, 26.4, 
26.3, 26.2, 25.0. IR (n/cm-1): 3854 (m), 3711 (m), 3566 (m), 2933 (m), 1748 (m), 1540 (s), 1507 
(s). MS (ESI+): [M+H]+ calcd for C13H24O2+ 211.17, found 211.18. 
 
(1R,2S,4S)-1-methyl-4-(prop-1-en-2-yl)-2-((R)-1-(4,4,5,5-tetramethyl-1,3,2-
dioxaborolan-2-yl)but-3-en-1-yl)cyclohexan-1-ol (2.33). Following the general 
procedure with 0.2 mmol of limonene oxide, 1,3-hydroxyboronate ester 2.33 was isolated in 
42% yield and >20:1 dr. (13.9 mg) as a clear oil. Yield was calculated assuming only one of the 
isomers of starting material reacts to give product. 1H NMR (600 MHz, CDCl3) δ 5.78 (ddt, J = 
17.0, 10.1, 6.8 Hz, 1H), 5.04 (dd, J = 17.1, 1.8 Hz, 1H), 4.99 – 4.92 (m, 1H), 4.85 – 4.75 (m, 2H), 
2.35 – 2.13 (m, 3H), 1.94 (dddd, J = 14.0, 6.0, 3.9, 1.5 Hz, 1H), 1.76 (d, J = 8.5 Hz, 1H), 1.72 (s, 
3H), 1.67 (dt, J = 9.0, 4.3 Hz, 1H), 1.62 – 1.55 (m, 1H), 1.52 (dq, J = 9.1, 4.0 Hz, 3H), 1.37 (dt, J = 
10.2, 5.4 Hz, 1H), 1.23 (s, 6H), 1.22 (s, 6H), 1.21 (s, 3H). 13C NMR (151 MHz, CDCl3) δ 147.8, 
138.8, 115.5, 110.2, 83.2, 73.9, 46.5, 38.7, 37.4, 36.5, 30.4, 26.5, 25.2, 25.2, 24.9, 22.1. IR (n/cm-
1): 3437 (br, m), 2977 (m), 1388 (m), 1371 (m), 1321 (m), 1143 (s). HRMS (ESI+) [2M+Na]+ 









(2.34). Following the general procedure, 1,3-hydroxyboronate ester 2.34 was isolated in 60% 
yield in 2:1 d.r. (12.6 mg) as a yellow solid.  
Major Disastereomer 
1H NMR (600 MHz, CDCl3) δ 5.88 – 5.76 (m, 1H), 5.14 – 5.09 (m, 2H), 4.12 (dddd, J = 10.5, 
7.0, 5.6, 1.6 Hz, 1H), 3.48 (s, 1H), 2.85 (s, 1H), 2.28 – 2.15 (m, 2H), 2.07 – 1.98 (m, 1H), 1.94 (td, 
J = 6.0, 3.4 Hz, 1H), 1.91 – 1.72 (m, 4H), 1.38 (dd, J = 14.2, 10.4 Hz, 1H), 1.23 (s, 3H), 1.13 (s, 
3H), 1.00 (d, J = 10.4 Hz, 1H). 13C NMR (151 MHz, CDCl3) δ 134.8, 118.1, 79.4, 68.6, 54.0, 47.9, 
42.9, 40.8, 38.6, 29.6, 27.9, 27.7, 24.2, 23.7. 
Minor Diastereomer  
1H NMR (600 MHz, CDCl3) δ 5.88 – 5.76 (m, 1H), 5.14 – 5.09 (m, 2H), 3.89 (dtd, J = 10.9, 6.2, 
1.9 Hz, 1H), 3.48 (s, 1H), 2.85 (s, 1H), 2.28 – 2.15 (m, 2H), 2.07 – 1.98 (m, 1H), 1.94 (td, J = 6.0, 
3.4 Hz, 1H), 1.91 – 1.72 (m, 4H), 1.38 (dd, J = 14.2, 10.4 Hz, 1H), 1.26 (s, 3H), 1.13 (s, 3H), 0.92 
(d, J = 9.8 Hz, 1H). 13C NMR (151 MHz, CDCl3) δ 134.7, 118.1, 79.1, 68.0, 49.8, 47.2, 42.7, 40.8, 
38.1, 28.4, 27.8, 27.7, 24.8, 23.6. 
MS (ESI+) [M+Na]+ calcd for C14H24O2Na+ 247.17, found 247.27.IR (n/cm-1): 3392 (br, s), 
2915 (s), 1651 (w), 1540 (s), 1507 (w), 995 (w), 914 (s), 750 (w). 
 
(1S,3R,E)-1-phenylhept-5-ene-1,3-diol (2.35). Following the general procedure, 1,3-diol 
2.35, was isolated in 52% yield (10.7 mg) in 3:1 SN2’ (2:1 dr) to SN2 (2:1 dr) ratio. 1H NMR (600 









1H), 5.48 – 5.33 (m, 1H), 5.10 (m, 1H), 4.97 (m, 1H), 3.94 (m, 1H), 3.88 (m, 1H), 3.77 (m, 1H), 
3.66 (m, 1H), 3.17 (s, 1H), 3.08 (s, 1H), 2.87 (s, 1H), 2.48 – 2.13 (m, 5H), 2.09 – 1.85 (m, 0H), 
1.71 (d, J = 5.1 Hz, 2H), 1.67 (d, J = 5.1 Hz, 2H), 1.06 (d, J = 6.8 Hz, 1H), 1.03 (d, J = 6.8 Hz, 1H). 
13C NMR (151 MHz, CDCl3) δ 144.7, 144.7, 144.6, 140.6, 140.3, 129.7, 129.7, 128.6, 128.6, 
128.6, 128.6, 127.9, 127.7, 127.4, 127.4, 127.4, 126.7, 125.8, 125.8, 125.7, 125.7, 125.6, 117.1, 115.9, 
71.9, 71.9, 71.9, 71.9, 69.0, 68.4, 44.1, 43.9, 41.8, 40.9, 35.1, 25.0, 18.3, 15.1, 13.3. IR (n/cm-1): 
3366 (br, s), 2917 (m), 2360 (m), 1452 (m), 1053 (m). HRMS (ESI+) [2M+Na]+ calcd for 
C26H36O4Na+ 435.2512, found 435.2493. 
 
1S,3R)-5-methyl-1-phenylhex-5-ene-1,3-diol (2.36). Following the general procedure, 
1,3-diol 2.36, was isolated in 93% yield in 10:1 d.r. (191.1 mg) as a white solid. 
1H NMR (600 MHz, CDCl3) δ 7.40 – 7.26 (m, 5H), 5.09 (dd, J = 8.5, 3.0 Hz, 1H), 4.89 (m, 1H), 
4.80 (tq, J = 2.1, 1.0 Hz, 1H), 4.02 (m, 1H), 3.02 (s, 1H), 2.29 – 2.17 (m, 3H), 1.99 – 1.81 (m, 
2H), 1.72 (t, J = 1.1 Hz, 3H), 1.59 (d, J = 23.2 Hz, 1H). 13C NMR (151 MHz, CDCl3) δ 144.7, 
142.4, 128.6, 127.4, 125.7, 114.0, 71.7, 66.2, 46.2, 44.6, 22.5. IR (n/cm-1): 3388 (s, br), 3073 (w), 
2917 (s), 1646 (m), 1455 (s), 1059 (s), 890 (m), 700 (s). MS (ESI+) [M+Na]+ calcd for 
C13H18O2Na+ 229.12, found 229.27. [a]22D = -8.45 (c = 2.14, CH2Cl2, l = 100 mm). 
 
(E)-6,10-dimethyl-1-phenylundeca-5,9-diene-1,3-diol (2.37). Following the general 
procedure, 1,3-diol 2.37 was isolated in 47% yield in 4:1 dr (11.3 mg) as a clear oil. 1H NMR 
(500 MHz, CDCl3) δ 7.36 (td, J = 8.3, 6.2 Hz, 4H), 7.29 – 7.23 (m, 1H), 5.26 – 4.97 (m, 3H), 3.85 
(qd, J = 4.9, 1.6 Hz, 1H), 3.21 (s, 1H), 2.27 – 1.85 (m, 8H), 1.67 (s, 3H), 1.63 (s, 3H), 1.59 (s, 3H). 









44.0, 40.0, 36.2, 26.6, 25.9, 17.9, 16.4. IR (n/cm-1): 3370 (s, br), 2915 (s), 1452 (m), 1057 (m), 
700 (s). HRMS (ESI+) [2M+Na]+ calcd for C38H56O4Na+ 599.4077, found 599.4064. [a]22D = -
23.5 (c =-0.625, CH2Cl2, l = 100 mm). 
 
(1S,3R)-4-(cyclohex-1-en-1-yl)-1-phenylbutane-1,3-diol (2.38). Following the general 
procedure, 1,3-diol 2.38 was recrystallized from pentane and diethyl ether to give 86% yield in 
>20:1 d.r. (21.2 mg) as a white solid. 1H NMR (600 MHz, CDCl3) δ 7.40 – 7.27 (m, 5H), 5.57 – 
5.51 (m, 1H), 5.08 (m, J = 8.0, 3.7 Hz, 1H), 3.95 (m, J = 11.2, 8.2, 5.0, 2.7 Hz, 1H), 3.18 (d, J = 
4.3 Hz, 1H), 2.19 (d, J = 2.5, 0.9 Hz, 1H), 2.18 – 2.09 (m, 2H), 2.04 – 1.99 (br s, 2fH), 1.89 (m, J 
= 68.8, 14.6, 8.5, 3.1 Hz, 4H), 1.61 (m, J = 11.0, 4.8, 2.3 Hz, 1H), 1.57 – 1.52 (m, 1H). 13C NMR 
(151 MHz, CDCl3) δ 144.8, 134.4, 128.5, 127.3, 125.7, 71.7, 66.2, 46.5, 44.5, 28.4, 25.4, 22.9, 22.4. 
IR (n/cm-1): 3365 (br, s), 2924 (s), 1652 (m), 1540 (m), 1455 (s), 1055 (m), 700 (m). MS 
(ESI+) [M+Na]+ calcd for C16H22O2Na+ 269.15, found 269.27. [a]22D = -12.04 (c = 0.195, CH2Cl2, 
l = 100 mm). 
 
(1S,3R)-6-methyl-1-phenylhept-5-ene-1,3-diol (2.39). Following the general procedure, 
1,3-diol 2.39, was isolated in 49% yield (10.7 mg) in 6:1 dr. 1H NMR (600 MHz, CDCl3) δ 7.45 – 
7.35 (m, 4H), 7.30 (m, 1H), 5.23 – 5.12 (m, 1H), 5.09 (dd, J = 8.0, 3.4 Hz, 1H), 3.98 – 3.77 (m, 
1H), 2.30 (m, 2H), 2.19 (m, 1H), 1.94 (qdd, J = 14.6, 8.2, 3.2 Hz, 2H), 1.75 (s, 3H), 1.66 (s, 3H). 
13C NMR (151 MHz, CDCl3) δ 144.7, 135.9, 128.5, 127.4, 1 25.7, 119.7, 71.9, 69.2, 44.1, 36.3, 26.1, 
18.2. IR (n/cm-1): 3420 (s, br), 2966 (w), 2915 (w), 1695 (m), 1454 (w), 1054 (m), 755 (m), 700 
(m). MS (ESI+) [M+Na]+ calcd for C14H20O2Na+ 243.14, found 243.27. [a]22D = -36.5 (c =-0.42, 










(1S,3S)-5-bromo-1-phenylhex-5-ene-1,3-diol (2.40). Following the general procedure, 
1,3-diol 2.40 was isolated in 42% yield in 7:1 dr (11.3 mg) as a clear oil. 1H NMR (500 MHz, 
CDCl3) δ 7.40 – 7.34 (m, 4H), 7.29 (ddd, J = 9.1, 5.2, 2.3 Hz, 1H), 5.70 (d, J = 1.5 Hz, 1H), 5.54 
(d, J = 1.7 Hz, 1H), 5.08 (dd, J = 8.6, 3.2 Hz, 1H), 4.30 – 4.20 (m, 1H), 2.77 (br,s, 1H), 2.66 (ddd, 
J = 14.4, 8.4, 0.9 Hz, 1H), 2.58 (ddd, J = 14.4, 4.4, 1.2 Hz, 1H), 2.50 (m, 1H), 1.97 (ddd, J = 14.5, 
8.6, 3.0 Hz, 1H), 1.89 (ddd, J = 14.6, 8.5, 3.3 Hz, 1H). 13C NMR (151 MHz, CDCl3) δ 144.3, 
130.3, 128.7, 127.7, 125.7, 120.0, 71.7, 66.8, 49.2, 43.9. IR (n/cm-1): 3367 (br, s), 2917 (m), 1630 
(s), 1125 (m), 1061 (s), 891 (m). HRMS (ESI+) [2M+Na]+ calcd for C24H30Br2O4Na+ 563.0409, 
found 563.0376. [a]22D = -31.2 (c =-0.475, CH2Cl2, l = 100 mm). 
 
(1S,3S)-1-(cyclohex-2-en-1-yl)-3-phenylpropane-1,3-diol (2.41). Following the general 
procedure, 1,3-diol 2.41 was isolated in 68% yield in 5:1 dr with respect to alcohol stereocenters 
and 1:1 dr of each with respect to the cyclohexane stereocenter (15.8 mg) as a white solid. 1H 
NMR (600 MHz, CDCl3) δ 7.49 – 7.34 (m, 4H), 7.34 – 7.28 (m, 1H), 5.87 (dt, J = 10.0, 3.1 Hz, 
1H), 5.70 (dd, J = 10.2, 2.4 Hz, 1H), 5.56 (dd, J = 10.2, 2.4 Hz, 1H), 5.10 (dt, J = 5.6, 2.7 Hz, 1H), 
3.85 (m, 1H), 3.78 – 3.69 (m, 1H), 2.99 – 2.91 (m, 1H), 2.26 (m, 1H), 2.09 – 1.85 (m, 5H), 1.85 – 
1.68 (m, 3H), 1.61 – 1.44 (m, 2H). 13C NMR (151 MHz, CDCl3) δ 144.7, 144.7, 130.9, 130.4, 
128.6, 128.6, 128.0, 127.5, 127.4, 126.8, 125.8, 125.7, 125.6, 72.6, 72.0, 72.0, 71.6, 53.6, 42.2, 41.7, 
41.6, 41.5, 25.6, 25.4, 23.3, 21.7, 21.4. IR (n/cm-1): 3366 (s, br), 2925 (m), 1603 (m), 1450 (m), 
1048 (m). MS (ESI+) [2M+Na]+ calcd for C30H40O4Na+ 487.2824, found 487.2816. [a]22D = -






To confirm the diastereoselectivity, 2.41 was hydrogenated according to the following 
procedure: 
 
Diol 2.77 (7 mg, 0.03 mmol) was dissolved in MeOH (0.5 mL) in an 8 mL vial containing a stir 
bar. The vial was sealed with a septum lined cap and purged with nitrogen. The cap was briefly 
removed and 10% palladium on carbon (0.7 mg) was added. The reaction was sealed and the vial 
was purged with nitrogen. A balloon of hydrogen was then attached and the reaction was 
sparged with hydrogen and then allowed to stir under an atmosphere of hydrogen for 1 hour. 
The reaction was quenched by passing the mixture over a pad of Celite followed by 
concentration in vacuo. The crude material was purified via column chromatography (2:1 
hexanes:ethyl acetate) to yield the desired hydrogenated product in 94% yield (6.4 mg). The 
NMR matched literature spectra and confirmed the 5:1 d.r. at the two alcohol stereocenters.59 1H 
NMR (600 MHz, CDCl3) δ 7.46 – 7.35 (m, 4H), 7.29 (d, J = 3.8 Hz, 1H), 5.10 (t, J = 5.7 Hz, 1H), 
3.64 (q, J = 6.1 Hz, 1H), 2.98 (s, 1H), 2.14 (s, 1H), 2.00 – 1.90 (m, 2H), 1.89 – 1.83 (m, 1H), 1.81 
– 1.73 (m, 2H), 1.71 – 1.65 (m, 2H), 1.40 (m, 1H), 1.24 (m, 2H), 1.15 (tt, J = 12.8, 3.4 Hz, 1H), 
1.05 – 0.91 (m, 2H). 13C NMR (151 MHz, CDCl3) δ 144.8, 128.6, 128.6, 127.4, 125.6, 73.6, 72.0, 
43.7, 41.7, 29.1, 28.3, 26.6, 26.3, 26.2. 
 
(1S,3R,E)-1-phenylocta-5,7-diene-1,3-diol (2.43). Following the general procedure, 1,3-
diol 2.43 was isolated in 45% yield (10.1 mg) in 8:1 d.r. 1H NMR (600 MHz, CDCl3) δ 7.39 – 
7.27 (m, 5H), 6.31 (dt, J = 17.0, 10.3 Hz, 1H), 6.14 (dd, J = 15.3, 10.4 Hz, 1H), 5.66 (dt, J = 15.1, 
7.5 Hz, 1H), 5.14 (dd, J = 16.8, 1.7 Hz, 1H), 5.07 (d, J = 4.4 Hz, 1H), 5.03 (d, J = 10.1 Hz, 1H), 






13C NMR (151 MHz, CDCl3) δ 144.5, 136.8, 134.7, 130.1, 128.6, 127.5, 125.7, 116.5, 71.9, 68.5, 
44.2, 40.9. IR (n/cm-1): 3351 (br, s), 2916 (s), 2297 (w), 1650 (m), 1556 (w), 1454 (m), 1004 (s), 
758 (m). MS (ESI+) [M+Na]+ calcd for C14H18O2Na+ 241.12, found 241.27. [a]22D = -10.48 (c = 
0.38, CH2Cl2, l = 100 mm). 
 
4-hydroxytetradecan-2-one (2.46). In a nitrogen filled glovebox, diborylethane (42.0 mg, 
0.15 mmol) was weighed into an 8-mL vial equipped with a magnetic stir bar. The diborylethane 
was dissolved in THF (0.4 ml) and the vial was sealed with a septa-lined cap and taped. Lithium 
2,2,6,6-tetramethylpiperidide (LTMP) (22.8 mg, 0.15 mmol) was weighed into a separate 8-mL 
vial, dissolved in THF (0.8 mL) and sealed with a septum lined cap and tape. The vials were 
removed from the dry box and the diborylethane and LTMP were cooled to 0 ºC in an ice water 
bath. The LTMP solution was transferred via cannula to the diborylethane solution at 0 ºC. This 
was allowed to stir at 0 ºC for 10 minutes. Dodeceneoxide (0.1 mmol) was then added via 
syringe and the solution was brought to room temperature and stirred for 24 hours. The 
reaction was quenched with saturated ammonium chloride, extracted with ether (x3), dried over 
magnesium sulfate and concentrated in vacuo. The resulting crude mixture was dissolved in 
THF (0.25 mL) and cooled to 0 ºC in an ice water bath. NaOH (0.25 mL, 3M) and H2O2 (0.125 
mL, 30%) were added and the reaction was allowed to stir and slowly warm to room 
temperature over two hours. The reaction was then cooled back to 0 ºC in an ice bath and 
quenched with a saturated solution of sodium thiosulfate. The mixture was warmed to room 
temperature, extracted with ether (x3), dried over magnesium sulfate, and concentrated in 
vacuo and purified via silica gel chromatography. 2.46 was isolated in 80% yield (18.0 mg) as a 
white solid. 1H NMR (500 MHz, CDCl3) δ 4.02 (m, 1H), 2.97 (d, J = 3.3 Hz, 1H), 2.63 (dd, J = 
17.7, 2.7 Hz, 1H), 2.52 (dd, J = 17.7, 9.2 Hz, 1H), 2.18 (s, 3H), 1.56 – 1.44 (m, 1H), 1.39 (m, 2H), 






32.0, 30.9, 29.8, 29.8, 29.7, 29.7, 29.5, 25.6, 22.8, 14.3. IR (n/cm-1): 3324 (m, br), 3234 (m, 
br), 2916 (s), 2848 (s), 1708 (s), 1464 (m). HRMS (ESI+) [2M+Na]+ calcd for C38H56O4Na+ 
479.4077, found 479.4060. 
 
benzyl ((1S,3R)-1-((tert-butyldimethylsilyl)oxy)-1-phenylhex-5-en-3-yl)carbamate 
(2.53). Following a literature procedure,48 a solution of O-methylhydroxylamine in THF (2.5 
mL, 1.45 mmol, 0.38 M) and THF (2.7 mL) were added to a flame dried 25 mL single neck round 
bottom flask containing a stir bar under inert nitrogen atmosphere. The flask was cooled to -78 
ºC in a dry ice/acetone bath. n-BuLi (1.09 mL, 1.45 mmol, 1.33M in hexanes) was added and the 
solution was allowed to stir at -78 ºC for 30 minutes. A separate flame dried 8 mL vial was 
charged with 1,3-hydroxyboronate ester (2.53) (201.3 mg, 0.48 mmol) and diluted with THF (1 
mL) under N2. The solution of 1,3-hydroxyboronate ester was then added dropwise via syringe 
to the solution of deprotonated O-methylhydroxylamine at -78 ºC. The reaction flask was 
warmed to room temperature and then heated to 60 ºC. After stirring at 60 ºC for 16 hours, the 
reaction flask was cooled to room temperature and benzyl chloroformate (0.22 mL, 1.55 mmol) 
was added. After stirring at room temperature for 1 hour the reaction was quenched with water 
(10 mL). The layers were separated and the aqueous layer was extracted with EtOAc (3 x 20 
mL). The combined organics were dried over sodium sulfate, concentrated, and purified via 
column chromatography (95:5 hexanes:EtOAc) to give the desired carbamate 31 in 87% yield in 
16:1 d.r. (184.2 mg) as a white solid. 1H NMR (600 MHz, CDCl3) δ 7.41 – 7.23 (m, 10H), 5.82 – 
5.72 (m, 1H), 5.22 (d, J = 8.1 Hz, 1H), 5.17 – 5.02 (m, 4H), 4.83 (dd, J = 9.3, 2.8 Hz, 1H), 3.93 – 
3.84 (m, 1H), 2.44 – 2.26 (m, 2H), 1.93 (ddd, J = 15.3, 10.9, 5.5 Hz, 1H), 1.67 (t, J = 14.7, 8.8, 2.9 
Hz, 1H), 0.90 (s, 9H), 0.06 (s, 3H), -0.26 (s, 3H). 13C NMR (151 MHz, CDCl3) δ 155.9, 145.0, 




-4.4, -5.0. IR (n/cm-1): 3326 (m), 3065 (m), 2928 (s), 2856 (s), 1708 (s), 1530 (s), 1256 (m), 
1096 (s). [a]22D = -31.73 (c = 3.32, CH2Cl2, l = 100 mm). 
 
tert-butyldimethyl(((1S,3R)-5-methyl-1-phenyl-3-(4,4,5,5-tetramethyl-1,3,2-
dioxaborolan-2-yl)hex-5-en-1-yl)oxy)silane (2.54). Following the general procedure, 1,3-
hydroxyboronate ester 2.54 was isolated in 67% yield in >20:1 d.r. (29.0 mg) as a clear oil. 1H 
NMR (600 MHz, CDCl3) δ 7.28 (d, J = 4.3 Hz, 4H), 7.20 (h, J = 4.3 Hz, 1H), 4.70 – 4.66 (m, 
2H), 4.64 (dd, J = 9.3, 3.4 Hz, 1H), 2.18 (dd, J = 14.3, 7.2 Hz, 1H), 2.02 (dd, J = 14.3, 8.5 Hz, 
1H), 1.70 (s, 3H), 1.66 (ddd, J = 13.6, 9.3, 4.4 Hz, 1H), 1.63 – 1.55 (m, 2H), 1.25 (s, 12H), 0.87 (s, 
9H), 0.04 (s, 3H), -0.21 (s, 3H). 13C NMR (151 MHz, CDCl3) δ 146.7, 145.3, 128.1, 126.8, 125.9, 
111.0, 83.1, 75.2, 42.5, 39.6, 26.1, 26.0, 25.2, 24.9, 22.2, 18.3, -4.3, -4.7. IR (n/cm-1): 2929 (m), 
2857 (m), 1386 (s), 1320 (m), 1255 (m), 1144 (s), 776 (s). HRMS (ESI+): [M+H]+ calcd for 




(2.55). Following a known literature procedure,50 inside the glovebox, 2.55 (34 mg, 0.08 
mmol) and [Pd(µ-Br)(PtBu3)]2 (1.6 mg, 0.002 mmol, 2 mol%) were weighed into an 8 mL vial 
containing a stir bar. The solids were dissolved in toluene (0.040 mL) and DCE (0.040 mL). 
Benzaldehyde (0.024 mL, 0.24 mmol, 3 equiv.) was added and the reaction was sealed and 
OTBSB(pin)Me
2.54
TBSO B(pin)Me [Pd(µ-Br)(PtBu3)]2 (2.5 mol%)
toluene, DCE












removed from the glovebox. The mixture was allowed to stir at room temperature for 24 hours. 
The reaction was then diluted in diethyl ether and passed over a pad of celite. The mixture was 
purified via silica gel chromatography to give a mixture of olefin isomers in 69% yield, 4:1 olefin 
ratio (22.7 mg). Using silica gel treated with silver nitrate, a small portion of pure 2.55 was 
obtained (11.8 mg, 29%) and used for NMR characterization. 1H NMR (600 MHz, CDCl3)  δ 
7.37 – 7.31 (m, 2H), 7.29 – 7.20 (m, 5H), 7.16 – 7.10 (m, 1H), 5.47 (dt, J = 15.5, 7.1 Hz, 1H), 5.34 
(dt, J = 15.7, 1.2 Hz, 1H), 4.75 (t, J = 5.8 Hz, 1H), 4.27 (s, 1H), 2.57 – 2.39 (m, 2H), 1.95 (s, 1H), 
1.61 (s, 1H), 0.95 (s, 3H), 0.90 (s, 9H), 0.86 (s, 3H), 0.04 (s, 3H), -0.09 (s, 3H). 13C NMR (151 
MHz, CDCl3) δ 144.9, 140.6, 139.3, 128.1, 127.8, 127.4, 127.3, 127.1, 126.2, 125.8, 80.6, 74.9, 
44.5, 41.8, 25.9, 25.0, 21.3, 18.4, -4.6, -4.8. MS (ESI+) [M+Na]+ calcd for C26H35O2SiNa+ 
433.25, found 433.36. IR (n/cm-1): 3468 (br, w), 2956 (m), 2928 (m), 2856 (m), 1492 (m), 1255 
(m), 1090 (m), 836 (s). [a]22D = 3.5 (c =0.58, CH2Cl2, l = 100 mm). 
 
(1S,3R)-1-phenyl-3-(p-tolyl)hex-5-en-1-ol (2.56). Following a known literature 
procedure,51 in a nitrogen filled dry box, diborylmethane (40.2 mg, 0.15 mmol) was weighed into 
an 8-mL vial equipped with a magnetic stir bar. The diborylmethane was dissolved in THF (0.4 
mL) and the vial was sealed with a septum-lined cap and taped. Lithium 2,2,6,6-
tetramethylpiperidide (LTMP) (22 mg, 0.15 mmol) was weighed into a separate 8-mL vial, 
dissolved in THF (0.8 mL) and sealed with a septum lined cap and tape. Copper (I) chloride (1.5 
mg, 0.015 mmol) was weighed into a third 8-mL vial with a magnetic stir bar and sealed with a 
septum lined cap and tape. The vials were removed from the dry box and the diborylmethane 
and LTMP were cooled to 0 ºC in an ice water bath. The LTMP solution was transferred via 





The epoxide (0.1 mmol) was added via syringe and the solution was brought to 22 ºC and stirred 
for 15 minutes. The reaction was returned to room temperature and transferred via cannula to 
the vial containing the copper chloride. Allyl bromide (26 µL, 0.3 mmol) was added to the 
reaction via syringe. The reaction was sealed with tape and allowed to stir at 60 ºC for 24 h. The 
mixture was then cooled to room temperature and quenched with a saturated solution of 
aqueous ammonium chloride, extracted with ether, dried over magnesium sulfate, filtered, and 
concentrated in vacuo. The crude mixture was sealed with a septum lined cap and the vial was 
purged with nitrogen. Inside the glovebox, Pd(dba)2 (0.6 mg, 1 mol%) and RuPhos (0.5 mg, 1 
mol%) were weighed into an 8-mL vial and dissolved in toluene (0.5 mL). 4-Bromotoluene was 
added to a separate vial and dissolved in THF (0.5 mL). These vials were sealed with septum 
lined caps and removed from the glovebox. The bromotoluene solution was cannula transferred 
under nitrogen to the crude hydroxyboronate. Once dissolved, this solution was cannula 
transferred to the catalyst mixture. A solution of nitrogen sparged KOH (aq.) (0.122 mL, 0.4 
mmol) was added to the reaction via syringe. The mixture was then stirred at 70 ºC for 14 hours. 
The reaction was quenched by plugging the mixture over a pad of Celite with ether and 
concentrated in vacuo. The mixture was purified via column chromatography to yield the 
desired product 2.56 in 40% yield in >10:1 dr (10.6 mg). 1H NMR (500 MHz, CDCl3) δ 7.35 – 
7.27 (m, 2H), 7.26 – 7.21 (m, 3H), 7.18 – 7.09 (m, 4H), 5.68 (ddt, J = 17.1, 10.1, 7.0 Hz, 1H), 5.05 
– 4.85 (m, 2H), 4.38 (dd, J = 10.4, 2.8 Hz, 1H), 3.02 (dtd, J = 11.3, 7.3, 4.0 Hz, 1H), 2.40 – 2.36 
(m, 1H), 2.35 (s, 3H), 2.10 (ddd, J = 14.3, 10.4, 4.0 Hz, 1H), 1.86 (ddd, J = 14.1, 11.3, 2.9 Hz, 1H), 
1.70 (s, 1H). 13C NMR (151 MHz, CDCl3) δ 145.5, 141.3, 137.0, 135.9, 129.4, 128.5, 127.9, 127.5, 
125.7, 116.3, 71.9, 45.6, 42.0, 21.2. HRMS (ESI+) [2M+Na]+ calcd for C38H44O2Na+ 555.3239, 
found 555.3230. IR (n/cm-1): 3371 (br, m), 2920 (m), 1639 (m), 1514 (m), 1452 (m), 1050 (m).  
[a]22D = 16.2 (c =0.215, CH2Cl2, l = 100 mm). 
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3-allyl-5-methyl-1-phenylhex-4-en-1-ol (2.57). Following the procedure used for the 
synthesis of 32 with 2-bromonapthalene instead of 4-bromotoluene, 2.57 was obtained in 54% 
yield in >10:1 dr (16.3 mg). 1H NMR (600 MHz, CDCl3) δ 7.86 (m, 3H), 7.72 (s 1H), 7.50 (m, 
2H), 7.43 (dd, J = 8.4, 1.8 Hz, 1H), 7.32 (tt, J = 6.6, 1.3 Hz, 2H), 7.26 (m, 3H), 5.83 – 5.56 (m, 
1H), 5.09 – 4.80 (m, 2H), 4.39 (dd, J = 10.5, 2.7 Hz, 1H), 3.27 (m, 1H), 2.65 – 2.38 (m, 2H), 2.22 
(ddd, J = 14.3, 10.5, 3.9 Hz, 1H), 2.01 (ddd, J = 14.3, 11.3, 2.8 Hz, 1H), 1.86 – 1.74 (s, 1H). 13C 
NMR (151 MHz, CDCl3) δ 145.4, 141.9, 136.8, 133.7, 132.5, 128.6, 128.4, 127.8, 127.8, 127.6, 
126.9, 126.1, 125.9, 125.6, 125.5, 116.4, 71.9, 45.5, 42.7, 41.8. MS (ESI+) [M+Na]+ calcd for 
C22H22ONa+ 325.41, found 325.27. IR (n/cm-1): 3393 (m, br), 2975 (m), 2928 (m), 1600 (m), 
1507 (m), 1453 (m), 747 (s), 700 (s). [a]22D = 33.6 (c =0.815, CH2Cl2, l = 100 mm). 
 
(4S,6S)-2,2-dimethyl-4-(((S)-2-methyloxiran-2-yl)methyl)-6-phenyl-1,3-dioxane 
(2.59). Diol 2.58 (1.03 g, 5.0 mmol) was dissolved in DCM (50 mL) in a 100-mL single neck 
round bottom flask containing a stir bar under inert nitrogen atmosphere. VO(acac)2 (9.9 mg, 
0.04 mmol) was added to the flask and the reaction was cooled to -5 ºC in an ice bath. 1.8 mL of 
5.5 M tBuOOH (10 mmol) in tBuOH was added dropwise over 1 minute. The reaction was then 
stirred at -5 ºC for an additional 30 minutes and then allowed to warm to room temperature and 
stirred for 8 hours, monitored by TLC. The mixture was then transferred to a separatory funnel 
and the organic layer was washed with a saturated solution of sodium thiosulfate. The aqueous 










was then washed once with a saturated sodium chloride solution. The organics were then dried 
over magnesium sulfate and concentrated in vacuo. The crude product was then dissolved in 
DMF (32.0 mL) in a 100-mL single neck round bottom flask containing a stir bar and fitted with 
a rubber septum. The flask was purged with nitrogen and 2,2-dimethoxypropane was added (6.2 
mL, 10 eq, 50.0 mmol) to the flask. The septum was then quickly removed and pyridinium p-
toluenesulfonate (125.6 mg, 10 mol%) was added. The vial was then sealed, purged with 
nitrogen for two minutes, and then allowed to stir at room temperature for 18 hours. 1.0 mL of 
triethylamine was added to the reaction followed by a saturated solution of sodium bicarbonate. 
The mixture was extracted with diethyl ether, dried over magnesium sulfate, and concentrated 
in vacuo. The crude mixture was purified via silica gel chromatography (9:1 hexanes: EtOAc) to 
yield the product 2.59 in 55% yield and >20:1 dr (721.1 mg) as a clear oil. 1H NMR (600 MHz, 
CDCl3) δ 7.39 – 7.27 (m, 5H), 4.86 (dd, J = 9.7, 6.4 Hz, 1H), 4.04 (tdd, J = 9.3, 6.2, 3.7 Hz, 1H), 
2.78 (d, J = 4.8 Hz, 1H), 2.58 (d, J = 4.9 Hz, 1H), 2.04 (dd, J = 14.8, 8.8 Hz, 1H), 2.01 – 1.96 (m, 
1H), 1.91 (ddd, J = 13.0, 9.3, 6.4 Hz, 1H), 1.69 (dd, J = 14.8, 3.8 Hz, 1H), 1.46 (s, 3H), 1.45 (s, 
3H), 1.37 (s, 3H). 13C NMR (151 MHz, CDCl3) δ 142.5, 128.6, 127.6, 126.1, 101.1, 68.7, 63.7, 55.3, 
53.3, 42.2, 40.6, 30.5, 25.1, 24.8, 22.6. MS (ESI+) [M+Na]+ calcd for C16H22O3Na+ 285.14, found 
285.09. IR (n/cm-1): 2986 (s), 2930 (s), 1716 (w), 1558 (w), 1507 (w), 1378 (s), 1225 (s) 699 (s) 
[a]22D = -36.9 (c =0.165, CH2Cl2, l = 100 mm). 
 
(2R,4S)-1-((4S,6S)-2,2-dimethyl-6-phenyl-1,3-dioxan-4-yl)-2-methylhept-6-ene-
2,4-diol (2.60). Following the general procedure, 1,3-diol 2.60 was isolated in 75% yield in 
4.5:1 d.r. (12.5 mg) as a white solid. 1H NMR (600 MHz, CDCl3) δ 7.39 – 7.26 (m, 5H), 5.86 
(ddt, J = 17.2, 10.3, 7.1 Hz, 1H), 5.15 – 5.03 (m, 2H), 4.98 – 4.88 (m, 1H), 4.63 (s, 1H), 4.45 







1H), 2.35 – 2.26 (m, 1H), 2.22 – 2.14 (m, 1H), 2.06 – 1.92 (m, 2H), 1.89 (dd, J = 14.5, 10.8 Hz, 
1H), 1.71 – 1.56 (m, 3H), 1.52 (s, 3H), 1.46 (s, 2H), 1.34 (s, 3H). 13C NMR (151 MHz, CDCl3) δ 
142.1, 135.3, 128.7, 127.7, 126.1, 117.3, 101.3, 74.0, 73.9, 68.6, 67.6, 65.1, 48.1, 47.9, 44.1, 42.5, 
40.6, 39.6, 25.1, 25.1, 24.9. IR (n/cm-1):  3346 (br, s), 2850 (s), 2360 (s), 2341 (s), 1456 (m), 
1226 (m), 752 (w), 668 (w). MS (ESI+) [M+Na]+ calcd for C20H30O4Na+ 357.19, found 357.18. 
[a]22D = -11.0(c = 0.265, CH2Cl2, l = 100 mm). 
 
hex-5-ene-1,3-diol (2.63). Inside the glovebox, diborylmethane (26.8 mg, 0.1 mmol) was 
weighed into an 8 mL vial containing a stir bar and dissolved in THF (0.25 mL). Lithium 
2,2,6,6-tetramethylpiperidide (LTMP) (14.7 mg, 0.1 mmol) was weighed into a separate 8 mL 
vial and dissolved in THF (0.5 mL). Copper chloride (1 mg, 0.01 mmol) and ligand (0.02 mmol) 
were weighed into a third vial containing a stir bar and dissolved in THF (0.1 mL). The vials 
were sealed with septa lined caps and removed from the glovebox. The diborylmethane and 
LTMP solutions were cooled to 0 ºC and the LTMP was cannula transferred to the 
diborylmethane solution. The reaction was stirred at 0 ºC for 10 minutes. A solution of ethylene 
oxide (40 µL) was added to the vial and the reaction was allowed to warm to 22 ºC and stir for 
15 minutes. The reaction was then cannula transferred to the vial containing the copper catalyst. 
Allyl bromide (26 µL, 0.3 mmol) was added and the reaction was heated to 60 ºC for 24 hours. 
The reaction was then cooled to 0 ºC and a solution of NaOH (0.25 mL, 3M) was added followed 
by H2O2 (0.15 mL). The reaction was stirred at 0 ºC for two hours and then quenched (dropwise) 
with a saturated solution of sodium thiosulfate. The organics were extracted with ethyl acetate 
(x3), dried over MgSO4, and concentrated in vacuo to yield crude 2.63. The conversion to 
product was determined by 1H-NMR spectroscopy using DMF as an internal standard. The diol 
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b. CuCl (10 mol%)
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1H NMR (600 MHz, CDCl3) δ 5.92-5.73 (m, 1H), 5.24-5.11 (m, 2H), 4.01-3.80 (m, 2H), 2.43-
2.21 (m, 3H), 1.75 (tq, J=8.4, 4.1 Hz, 2H). 
 
Inside the glovebox, diborylmethane (26.8 mg, 0.1 mmol) was weighed into a vial with a stir bar 
and dissolved in THF (0.3 mL). Lithium 2,2,6,6-tetramethylpiperidide (LTMP) (15.5 mg, 0.105 
mmol) was weighed into a separate vial and dissolved in THF (0.7 mL). The vials were caped 
with septa lined caps and removed from the glovebox. Outside the glovebox, the vials were 
cooled to 0 ºC and the LTMP solution was cannula transferred to the diborylmethane solution. 
The reaction was stirred at 0 ºC for 10 minutes. Ethylene oxide in THF (80 µL, 0.2 mmol) was 
added and the reaction was allowed to warm to 22 ºC and stir for 15 minutes. The solvent was 
removed under a stream of dry nitrogen. Once dry, the vial was brought back into the glovebox. 
The solid residue was washed three times with hexanes and dried under vacuum. 1H NMR (500 
MHz, THF-d8) d 3.53 (m, 1H), 3.46 (m, 1H), 1.73 (m, 1H), 1.61-1.51 (m, 1H), 1.21 (m, 13H), 1.14-
0.93 (m, 13H), 0.14 (m, 1H). 13C NMR (126 MHz, THF-d8) d 80.8, 64.6, 31.6, 30.0, 22.5, 13.5. 
11B NMR (160 MHz, THF-d8) d 12.45. 
 
(1S)-1-phenyl-3-(p-tolyl)propane-1,3-diol (2.81). Inside the glovebox, diborylmethane 
(40.2 mg, 0.15 mmol) was weighed into an 8 mL vial containing a stir bar and dissolved in THF 
(0.4 mL). Lithium 2,2,6,6-tetramethylpiperidide (LTMP) (22.1 mg, 0.15 mmol) was weighed 
into a separate 8 mL vial and dissolved in THF (0.8 mL). The desired copper source (0.005 
mmol), palladium source (0.005 mmol), the desired ligand (0.006 mmol), and 4-bromotoluene 
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sealed with septa lined caps and removed from the glovebox. The diborylmethane and LTMP 
solutions were cooled to 0 ºC and the LTMP was cannula transferred to the diborylmethane 
solution. The reaction was stirred at 0 ºC for 10 minutes. R-styrene oxide (11 µL, 0.1 mmol) was 
added and the reaction was allowed to warm to 22 ºC and stir for one hour. The reaction was 
then cannula transferred to the vial containing the catalyst solution and the mixture was heated 
to 60 ºC for 24 hours. After 24 hours, the reaction was cooled to 0 ºC and a solution of NaOH 
(0.25 mL, 3 M) was added followed by H2O2. The reaction was stirred (with venting) at 0 ºC for 
2 hours. The reaction was then quenched (dropwise) at 0 ºC with a solution of saturated sodium 
thiosulfate. The organics were extracted with diethyl ether (x3), dried over magnesium sulfate, 
and concentrated in vacuo to yield the crude diol product. Conversion to product was 
determined using 1H-NMR spectrometry with DMF as internal standard. The product was 
isolated via silica gel chromatography and the structure confirmed through 1H-NMR analysis 
and matched known literature spectra.61 1H NMR (500 MHz, CDCl3) d 7.43 – 7.33 (m, 5H), 7.32 
– 7.24 (m, 4H), 7.18 (dd, J = 7.8, 5.9 Hz, 2H), 5.04 (dd, J = 10.2, 2.8 Hz, 1H), 5.01 (dt, J = 7.3, 
3.8, 1H), 4.96 (dd, J = 7.4, 4.4, 1H), 3.37 (s, 1H), 3.15 (s, 1H), 2.91 (s, 1H), 2.75 (s, 1H), 2.37 (s, 
3H), 2.36 (s, 1H), 2.23 -2.15 (m, 2H). 
 
(3R)-1-(p-tolyl)butane-1,3-diol (2.66) was prepared from propylene oxide according to the 
same procedure as 2.81. The conversion was determined using 1H-NMR spectroscopy with DMF 
as internal standard. The product was isolated via silica gel chromatography and the structure 
was confirmed using 1H-NMR analysis and comparison to reported literature spectra.62 1H 
NMR (500 MHz, CDCl3) d 7.33 – 7.24 (m, 3H), 7.16 (d, J = 7.9 Hz, 2H), 5.03 (dd, J = 7.9, 3.6 
Hz, 1H), 4.91 (dd, J = 10.3, 2.9 Hz, 1H), 4.18 – 4.11 (m, 1H), 4.07 (ddd, J = 8.2, 6.2, 3.0 Hz, 1H), 







(1S)-1-phenylbutane-1,3-diol (2.82) was prepared following a modified literature 
procedure.55 Inside the glovebox, diborylethane (42.0 mg, 0.15 mmol) was weighed into an 8 mL 
vial containing a stir bar and dissolved in THF (0.4 mL). Lithium 2,2,6,6-tetramethylpiperidide 
(LTMP) (22.1 mg, 0.15 mmol) was weighed into a separate 8 mL vial and dissolved in THF (0.8 
mL). Cesium fluoride (23 mg, 0.15 mmol) was weighed into a third vial containing a stir bar. All 
of the vials were sealed with septa lined caps and removed from the glovebox. The LTMP and 
diborylethane solutions were cooled to 0 ºC and the LTMP solution was cannula transferred to 
the diborylethane solution. The reaction was stirred at 0 ºC for 10 minutes. Styrene oxide (11 µL, 
0.1 mmol) was added and the reaction was heated to 45 ºC for 24 hours. After 24 hours, the 
reaction was cooled to 22 ºC and cannula transferred to the vial containing the cesium chloride. 
Water (2 µL, 0.11 mmol) was added to the reaction and it was heated to 45 ºC for 24 hours. After 
24 hours, the reaction was cooled to 22 ºC and quenched with a saturated, aqueous solution of 
ammonium chloride. The organics were extracted with diethyl ether (x3), dried over magnesium 
sulfate, and concentrated in vacuo to yield crude 2.69. The crude conversion was determined to 
be 43% with 8:1 dr by 1H-NMR analysis using DMF as an internal standard. To confirm the 
structure of the product, 2.69 was oxidized to 2.81. Crude 2.69 was dissolved in THF (0.25 
mL) and cooled to 0 ºC. NaOH (0.25 mL, 3 M) was added followed by hydrogen peroxide (0.15 
mL) and the reaction was allowed to stir (with venting) for 2 hours at 0 ºC. The reaction was 
quenched (dropwise) at 0 ºC with a saturated aqueous solution of sodium thiosulfate. The 
organics were extracted with diethyl ether (x3), dried over magnesium sulfate, and concentrated 
in vacuo to yield crude 2.82. A sample of the pure diol was isolated via silica gel 
chromatography and the structure was confirmed via 1H-NMR analysis and comparison to 








1. THF, 45 ºC, 24 h
2. CsF (1.5 eq), H2O (1.1 eq)
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1H), 5.09 (dd, J = 7.7, 3.7 Hz, 1H), 4.97 (dd, J = 10.2, 3.0 Hz, 1H), 4.29 – 4.17 (m, 1H), 4.10 (ddd, 
J = 8.2, 6.3, 3.1 Hz, 1H), 1.91 (qdd, J = 14.6, 7.9, 3.4 Hz, 2H), 1.27 (m, 3H). 
 
tert-butyldimethyl(((4R,6R)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-
yl)hexadec-1-en-6-yl)oxy)silane (2.28). 2.28 was prepared following a modified literature 
procedure.55 Inside the glovebox, allyl diboronate ester (23 mg, 0.075 mmol) was weighed into 
an 8 mL vial containing a stir bar and dissolved in THF (0.2 mL). Lithium 2,2,6,6-
tetramethylpiperidide (LTMP) (11 mg, 0.075 mmol) was weighed into a separate 8 mL vial and 
dissolved in THF (0.4 mL). Cesium fluoride (12 mg, 0.075 mmol) was weighed into a third vial 
containing a stir bar. All of the vials were sealed with septa lined caps and removed from the 
glovebox. The LTMP and diborylethane solutions were cooled to 0 ºC and the LTMP solution 
was cannula transferred to the diborylethane solution. The reaction was stirred at 0 ºC for 10 
minutes. Dodecene oxide (11 µL, 0.05 mmol) was added and the reaction was heated to 45 ºC for 
24 hours. After 24 hours, the reaction was cooled to 22 ºC and cannula transferred to the vial 
containing the cesium chloride. Water (1 µL, 0.05 mmol) was added to the reaction and it was 
heated to 45 ºC for 24 hours. After 24 hours, the reaction was cooled to 22 ºC and quenched 
with a saturated, aqueous solution of ammonium chloride. The organics were extracted with 
diethyl ether (x3), dried over magnesium sulfate, and concentrated in vacuo to yield crude 2.28. 
The crude conversion was determined to be 59% with 3:1 dr by 1H-NMR analysis using DMF as 
an internal standard. To confirm the structure of the product, the crude mixture was dissolved 
in DMF (0.3 mL) and treated with TBSCl (23 mg, 0.15 mmol) and imidazole (10 mg, 0.15 mmol). 
The reaction was stirred for 24 hours at 22 ºC and then quenched with a saturated solution of 








a. THF, 45 ºC, 24 h
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chloride, and concentrated in vacuo to yield the crude product. The structure was confirmed by 
comparison of the 1H-NMR spectra to that previously reported.  
2.8.6 NMR Studies 
 
Inside the glovebox, diborylmethane (40.2 mg, 0.15 mmol) was weighed into a vial with a stir 
bar and dissolved in THF-d8 (0.4 mL). Lithium 2,2,6,6-tetramethylpiperidide (LTMP) (22 mg, 
0.15 mmol) was weighed into a separate vial and dissolved in THF-d8 (0.8 mL). An NMR tube 
was sealed inside the glovebox with a septa cap. The vials and NMR tubes we all removed from 
the glovebox. The diborylmethane and LTMP solutions were cooled to 0 ºC in an ice water bath 
and the LTMP solution was cannula transferred to the diborylmethane solution. This mixture 
was allowed to stir at 0 ºC for 10 minutes. (R)-styrene oxide was then added via syringe and the 
reaction was allowed to warm to room temperature until the reaction became homogeneous. 
The mixture was then canula transferred to the NMR tube. The septa cap of the NMR tube was 
then sealed tightly with electrical tape. 1H-NMR spectra were taken at 22 ºC, 40 ºC, and 60 ºC. 
11B-NMR spectrum was obtained at 22 ºC. Inside the glovebox CuCl was weighed into a vial. The 
vial was sealed with a septa cap and removed from the glovebox. A new NMR tube was also 
sealed with a septa cap inside the glovebox and removed. The reaction mixture was cannula 
transferred from the NMR tube to the vial containing CuCl. Allyl bromide was added to the vial 
via syringe. The mixture was then transferred to the new NMR tube and the septa cap of the 
NMR tube was sealed tightly with electrical tape. The reaction was monitored via 1H-NMR at 22 
ºC, 40 ºC, and 60 ºC and 11B-NMR at 60 ºC. 













































































































1H-NMR (500 MHz, THF-d8)














1H-NMR (500 MHz, THF-d8)
NOESY at 4.640 ppm
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2.77
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13C-NMR (CDCl3, 151 MHz)
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Chapter 3 Synthesis of Stereodefined Alkenyl Boronates from Epoxides and 
Diborylmethane through Pd-Catalyzed Dehydroboration1 
 
3.1 Introduction 
Developing new methods for the synthesis of versatile functional groups is a primary 
goal of organic chemistry research. Even when methods exist for making a specific functional 
group, new methods that do so more efficiently or from different starting materials are always 
useful. In particular, multicomponent or tandem reactions which generate multiple new 
functional groups in one reaction from simple, readily available starting materials are attractive 
transformations. Tandem reactions increase the efficiency with which important chemical 
building blocks are accessed. One class of useful chemical building blocks are alkenyl boronate 
esters. 
3.2 Background 
Alkenylboronate esters are an attractive functional group for organic synthesis as they 
can be used to install a wide variety of functionality into a molecule. For example, new C-C 
bonds can be formed utilizing cross-coupling methodologies.1–4 Additionally, transformation 
such as cycloproponation5,6, hydroboration7, allylation8, and enantioselective diboration9 can be 
conducted on the olefinic component.  The abundance of functional groups that are easily 
accessible from vinyl boronate esters makes them useful moieties for the synthesis of complex 
molecules.  
																																																						
1 A portion of this work appeared as a communication in Organic Letters. The full reference is as 
follows: Murray, S. A.; Luc, E. C. M.; Meek, S. J. Org Lett. 2018, 20, 469-471.	
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3.2.1 Current methods for preparation of alkenyl boronates 
A variety of methodologies for the synthesis of akenylboronate esters currently exist. 
Figure 3.1 highlights some of these methods including olefin C-H borylation,10–15 alkyne 
hydroboration,16,17 cross-metathesis,18–20 cross-coupling,21,22 and boron-Wittig.23–31 Each of these 
methodologies have their own benefits and limitations. Alkene C-H borylation methods include 
rhodium, iridium, and palladium catalyzed approaches. One of the major challenges in these 
methodologies is selective incorporation of only a single boron unit as opposed to 
polyborylation.10–15 Alkyne hydroboration is a well-studied area of organic chemistry and can be 
catalyzed by a multitude of metals including copper, iron, rhodium, zirconium, and cobalt. 
Additionally, metal free methodologies also exist. While these methodologies have been widely 
studied and are often used, they are not always the most attractive approach for two reasons: it 
can be difficult to achieve selective monoboylation at the desired position and the borane 
derivatives required are highly reactive and air sensitive making them difficult to work with.16,17  
Cross metathesis using ruthenium, molybdenum or tungsten based catalysts can be a 
useful way to make vinyl boronate esters in both good yield and olefin geometry selectivity 
which is dependent upon the identity of the catalyst. The main drawback of these methodologies 
is the inability to make tri and tetra-substituted alkenyl boronate esters.18–20 Cross coupling has 
been studied as well using a palladium catalyst to couple together B2(pin)2 and either vinyl 
bromides or vinyl triflates.21,22 
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Figure 3.1 Metal catalyzed methods for the synthesis of vinyl boronate esters 
The boron-Wittig reaction is one method for synthesizing vinyl boronic acid pinacol 
esters that does not require a metal catalyst. The boron-Wittig reaction was pioneered by 
Matteson23–26 and recently presented as a method for the synthesis of vinyl boronate esters by 
Morken and coworkers (Scheme 3.1).30 The reaction couples together aldehydes and 1,1-
organodiboron compounds to produce the desired olefinic products. The diboron reagent is first 
treated with LTMP to deprotonate the methylene unit forming the reactive boron-stabilizd 
carbanion. This carbanion then adds to the carbonyl carbon of the aldehyde generating a 1,2-
hydroxy-bisboryl species. The resulting negatively charged oxygen species can then chelate to 
(b) Hydroboration of Alkynes
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one of the adjacent boron groups creating a 4-membered borate containing ring. The formation 
of this borate will induce a Wittig type elimination to occur expelling the LiOB(pin) group and 
forming the desired olefin. Morken’s methodology enables the synthesis of vinyl boronates with 
a variety of substitution patterns depending on the conditions used. For example, the use of the 
pinacol derived diboron reagent typically yields the Z product in moderate selectivity while 
switching to the dimethyl pentanediol (dmpd) protected boron reagent leads the E product in 
moderate selectivity. While the boron-Wittig elimination process is a useful means of forming 
alkenyl boronates, it does come with the drawback that the useful alcohol functional group that 
is generated from the initial attack from the diboronate ester onto the carbonyl is removed from 
the product in the elimination step.  
 
Scheme 3.1 Synthesis of vinyl boronate esters via boron-Wittig elimination 
3.2.2 Synthesis of enantioenriched b-hydroxy alkenyl boronates 
A straightforward approach to synthesizing enantioenriched b-hydroxy alkenyl 
boronates is the metathesis reaction of a vinyl boronate ester and a stereodefined allylic alcohol 
as illustrated in Figure 3.2. Vinyl boronate ester 3.6 is commercially available, however the 
necessary chiral allylic alcohol coupling partner typically need to be synthesized. There are 
several ways to make the allylic alcohols in high levels of enantioselectivity. The first is an 
iridium-catalyzed allylic substitution methodology developed by Carreira and Helmchen.32–34 
This method utilizes an iridium phosphoramidite catalyst system to convert linear allylic 
carbonates to stereodefined secondary allylic alcohols under mild conditions. Enzymatic 
methods also exist to resolve racemic mixtures of secondary allylic alcohols. This methodology 
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enantiomer as the secondary alcohol.35 Additionally, Hoveyda and coworkers have develop a 
methodology that employs a copper-NHC catalyst for the enantioselective allylic substitution of 
allylic carbonates to secondary allylic boronates which can then be stereospecifically oxidized to 
yield the desired enantioenriched allylic alcohols.36 Of particular note, this methodology can be 
utilized for the enantioselective synthesis of tertiary allylic alcohols.   
 
Figure 3.2 Synthesis of enantioenriched allylic alcohols 
While methodologies to make these molecular scaffolds do exist, there are some 
drawbacks that are illustrated in the previous examples. While the methods to obtain 
enantioenriched allylic alcohols for use in metathesis exist, this approach is not the most 
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pathways are often substrate dependent so the breadth of scope of available starting materials is 
limited. Therefore, the development of new methodologies for the synthesis of enantioenriched 
b-hydroxy alkenyl boronates that take a different synthetic approach and can potentially utilize 
more commercially available starting materials would be useful to the synthetic community. 
3.2.3 Synthesis of b-hydroxy alkenyl boronates via dehydroboration 
Epoxides are an attractive class of molecules to use in the synthesis of b-hydroxy alkenyl 
boronates since many enantioenriched epoxides are commercially available and the synthesis 
and resolution of epoxides is a well-developed field. Using deprotonated 1,1-organodiboronate 
esters to open epoxides generates the compound 3.27 shown in Scheme 3.2. Since previous 
work had illustrated that this intermediate is reactive in boron based functionalization, it had 
potential to be a useful intermediate for the synthesis of b-hydroxy alkenyl boronates.  
 
Scheme 3.2 Epoxide opening with diborylmethane to generate a chelated borate intermediate 
In order to use intermediate 3.27 as a means of forming alkenyl boronates, an approach 
different from the boron-Wittig reaction must be taken. The reasoning for this is two-fold. First, 
the alcohol is a desirable functional group and incorporating it into the product would be very 
useful. Additionally, intermediate 3.27 can be achieved with defined stereochemistry at the 
alcohol position through the use of an enantioenriched epoxide starting material. This then 
allows for the incorporation of a chiral alcohol into the product. Secondly, the 1,3 relationship 
between the alcohol and the boron will allow for a chelate to form, however it will not allow for 
the Wittig type elimination to occur. The boron-Wittig elimination requires a 1,2 orientation 



















allylation of intermediate 3.27 illustrated that the activation of the boron by the coordinating 
oxygen is enough to facilitate transmetallation to a copper catalyst. It was therefore plausible 
that transmetallation to other metal catalysts could be achieved.  
3.2.4 Precedent for Pd-catalyzed formation of olefins via dehydrogenation 
In 2015, Newhouse and coworkers reported the palladium-catalyzed dehydrogenation of 
esters and nitriles.37 Up to this point, dehydrogenation of strongly electron withdrawing groups 
such as esters and nitriles could not be accomplished in a single synthetic step. Newhouse’s 
work presented a methodology to achieve the formation of carbon-carbon double bonds 
adjacent to electron withdrawing groups in a single step using a palladium catalyst. Using a 
strong base such as LTMP and a zinc additive, an alkyl ester is deprotonated at the b-position. 
This alkyl zinc (3.33) can then undergo transmetallation to the palladium catalyst (3.32). This 
alkyl palladium species (3.34) can then undergo b-hydride elimination to release the desired 
product (3.29). This methodology proved to be suitable for a variety of alkyl esters and nitriles. 
Later in 2016, this work was extended to include amides and was even viable in the presence of 
free alcohols and amines.38 
A similar mechanistic approach can be envisioned for transforming intermediate 3.27 
into a b-hydroxy alkenyl boronate ester. The boron participating in the oxygen chelate is ready 
for transmetallation to palladium. If the intermediate can successfully transmetallate to 
palladium, the resulting alkyl palladium species will behave analogously to intermediate 3.34 in 
the mechanism proposed by Newhouse resulting in a b-hydride elimination to furnish the 
desired alkenyl boronate ester. This proposed reaction is outlined in Scheme 3.3. 
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Figure 3.3 Pd-catalyzed ester dehydrogenation developed by Newhouse and coworkers 
 
Scheme 3.3 Proposed reaction 
3.3 Synthesis of alkenyl boronates via Pd-catalyzed dehydroboration39 
3.3.1 Reaction optimization 
Initial reaction screening was completed using a palladium allyl chloride dimer as 
catalyst, allyl chloride as the oxidant, and styrene oxide at 20 ºC for 24 hours which did not 
result in the generation of product (Table 3.1, Entry 1). Increasing the temperature to 40 ºC 
afforded the desired product in 42% yield (Table 3.1, Entry 2) and further warming to 60 ºC 
increased the conversion to 63% (Table 3.1, Entry 3). Initially, it appeared that the product 
was formed as a mixture of olefin isomers as two pairs of doublets were visible for the olefin in 
the 1H-NMR spectra of the compound. However, upon purification via silica gel chromatography 
only the trans-olefin isomer was isolated. Revisiting the crude 1H-NMR spectra of the compound 
showed that the two pairs of doublets had almost identical coupling constants indicating that 
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the two compounds being formed were not likely to be olefin isomers as a significant difference 
in coupling constants would be expected. It was then proposed that the two observed 
compounds were the desired product and a related compound where the B(pin) group was still 
bound to the oxygen. This coordination of boron to the oxygen occurs in the catalytic cycle but 
should be substituted out by a proton during the aqueous ammonium chloride workup 
conditions that the reaction is subjected to. It was theorized that the ammonium chloride 
quench followed by immediate extraction was not sufficiently protonating the alcohol in the 
product. To overcome this, the workup was modified to include a 30-minute stir of the crude 
reaction with a solution of saturated aqueous ammonium chloride. This resulted in the 
formation of a single product as the free alcohol under all reaction conditions. 
Table 3.1 Reaction optimization 
 
Both monodentate and bidentate ligands were then explored to try to increase the 
conversion to the desired alkenyl boronate product, however Pd complexes with phosphine 




B(pin) 1. THF, 22 ºC, 1 h
2. [Pd] 2.5 mol%








entrya Pd catalyst temp ºC convb (%); 3.31:3.32 E:Z
1 [Pd(allyl)Cl]2 20 <5: -
2 [Pd(allyl)Cl]2 40 42; >98:2 >20:1
3 [Pd(allyl)Cl]2 60 63; >98:2 >20:1
4 Pd(PPh3)4 60 59; <2:98
5 PdCl2(dppb) 60 76; <2:98
6 PdCl2(dppf) 60 46; <2:98
7 Pd(dba)2, binap 60 63; <2:98
8c [Pd(allyl)Cl]2 60 62; >98:2
9d [Pd(allyl)Cl]2 60 60; >98:2
>20:1
>20:1
aReactions performed under N2 atm. bValues determined by analysis of 400 
or 600 MHz 1H NMR spectra of unpurified mixtures with DMF as internal 
standard. cReaction run at [0.16M]. dReaction run at [0.05M]
3.39 3.25 3.40 3.41
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3.1, Entries 4-7) all provided moderate to good yields of the O-allylated product 3.41 instead 
of the desired alkenyl boronate ester 3.40. Lastly, the role that concentration played in the 
reaction was explored by conducting the reaction at both an increased and decreased 
concentration however no major change in conversion was observed (Table 3.2, Entries 8 & 
9). Allyl acetate was also studied as the oxidant instead of allyl chloride since it is the best 
oxidant in the work by Newhouse and coworkers37,38 however, it resulted in a decrease in 
conversion to 54%. 
3.3.2 Substrate scope 
Aryl epoxides were the first class of epoxides applied to this reaction. Substitution at the 
ortho, meta, and para positions were all tolerated as illustrated in Figure 3.4 with compounds 
3.40 and 3.42 – 3.45. It was also illustrated using the unsubstituted styrene oxide that the 
defined alcohol stereocenter derived from the epoxide remains enriched in the product by 
determining the enantiomeric excess of product 3.31 via chiral HPLC separation. After proving 
that the stereocenter is maintained throughout the reaction with model substrate 3.31, most 
other substrates explored in this scope were racemic. When enantioenriched epoxides were used 
as substrates the stereochemistry is clearly illustrated in the product.  
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Figure 3.4 Substrate scope - aryl epoxides 
A variety of simple alkyl epoxides were also successful in this reaction and typically gave 
better yields than what was observed with the aryl epoxides. Dodecyl and cyclohexyl substituted 
epoxides both yielded the desired alkenyl boronate in 71% yield as a single olefin isomer. The 
reaction to yield product 3.48 was completed on a gram scale in 61% yield. Benzyl substituted 
epoxide 3.49 also fared well giving the desired product in 69% yield as a single diastereomer. 
The simplest epoxide available, ethylene oxide, was successful in the reaction albeit in lower 
yield at only 23%. In the optimized reaction, the boron reagent is present in excess (1.5 eq) but 
due to the volatile nature of ethylene oxide, excess ethylene oxide was used in this reaction 
which most likely contributed to the decreased yield. 
The simple transition from ethylene oxide to propylene oxide (3.50) resulted in a 
dramatic increase in yield to 71%. Propylene oxide is a liquid at room temperature and therefore 
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Reactions performed under N2 atm. Yield represents isolated yield of purified material and is an 
average of two runs.
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(3.52) yielded a similar result to propylene oxide at 75%. Both of these products were obtained 
as single olefin isomers.  
 
Figure 3.5 Substrate scope - alkyl epoxides 
In addition to isobutylene oxide, other 1,1-disubsituted epoxides were also tolerated such 
as a-methyl styrene oxide (3.53). Product 3.54 which was obtained in 53% yield was derived 
from the previous work through a ring opening, allylation, epoxidation, and protection sequence 
which was explained in detail in Chapter 2. Both of these products were isolated as single olefin 
isomers.  
The reaction was also tolerant of epoxides fused on 6-membered rings. Cyclohexene 
oxide opened in 50% yield (3.55) as a single olefin isomer with the boron unit trans to the 
alcohol substituent as expected. The more complex limonene oxide (3.56) led to a diminished 
34% conversion. Interestingly, cyclopentene oxide (3.57) was not a viable substrate for this 
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reaction. The epoxide did not appear to undergo ring opening under the optimized reaction 
conditions or at increased temperature.  
 
Figure 3.6 Substrate scope - di & trisubstituted epoxides 
The last epoxide substrates explored for this reaction were complex steroid derived 
molecules. In particular, a progesterone derived epoxide which led to product 3.58 in 47% yield 
as a single olefin isomer and an androsterone derived epoxide which yielded product 3.59 in 
67% yield and 5:1 dr as a single olefin isomer. The dr for the androsterone based product is the 
same dr as the starting epoxide.  
Reactions performed under N2 atm. Yield represents isolated yield of purified material 
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Figure 3.7 Substrate scope - steroid derived epoxides 
After successfully exploring the substrate scope with respect to the epoxide, further 
expansion of the substrate scope was explored. Oxetanes, the four-membered analogs of 
epoxides, can also undergo ring opening when treated with a nucleophile such as a Grignard 
reagent.40,41 Exposing an oxetane to the lithiated diborylmethane species should result in ring 
opening and the formation of a chelate similar to that with the epoxides. In this case, the chelate 
would be a six-membered ring instead of the five-membered ring generated from reaction with 
an epoxide. Six membered rings are an energetically favorable ring size so forming this chelate 
should be possible. Treating trimethylene oxide with 3.25 in THF at 45 ºC for 24 hours followed 
by addition of palladium and allyl chloride and increasing the reaction temperature to 60 ºC for 
an additional 24 hours resulted in a 20% NMR conversion to the desired alkenyl boron 
compound 3.62 as a single olefin isomer. In an attempt to increase the yield, an excess of 
oxetane was used however this did not result in an improved reaction.  
 
Scheme 3.4 Substrate scope – oxetane 
Reactions performed under N2 atm. Yield represents isolated yield of purified material 
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B(pin) 1. THF, 45 ºC, 24 h
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There are a couple of possible reasons why the reaction with the oxetane is not as high 
yielding as the epoxide reactions. First, trimethylene oxide is a completely unsubstituted 
oxetane and the most comparable epoxide would be ethylene oxide. As previously discussed, 
ethylene oxide is a very poor substrate for this reaction producing a yield that is quite 
comparable to that observed with oxetane. With the epoxides, the addition of a simple methyl 
group was enough to dramatically increase the conversion from 23% to 71%. It is possible that 
this increase is simply due to the highly volatile nature of ethylene oxide or that the presence of 
substitution on the ring helps to improve the efficiency of the ring opening or stability of the 
chelated intermediate. Applying this reaction to more substituted oxetanes could result in an 
increase in yield. 
Another possible reason for the decrease in reactivity could be the change in shape from 
epoxide to oxetane. The bond angles in a four-membered ring are significantly bigger (around 
90º) than those in a three-membered ring (around 60º) and the approach of the nucleophile to 
the ring might need to occur differently than in the epoxide chemistry. This could be similar to 
the reaction with cyclopentene oxide in which the epoxide did not open most likely due to 
conformational or steric restraints. One more possible explanation is derived from the size of the 
chelate. As is illustrated by the increased temperature (60 ºC) required to give appreciable 
product yields in this reaction, transmetallation from the chelated intermediate to the palladium 
is potentially a challenging mechanistic step. The transmetallation from the six-membered 
chair-like chelate formed from opening the oxetane might be an even more difficult ring to break 
than the five-membered chelate which could contribute to the decreased yield. 
The other component to the scope of the reaction is with respect to the boron reagent. 
When diborylethane, 3.63, was used in place of diborylmethane no product was observed. It 
was known from previous work (see Chapter 2) that the lithiated derivative of diborylethane is 
reactive enough to open dodecene oxide at 45 ºC over 24 hours, however this ring opened 
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intermediate had not been reactive towards allylation chemistry. This same trend was observed 
in this palladium-catalyzed reaction resulting in no conversion to the desired product.  
 
Scheme 3.5 Substrate scope – diborylethane 
Another potential modification to expand the scope of the reaction would be to substitute 
one of the boron moieties for a different group. This would potentially allow for the chelate to 
still exist through the remaining boron and allow for transmetallation to the palladium, however 
instead of eliminating to form an alkenyl boronate ester, an alkene with a different terminal 
group would be formed. In order for this to work, a derivative of diborylmethane is needed that 
was easy to synthesize, stable, and sufficiently acidic at the methylene protons to allow for easy 
deprotonation. In 1982 Matteson and coworkers reported the synthesis of mixed boron silicon 
reagents such as compound 3.65.42 In their work, they illustrated the synthesis for this reagent 
and conducted deprotonation studies to explore the relative acidity of the methylene unit. Their 
work suggested that this reagent could be viable in our reaction as the methylene position could 
be deprotonated by LTMP with TMEDA as activator.42 This reagent could either generate the 
alkenyl silane via boron transmetallation to palladium followed by elimination or generate an 
undesired 1,4-Brook rearrangement side product.  
To test the viability of 3.65 in this reaction, it was treated with LTMP at 0 ºC for 30 
minutes followed by addition of styrene oxide and warming to room temperature for one hour. 
After one hour at room temperature the reaction mixture was transferred to the Pd catalyst and 
allyl chloride was added. The reaction was heated to 60 ºC for 24 hours and a 20% yield of a 
single olefin isomer was observed. Additionally, 23% of the ring opened but not eliminated 
product was observed. The vinyl silane product was the only elimination product observed, no 
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both the dehydrosilylation reaction and the 1,4-Brook rearrangement. Adding TMEDA to the 
deprotonation step to emulate Matteson’s conditions42 did not yield any of the desired product. 
This is most likely due to the TMEDA ligating to the palladium catalyst generating a species that 
is not catalytically competent. 
 
Scheme 3.6 Substrate scope - mixed boron silicon reagent 
3.3.3 Mechanistic studies of vinyl silane formation 
To gain additional insight into why this reaction was so low yielding relative to the 
diborylmethane variant, an NMR study was undertaken. 3.65 was treated with LTMP in 
deuterated THF followed by addition of styrene oxide. Following the reaction via 1H NMR 
revealed a 59% conversion to cyclic borates 3.67 and 3.68 in a 1.7:1 ratio. This is slightly lower 
yielding and slightly more diastereoselective than what is oberserved via 1H NMR when the 
reaction is conducted with diborylmethane (see Chapter 2). Additionally, 32% of unreacted 3.39 
was observed. The ratio and quantity of the cyclic borates did not change upon heating the 
reaction mixture to 60 ºC in the spectrometer. Upon addition of the palladium and allyl 
chloride, a complex mixture was observed. Both of the cyclic borates began to be consumed, the 
olefin peaks of the product began to grow in, and a multitude of unidentifiable peaks grew in 
(see Experimental). This complex spectrum prevented further analysis of the reaction after the 
addition of the palladium catalyst and allyl chloride. However, since the conversion to the cyclic 
borates is significantly higher than the conversion to the final product, the decreased efficiency 
must be related to the dehydroboration step. This was further confirmed through a separate 
control reaction in which 3.65 was deprotonated with LTMP under these conditions and the 
resulting anion was quenched with allyl bromide. The resulting allyl product was obtained in 
(pin)B H
SiMe3
1. LTMP (1.5 eq), THF 
0 ºC, 30 min
2. THF, 22 ºC, 1 h
3. [Pd(Cl)(η3-C3H5)]2 (2.5 mol%)

















65% conversion with 26% returned starting material (see Experimental). This supports the 
theory that the difficult step is the dehydroboration reaction since the conversion to allyl 
product is comparable to the amount of cyclic borate seen in the NMR experiment. 
 
Scheme 3.7 Mechanistic studies 
2.3.4 Product Functionalizations 
To illustrate the versatility of the products two types of functionalizations were 
undertaken. First, the application of these alkenyl boronates to cross coupling was studied 
(Figure 3.8). Using cross coupling conditions employing 
tetrakis(triphenylphosphine)palladium as catalyst and cesium carbonate as a base additive in a 
mixture of toluene and water at 80 ºC, good yields of cross coupled product were obtained. 
Compound 3.47 was successfully coupled to a vinyl bromide to yield diene 3.70 in 65% yield as 
well as with 3-bromopyridine to yield the heterocyclic product 3.73 in 59% yield. Notably, these 
cross couplings could be carried out directly on the alkenyl boronates without protection of the 
alcohol.  
 
Figure 3.8 Cross coupling of alkenyl boronate products 
(pin)B H
SiMe3
1. LTMP (1.5 eq), 
THF-d8 
0 ºC, 30 min
2. THF-d8, 



















59% conv, 1.7:1 dr 
32% unreacted 3.39
dr & conv unchanged at 60 ºC
3. [Pd(Cl)(η3-C3H5)]2 
(2.5 mol%)



































The second functionalization studied employed the adjacent hydroxyl group as a 
directing group in a diastereoselective Simmons-Smith cycloproponation following conditions 
developed by Shi and coworkers.5,6 Taking vinyl boronate 3.74 and treating it with an excess of 
diethylzinc and diiodomethane in a mixture of trifluoroethanol and hexanes at 22 ºC for 24 
hours resulted in the cycloproponation of the olefin in 65% yield as a single diastereomer (3.75).  
 
Figure 3.9 Cycloproponation of alkenyl boronate ester 
3.4 Conclusion 
In summary, an efficient synthesis of alkenyl boronates from 1,1-diborylmethane and 
epoxides utilizing a simple palladium catalyst system and allyl chloride as a sacrificial hydride 
acceptor was developed. This reaction gives the desired hydroxy alkenyl boronates in good yield 
as a single olefin isomer for both alkyl and aryl epoxides. The readily available nature of 
enantioenriched epoxides makes this an attractive method for the synthesis of these compounds 
as single enantiomers. Further application of this methodology to oxetanes and mixed boron-
silicon reagents was explored with minimal success resulting in about 20% yield to the desired 
products in both cases. 1H-NMR studies indicated that the epoxide was undergoing ring opening 
with the boron-silican reagent in higher yields (59%), therefore the reason for the decreased 
efficiency must be related to the dehydroboration step. The complex mixture obtained upon the 
addition of palladium and allyl chloride to the 1H-NMR reaction prevented further study of the 
mechanism. Versatility of the products was demonstrated through cross coupling of the alkenyl 



















All reactions were carried out in oven-dried (150 ºC) or flame dried glassware under 
inert atmosphere of dried nitrogen unless otherwise noted. Analytical thin-layer 
chromatography was performed on glass plates coated with 0.25 mm of 60 Å mesh silica gel. 
Plates were visualized by exposure to UV light (254 nm) and/or immersion into Seebach’s or 
KMnO4 stain followed by heating. Column chromatography using silica gel was performed using 
P60 (mesh 230-400) supplied by Silicycle. All solvents were sparged with argon and then 
purified under a positive pressure of argon through an SG Water, USA Solvent Purification 
System. Tetrahydrofuran (Omnisolv) was passed successively through two columns of neurtral 
alumina. The ambient temperature in the laboratory was approximately 22 ºC. 
3.5.2 Instrumentation 
All 1H NMR spectra were recorded on Bruker Spectrometers (AVANCE-600, Bruker 500, 
and DRX 400). Chemical shifts are reported in ppm from tetramethylsilane and referenced to 
the residual protio solvent peak (CDCl3: δ 7.26; C6D6: δ 7.16; THF-d8 δ 3.58). Data are reported 
as follows: chemical shift, multiplicity (s = singlet, d = doublet, t = triplet, qu = quartet, quint = 
quintet, br = broad, m = multiplet, app = apparent), integration, and coupling constants are 
given in Hz. 13C NMR spectra were recorded on Bruker Spectrometers (AVANCE-600 and 
Bruker 500) with carbon and proton decoupling. Chemical shifts are reported in ppm from 
tetramethylsilane and referenced to the residual protio solvent peak (CDCl3: δ 77.16; C6D6: δ 
128.06, THF-d8 δ 67.21). 11B NMR spectra were recorded on a Bruker model 500 MHz 
spectrometer. All IR spectra were recorded on a Jasco 260 Plus Fourier transform infrared 
spectrometer. High-resolution mass spectrometry samples were analyzed with a hybrid LTQ FT 
(ICR 7T) (ThermoFisher, Bremen, Germany) mass spectrometer. Samples were introduced via a 
microelectrospray or APPI source at a flow rate of 10 µL/min in methanol or acetone. Xcalibur 
(ThermoFisher, Breman, Germany) was used to analyze the data. Molecular formula 
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assignments were determined with Molecular Formula Calculator (v 1.2.3). All observed species 
were singly charged, as verified by unit m/z separation between mass spectral peaks 
corresponding to the 12C and 13C12Cc-1 isotope for each elemental composition. MassHunter 
Quantitative Analysis (Agilent, Waldbronn, Germany) was used to analyze the data. Solutions 
were dissolved in MeOH at 0.1 mg/mL or less and diluted appropriately based on 
responsiveness to the ESI mechanism. Molecular formula assignments were determined with 
Molecular Formula Calculator (v 1.2.3). The success of mass data for molecular ions was 
considered based on the widely-accepted accuracy threshold for confirmation of elemental 
compositions established at 5 ppm. All observed species were singly charged, as verified by unit 
m/z separation between mass spectral peaks corresponding to the 12C and 13C12Cc-1 isotope for 
each elemental composition. Optical rotations were determined using a Jasco P1010 polarimeter 
and concentrations are reported in g/100mL. Enantiomeric ratios were determined on an 
Agilent Technologies 1220 Infinity LC using a Diacel CHIRALPAK IA (4.6 mm x 250 mm x 5µm) 
column. Melting points were determined using a Mel-TempÒ apparatus. 
3.5.3 Reagents 
Allylbenzene was purchased from Alfa Aesar and used as received. 
Allylchloride was purchased from Sigma Aldrich, plugged through neutral alumina before use 
and stored under nitrogen. 
Allyl palladium(II) chloride dimer ([Pd(allyl)Cl]2) was purchased from Strem, stored at 
-20 ºC in a nitrogen filled glovebox and used as received. 
a-methylstyrene was purchased from Alfa Aesar and used as received.  
Ammonium chloride was purchased from Alfa Aesar and used as received. 
Benzene-d6 was purchased from Cambridge Isotope Laboratories and used as received. 
Bis(dibenzylideneacetone)palladium (0) (Pd(dba)2) was purchased from Strem and 
stored in a nitrogen filled glovebox.  
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1,4-Bis(diphenylphosphino)butane (dppb) was purchased from Strem and stored in a 
nitrogen filled glovebox. 
[1,1’-Bis(diphenylphosphino)ferrocene]dichloropalladium (II) (Pd(dppf)Cl2) was 
purchased from Strem and stored in a nitrogen filled glovebox. 
3-Bromopyridine was purchased from Alfa Aesar and used as received. 
nButyl Lithium was purchased from Strem and used as received. 
iButylene oxide was purchased from Alfa Aesar and used as received.  
Chloroform-d (CDCl3) was purchased from Cambridge Isotope Laboratories and used as 
received.  
3-Chloroperbenzoic acid (50-55% wt in water) was purchased from Alfa Aesar and used 
as received.  
Cyclohexene oxide was purchased from Alfa Aesar and used as received. 
Dibromomethane was purchased from Alfa Aesar and passed through a plug of neutral 
alumina prior to use.  
Diethyl zinc (1M in Hexanes) was purchased from Sigma Aldrich and used as received. 
1-Dodecene was purchased from Alfa Aesar and used as received.   
Dimethylformamide, anhydrous (DMF) was purchased from EMD and used as received. 
Diborylmethane was prepared according to literature procedures43 and matched literature 
spectra. It was purified via silica gel chromatography, dried via azeotropic distillation from 
benzene, and stored in a nitrogen filled glovebox. 
Ethylene glycol was purchased from BDH and used as received. 
Ethylene oxide was purchased from Sigma Aldrich and used as received. 
4-Fluorostyrene was purchased from Alfa Aesar and used as received  
Imidazole was purchased from Alfa Aesar and used as received.  
 (+)-Limonene oxide, mixture of cis and trans was purchased from Sigma Aldrich and 
dried via azeotropic distillation from benzene. 
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Lithium 2,2,6,6-tetramethylpiperidide (LTMP) was purchased from Sigma Aldrich and 
stored in a nitrogen filled dry box.  
2-Methylstyrene was purchased from Alfa Aesar and used as received.  
3-Methylstyrene was purchased from Alfa Aesar and used as received.  
4-Methylstyrene was purchased from Alfa Aesar and used as received.   
Palladium (II) Dichloride was purchased from Strem and stored in a nitrogen filled dry box. 
Potassium tert-Butoxide was purchased from Strem Chemicals, stored in a desiccator, and 
used as received.  
Progesterone was purchased from Sigma Aldrich and used as received. 
(R)-Propylene oxide was purchased from Alfa Aesar and used as received. 
p-Toluenesulfonic acid monohydrate was purchased from Sigma Aldrich and used as 
received. 
(R)-BINAP was purchased from Strem Chemicals and stored in a nitrogen filled dry box.  
(R)-Styrene oxide was purchased from Sigma Aldrich and dried via azeotropic distillation 
before use.  
tert-Butyldimethylsilyl (R)-(-)-glycidyl ether was purchased from Sigma Aldrich and used 
as received.   
tert-Butyldimethylsilyl chloride was purchased from Alfa Aesar and used as received.  
trans-Androsterone was purchased from Sigma Aldrich and used as received. 
Tetrakis (triphenylphosphine)palladium (0) was purchased from Strem and stores a 0 
ºC in a nitrogen filled dry box. 
Trifluoroethanol was purchased from Sigma Aldrich, dried over calcium sulfate, distilled, and 
sparged with N2 prior to use.  
Trimethyl((4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)methyl)silane (8) was 
synthesized according to known literature methods.42 
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Trimethylsulfoxonium iodide was purchased from Bean Town Chemical and used as 
received. 
Vinylcyclohexane was purchased from Alfa Aesar and used as received.  
3.5.4 General Procedures 
General Procedure for the Synthesis of Epoxides – Epoxides yielding products 3.42-
3.47, 3.49 and 3.53 – 3.54 were synthesized according to the following general procedure as 
previously disclosed (Chapter 2).44 
 
Trans-androsterone (500 mg, 1.7 mmol, 1 eq) was dissolved in DMF (18 mL) in a round bottom 
flask containing a stir bar. Imidazole (347 mg, 5.1 mmol, 3 equiv) was then quickly added and 
the flask was purged with N2. tert-Butyldimethylsilyl chloride (769 mg, 5.1 mmol, 3 equiv) was 
then quickly added as a solid and the flask was again purged with N2. The reaction was allowed 
to stir overnight at 22 ºC upon which it turned into a thick white slurry. The reaction was cooled 
to 0 ºC, quenched with aqueous ammonium chloride, extracted with diethyl ether, dried over 
magnesium sulfate, and concentrated in vacuo. The crude reaction mixture was purified via 
silica gel chromatography to yield the desired silyl protected steroid 3.75 in 86% yield (594 mg) 
which matched known literature spectra.45 
Epoxide S3 was synthesized following a procedure reported by Hamilton et al.46 3.75 (250 mg, 
0.62 mmol, 1eq), potassium tert-butoxide (278.3 mg, 2.48 mmol, 4 equiv), and 
trimethylsulfoxonium iodide (546 mg, 2.48 mmol, 4 equiv) were weighed into an 8 mL vial 
containing a stir bar. The flask was sealed with a septum and purged with N2. The solids were 
slurried in THF (1.5 mL) and DMF (1.5 mL) and stirred at 22 ºC for 24 hours. The slurry was 
































collected and purified via silica gel chromatography to give the desired epoxide 3.76 in 52% 
yield (134 mg) and 2:1 dr. 
Major Diastereomer 
1H NMR (600 MHz, CDCl3) δ 3.54 (tt, J = 11.0, 4.6 Hz, 1H), 2.89 (d, J = 5.1 Hz, 1H), 2.59 (d, 
J = 5.1 Hz, 1H), 1.97 (ddd, J = 14.2, 11.0, 2.1 Hz, 1H), 0.88 (s, 9H), 0.87 (s, 3H), 0.81 (s, 3H), 
0.05 (s, 6H). 
Minor Diastereomer 
1H NMR (600 MHz, CDCl3) δ 3.54 (tt, J = 11.0, 4.6 Hz, 1H), 2.73 (d, J = 4.5 Hz, 1H), 2.66 (d, 
J = 4.5 Hz, 1H), 2.26 (ddd, J = 15.3, 10.5, 2.3 Hz, 1H), 0.88 (s, 9H), 0.81 (s, 3H), 0.80 (s, 3H), 
0.05 (s, 6H). 
13C NMR (151 MHz, CDCl3) δ 72.3, 70.7, 70.2, 54.7, 54.4, 53.8, 53.1, 52.9, 47.5, 45.3, 45.2, 
41.7, 40.3, 38.8, 38.8, 37.4, 35.8, 35.8, 35.8, 35.7, 34.2, 32.1, 32.1, 32.1, 31.8, 30.4, 30.1, 29.2, 
28.8, 28.8, 26.1, 26.1, 24.2, 23.7, 20.8, 20.4, 18.4, 16.3, 14.5, 12.5, -4.4. 
HRMS (APCI+) [M(-OH)]+ calcd for C26H45OSi+ 401.3234, found 401.3200. IR (n/cm-1): 
2928 (s), 2855 (s), 1470 (m), 1449 (m), 1376 (m), 1359 (m), 1249 (s), 1096 (s), 1081 (s). Melting 
Point: 129-131 ºC. 
 
 Compound 3.78 was synthesized using a known literature procedure and matched literature 
spectra.47 3.77 (200 mg, 0.56 mmol, 1 equiv) was weighed into an 8 mL vial containing a stir 
bar. Palladium on carbon (20 mg, 10% wt/wt) was added to the vial. The solids were dissolved in 
degassed pyridine, the vial was sealed with a septum lined cap, and the vial was purged with N2. 
The atmosphere was replaced with hydrogen by purging the reaction with a balloon of hydrogen 































The mixture was then filtered over a plug of celite with ethyl acetate. The organics were washed 
with a solution of copper acetate to remove the pyridine. The organics were dried over 
magnesium sulfate and concentrated in vacuo to give the crude product. The mixture was 
purified vial silica gel chromatography to yield the desired product in 77% yield (155 mg) and 
>20:1 dr favoring the cis decalin.48,49 1H NMR (500 MHz, CDCl3) δ 4.06 – 3.98 (m, 1H), 3.95 
(td, J = 7.2, 5.9 Hz, 1H), 3.89 (p, J = 7.2 Hz, 2H), 2.70 (dd, J = 15.1, 13.5 Hz, 1H), 2.34 (td, J = 
14.6, 5.4 Hz, 1H), 2.18 – 2.13 (m, 1H), 2.10 – 1.97 (m, 3H), 1.96 – 1.79 (m, 3H), 1.77 – 1.68 (m, 
2H), 1.64 (dt, J = 7.1, 4.8 Hz, 1H), 1.55 – 1.32 (m, 6H), 1.30 (s, 3H), 1.25 (ddd, J = 9.6, 4.5, 2.2 
Hz, 3H), 1.17 – 1.07 (m, 3H), 1.02 (s, 3H), 0.78 (s, 3H). 13C NMR (126 MHz, CDCl3) δ 213.6, 
112.0, 65.4, 63.4, 58.5, 56.5, 44.5, 42.5, 42.3, 40.9, 39.9, 37.4, 37.2, 35.2, 35.1, 26.8, 25.9, 24.7, 
23.9, 23.1, 22.8, 21.1, 13.2. HRMS (ESI+) [2M+Na]+ calcd for C46H72O6Na 743.5227, found 
743.5204. IR (n/cm-1): 2939 (s), 2878 (m), 1716 (s), 1540 (m), 1455 (m). [a]22D = 31.6 (c = 
0.185, CH2Cl2, l = 100 mm). Melting Point: 171 ºC 
Following a modified literature procedure,50 inside a glovebox LiBr (22 mg, 0.25 mmol, 1.1 
equiv) was weighed into an 8 mL vial containing a stir bar. The solid was then dissolved in THF 
(1 mL), diethyl ether (0.2 mL), and pentane (0.1 mL). The vial was sealed with a septum lined 
cap and removed from the glovebox. Dibromomethane (0.018 mL, 0.25 mmol, 1.1 equiv) was 
added via syringe. The mixture was then cooled to -130 ºC in a pentane/liquid N2 bath. nBuLi 
(0.156 mL, 0.25 mmol, 1.1 equiv) was added dropwise via syringe. The mixture was allowed to 
stir at -130 ºC for 30 minutes. A solution of 3.78 (82 mg, 0.23 mmol, 1 equiv) in a minimal 
amount of THF was added via cannula to the cooled reaction mixture. The reaction was stirred 
at -130 ºC for 90 minutes and then allowed to warm to room temperature slowly. The reaction 
was quenched with saturated ammonium chloride, extracted with diethyl ether (x3), dried over 
magnesium sulfate, and concentrated in vacuo. The crude reaction mixture was purified via 
silica gel chromatography to yield the desired product in 54% yield (46 mg) and >20:1 dr. 
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1H NMR (600 MHz, CDCl3) δ 4.02 (dt, J = 7.6, 6.5 Hz, 1H), 3.97 (td, J = 7.2, 6.0 Hz, 1H), 
3.94 – 3.86 (m, 2H), 2.69 – 2.60 (m, 2H), 2.41 (t, J = 13.8 Hz, 1H), 2.07 (dt, J = 12.3, 3.0 Hz, 
1H), 2.01 – 1.88 (m, 2H), 1.32 (s, 3H), 1.03 (s, 3H), 0.79 (s, 3H). 13C NMR (151 MHz, CDCl3) δ 
112.1, 65.4, 63.4, 59.4, 58.6, 56.7, 53.7, 42.3, 40.9, 40.3, 40.1, 35.3, 34.8, 34.4, 33.7, 28.3, 26.6, 
26.3, 24.7, 23.9, 23.6, 23.2, 21.1, 13.2. IR (n/cm-1): 2930 (s), 2869 (s), 1540 (m), 1472 (m), 1455 
(m), 1446 (m), 1374 (m), 1260 (m), 1244 (m), 1216 (m), 1052 (m). HRMS (APCI+) [M+H]+ 
calcd for C24H39O3+ 375.2899, found 375.2868. [a]22D = 17.1 (c = 0.540, CH2Cl2, l = 100 mm). 
Melting Point: 156-163 ºC 
General procedure for dehydroboration reactions 
 
Inside of a nitrogen filled dry box, diborylmethane (40.2 mg, 0.15 mmol, 1.5 equiv) was weighed 
into an 8-mL vial containing a magnetic stir bar. The solids were dissolved in THF (0.4 mL) and 
sealed with a septum lined cap. Lithium 2,2,6,6-piperidine (LTMP) (22.0 mg, 0.15 mmol, 1.5 
equiv) was added to a separate 8-mL vial, dissolved in THF (0.8 mL) and sealed with a septum 
lined cap. Palladium (allyl)chloride dimer ([Pd(allyl)Cl]2) (0.9 mg, 0.0025 mmol, 2.5 mol%) was 
weighed into a third 8-mL vial containing a stir-bar. The vials were sealed with a septum lined 
cap and all vials were removed from the glovebox. The vial containing diborylmethane and 
LTMP were cooled to 0 ºC in an ice water bath. The LTMP solution was then cannula 
transferred under nitrogen to the diborylmethane solution at 0 ºC. The mixture was allowed to 
stir at 0 ºC for 10 min (30 minutes for 3.65) after which epoxide (0.1 mmol, 1 equiv) was added 
via syringe. The solution was then allowed to warm to 22 ºC and stirred at the necessary 
temperature for the required time period based on the epoxide used (monosubstituted epoxides: 
22 ºC, 1h; disubstituted epoxides: 22 ºC, 24 h; trisubstituted epoxides, 3.54, 3.58 & 3.59: 45 






THF, 22 ºC, 1 h;
2.5 mol% [Pd(Cl)(ƞ3-C3H5)]2
allyl chloride (3 eq)





containing the palladium catalyst. Allyl chloride (24 µL, 0.3 mmol, 3 equiv) was added to the 
vial via syringe and the vial was sealed with Teflon tape. The reaction was stirred at 60 ºC for 24 
h then allowed to cool to 22 ºC and quenched with a saturated aqueous solution of ammonium 
chloride. The biphasic mixture was rapidly stirred for 30 minutes. The organics were then 
extracted three times with diethyl ether, dried over magnesium sulfate and concentrated in 
vacuo to yield the crude product. The product was purified via silica gel chromatography (8:1 to 
2:1 Hexanes:Ethyl Acetate; visualized with Seebach stain).  
General procedure for gram scale dehydroboration reactions 
 
Inside of a nitrogen filled dry box, diborylmethane (2.2 g, 8.15 mmol, 1.5 equiv) was weighed 
into a round bottom flask containing a magnetic stir bar. The solids were dissolved in THF (22 
mL) and sealed with a septum. Lithium 2,2,6,6-piperidine (LTMP) (1.2 g, 8.15 mmol, 1.5 equiv) 
was added to a separate round bottom flask, dissolved in THF (43 mL) and sealed with a 
septum. Palladium (allyl)chloride dimer ([Pd(allyl)Cl]2) (50.0 mg, 0.14 mmol, 2.5 mol%) was 
weighed into a third flask containing a stir-bar. The flasks containing diborylmethane and LTMP 
were cooled to 0 ºC in an ice water bath. The LTMP solution was then cannula transferred under 
nitrogen to the diborylmethane solution at 0 ºC. The mixture was allowed to stir at 0 ºC for 10 
min after which epoxide (1.2 mL, 5.43 mmol, 1 equiv) was added via syringe. The solution was 
then allowed to warm to 22 ºC and stirred at 22 ºC for 1 hour. The reaction mixture was then 
cannula transferred under nitrogen to the flask containing the palladium catalyst. Allyl chloride 
(1.3 mL, 16.8 mmol, 0.3 equiv) was added to the flask via syringe. The reaction was stirred at 60 
ºC for 24 h then allowed to cool to 22 ºC and quenched with a saturated aqueous solution of 
ammonium chloride. The biphasic mixture was rapidly stirred for 30 minutes. The organics 
were then extracted three times with diethyl ether, dried over magnesium sulfate and 
THF, 22 ºC, 1 h;
2.5 mol% [Pd(Cl)(ƞ3-C3H5)]2
allyl chloride (3 eq)










concentrated in vacuo to yield the crude product. The product was purified via silica gel 
chromatography (10:1 Hexanes:Ethyl Acetate; visualized with Seebach stain) to yield 3h in 61% 
(1.14 g) and >20:1 E:Z as a yellow oil.  
3.5.5 Product characterization 
 
(S,E)-1-phenyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)prop-2-en-1-ol 
(3.40). Following the general procedure, vinyl boronate ester 3.40 was isolated in 56% yield 
and >20:1 E:Z (14.4 mg) as a white solid. 1H NMR (400 MHz, CDCl3) δ 7.46 – 7.35 (m, 4H), 
7.31 (dd, J = 5.6, 3.1 Hz, 1H), 6.78 (dd, J = 18.0, 5.3 Hz, 1H), 5.77 (dd, J = 18.0, 1.6 Hz, 1H), 5.27 
(d, J = 5.3 Hz, 1H), 2.08 – 1.93 (m, 1H), 1.28 (s, 12H). 13C NMR (151 MHz, CDCl3) δ 153.7, 
142.0, 128.7, 128.0, 126.6, 83.5, 76.3, 24.9, 24.9. HRMS (ESI+) [M+Na]+ calcd for 
C15H21BONa+ 283.1481, found 283.1471. IR (n/cm-1): 3446 (m, br), 2978 (m), 1639 (s), 1358 (s), 
1144 (s), 849 (m), 700 (m). [a]22D = -28.7 (c = 0.755, CH2Cl2, l = 100 mm). Melting Point: 
108-110 ºC. 
Retention of stereochemistry was confirmed by comparing the chiral HPLC traces of the product 
made with racemic styrene oxide to that made with R-styrene oxide. Daicel CHIRALPAK IA; 













Following the general procedure, vinyl boronate ester 3.41 was isolated in 57% yield and >20:1 
E:Z (15.7 mg) as a white solid. 1H NMR (500 MHz, CDCl3) δ 7.28 (d, J = 4.3 Hz, 2H), 7.18 (d, J 
= 7.8 Hz, 2H), 6.77 (dd, J = 18.0, 5.2 Hz, 1H), 5.76 (dd, J = 17.9, 1.5 Hz, 1H), 5.24 (d, J = 5.2 Hz, 
1H), 2.36 (s, 3H), 1.99 (s, 1H), 1.27 (s, 12H). 13C NMR (151 MHz, CDCl3) δ 153.9, 137.7, 129.4, 






found 297.1629. IR (n/cm-1): 3446 (m, br), 2978 (m), 1640 (s), 1322 (s), 1144 (s), 970 (m), 950 
(m), 900 (m), 849 (m). Melting Point: 83 ºC. 
 
(E)-1-(4-fluorophenyl)-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)prop-2-en-1-
ol (3.42). Following the general procedure, vinyl boronate ester 3.42 was isolated in 57% yield 
and >20:1 E:Z (15.7 mg) as a clear oil. 1H NMR (600 MHz, CDCl3) δ 7.37 – 7.26 (m, 3H), 7.03 
(t, J = 8.7 Hz, 2H), 6.71 (dd, J = 18.0, 5.3 Hz, 1H), 5.73 (dd, J = 18.0, 1.5 Hz, 1H), 5.23 (m, 1H), 
2.03 (d, J = 3.6 Hz, 1H), 1.26 (s, 12H). 13C NMR (151 MHz, CDCl3) δ 162.5 (d, J = 246.0 Hz), 
153.5, 137.7 (d, J = 3.0 Hz), 128.3 (d, J = 8.3 Hz), 115.5 (d, J = 21.2 Hz), 83.6, 75.6, 24.9, 24.9. 
HRMS (ESI+) [M+Na]+ calcd for C15H2BFONa+ 301.1387, found 301.1376. IR (n/cm-1): 3435 
(m, br), 2979 (m), 1642 (m), 1509 (s), 1390 (s), 1358 (s), 1324 (s), 1221 (m), 1143 (s), 970 (m).  
 
 (E)-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1-(m-tolyl)prop-2-en-1-ol 
(3.44). Following the general procedure, vinyl boronate ester 3.44 was isolated in 64% yield 
and >20:1 E:Z (17.5 mg) as a white solid. 1H NMR (600 MHz, CDCl3) δ 7.23 (t, J = 7.6 Hz, 1H), 
7.17 (s, 1H), 7.15 (d, J = 7.7 Hz, 1H), 7.09 (d, J = 7.5 Hz, 1H), 6.75 (dd, J = 18.0, 5.3 Hz, 1H), 5.74 
(dd, J = 18.0, 1.6 Hz, 1H), 5.21 (dd, J = 5.3, 1.5 Hz, 1H), 2.35 (s, 3H), 1.25 (s, 12H). 13C NMR (151 
MHz, CDCl3) δ 153.9, 142.0, 138.4, 128.7, 128.6, 127.2, 123.6, 83.5, 76.3, 24.9, 24.9, 21.6. HRMS 
(ESI+) [M+Na]+ calcd for C16H23BONa+ 297.1638, found 297.1628. IR (n/cm-1): 3432 (m, br), 













Following the general procedure, vinyl boronate ester 3.45 was isolated in 45% yield and >20:1 
E:Z (12.3 mg) as a clear oil. 1H NMR (600 MHz, CDCl3) δ 7.45 (dd, J = 7.5, 1.5 Hz, 1H), 7.24 (td, 
J = 7.5, 1.6 Hz, 1H), 7.21 (td, J = 7.4, 1.6 Hz, 1H), 7.17 – 7.14 (m, 1H), 6.75 (ddd, J = 18.1, 5.2, 0.7 
Hz, 1H), 5.75 (dd, J = 18.1, 1.5 Hz, 1H), 5.49 (d, J = 5.1 Hz, 1H), 2.37 (s, 3H), 2.00 – 1.91 (m, 1H), 
1.28 (s, 12H). 13C NMR (151 MHz, CDCl3) δ 152.9, 139.9, 135.5, 130.6, 127.8, 126.5, 126.2, 83.5, 
72.9, 24.9, 24.9, 19.4. HRMS (ESI+) [M+Na]+ calcd for C16H23BONa+ 297.1638, found 
297.1627. IR (n/cm-1): 3446 (br, m), 2978 (m), 2929 (m), 1638 (m), 1357 (s), 1322 (s), 1144 (s), 
970 (m), 849 (m). 
 
(E)-1-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)tridec-1-en-3-ol (3.46). Following 
the general procedure, vinyl boronate ester 3.46 was isolated in 71% yield and >20:1 E:Z (22.9 
mg) as a clear oil. 1H NMR (600 MHz, CDCl3) δ 6.64 (dd, J = 18.1, 5.3 Hz, 1H), 5.64 (dd, J = 
18.2, 1.4 Hz, 1H), 4.17 (m, 1H), 1.55 (m, 3H), 1.28 (m, 27H), 0.99 – 0.80 (m, 3H). 13C NMR (151 
MHz, CDCl3) δ 155.5, 83.4, 73.9, 36.8, 32.1, 29.8, 29.7, 29.5, 25.5, 24.9, 24.9, 24.9, 22.8, 14.3. 
HRMS (ESI+) [M+Na]+ calcd for C19H37BONa+ 347.2733, found 347.2723. IR (n/cm-1): 3435 
(br, m), 2977 (m), 2925 (s), 2854 (s), 1643 (m), 1466 (m), 1389 (s), 1359 (s), 1321 (s), 1145 (s). 
 
(E)-1-cyclohexyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)prop-2-en-1-ol 
(3.47). Following the general procedure, vinyl boronate ester 3.47 was isolated in 71% yield and 












5.61 (dd, J = 18.1, 1.4 Hz, 1H), 3.91 (t, J = 5.9 Hz, 1H), 1.89 – 1.56 (m, 5H), 1.42 (m, 1H), 1.27 (s, 
12H), 1.24 – 1.10 (m, 4H), 1.02 (m, 2H). 13C NMR (151 MHz, CDCl3) δ 154.2, 83.4, 78.4, 43.3, 
29.1, 28.1, 26.6, 26.3, 26.2, 24.9, 24.9. HRMS (ESI+) [M+Na]+ calcd for C15H27BONa+ 
289.1951, found 289.1939. IR (n/cm-1): 3437 (br, m), 2978 (m), 2926 (s), 2852 (m), 1642 (m), 
1450 (m), 1389 (s), 1359 (s), 1321 (s), 1144 (s). 
   
(R,E)-1-((tert-butyldimethylsilyl)oxy)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-
yl)but-3-en-2-ol (3.48). Following the general procedure, vinyl boronate ester 3.48 was 
isolated in 61% yield and >20:1 E:Z (1.14 g) as a yellow oil. 1H NMR (500 MHz, CDCl3) δ 6.54 
(dd, J = 18.2, 4.8 Hz, 1H), 5.76 (dd, J = 18.2, 1.7 Hz, 1H), 4.23 (m, 1H), 3.69 (dd, J = 10.1, 3.6 Hz, 
1H), 3.45 (dd, J = 10.1, 7.8 Hz, 1H), 2.57 (d, J = 3.6 Hz, 1H), 1.26 (s, 12H), 0.89 (s, 9H), 0.06 (s, 
6H). 13C NMR (151 MHz, CDCl3) δ 150.8, 83.4, 73.8, 66.7, 26.0, 24.9, 24.9, 24.8, 18.5, -5.2, -5.2. 
HRMS (ESI+) [2M+Na]+ calcd for C32H66B2O8Si2Na+ 679.4380, found 679.4355. IR (n/cm-1): 
3481 (br, m), 2979 (m), 2955 (m), 2929 (m), 2857 (m), 1644 (m), 1471 (m), 1389 (m), 1354 (s), 
1324 (s), 1257 (m), 1145 (s), 1109 (s). [a]22D = 4.0 (c = 0645, CH2Cl2, l = 100 mm). 
 
(E)-1-phenyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)but-3-en-2-ol (3.49). 
Following the general procedure, vinyl boronate ester 3.49 was isolated in 69% yield and >20:1 
E:Z (18.9 mg) as a clear oil. 1H NMR (600 MHz, CDCl3) δ 7.31 (m, 2H), 7.24 (m, 3H), 6.71 (dd, 
J = 18.1, 4.9 Hz, 1H), 5.69 (dd, J = 18.2, 1.5 Hz, 1H), 4.43 – 4.32 (m, 1H), 2.92 (dd, J = 13.7, 4.3 
Hz, 1H), 2.73 (dd, J = 13.7, 8.8 Hz, 1H), 1.68 (s, 1H), 1.27 (s, 12H). 13C NMR (151 MHz, CDCl3) δ 









C16H23BO3SiNa+ 297.1638, found 297.1627. IR (n/cm-1): 3436 (br, m), 2978 (m), 2928 (m), 
1642 (s), 1390 (s), 1359 (s), 1321 (s), 1144 (s). 
 
(R,E)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)but-3-en-2-ol (3.50). Following 
the general procedure, vinyl boronate ester 3.50 was isolated in 71% yield and >20:1 E:Z (14.0 
mg) as a clear oil.51 1H NMR (600 MHz, CDCl3) δ 6.65 (dd, J = 18.1, 5.0 Hz, 1H), 5.61 (dd, J = 
18.1, 1.5 Hz, 1H), 4.34 (qdd, J = 6.6, 4.9, 1.5 Hz, 1H), 1.28 (m, 15H). 13C NMR (151 MHz, CDCl3) 
δ 156.3, 83.5, 69.8, 24.9, 22.8. [a]22D = -5.6 (c = 0.67, CH2Cl2, l = 100 mm). 
 
(E)-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)prop-2-en-1-ol (3.51). Following 
the general procedure, vinyl boronate ester 3.51 was isolated in 23% yield and >20:1 E:Z (4.3 
mg) as a clear oil.52 1H NMR (600 MHz, CDCl3) 6.74 (dt, J = 18.2, 4.2 Hz, 1H), 5.71 (dt, J = 18.2, 
1.9 Hz, 1H), 4.24 (dd, J = 4.3, 1.9 Hz, 2H), 1.27 (s, 12H). 13C NMR (151 MHz, CDCl3) δ 151.8, 
83.5, 64.7, 24.9. 
 
(E)-2-methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)but-3-en-2-ol (3.52). 
Following the general procedure, vinyl boronate ester 3.52 was isolated in 76% yield and >20:1 
E:Z (16.1 mg) as a clear oil.53 1H NMR (500 MHz, CDCl3) δ 6.71 (d, J = 18.2 Hz, 1H), 5.61 (d, J = 
18.2 Hz, 1H), 1.49 (s, 1H), 1.31 (s, 6H), 1.27 (s, 12H). 13C NMR (126 MHz, CDCl3) δ 159.9, 83.4, 
71.9, 29.3, 24.9. HRMS (ESI+) [M+Na]+ calcd for C11H21BO3Na+ 235.1481, found 235.1471. IR 
(n/cm-1): 3436 (br, m), 2977 (m), 1638 (m), 1458 (m), 1372 (s), 1348 (s), 1320 (s), 1215 (m), 
















Following the general procedure, vinyl boronate ester 3.53 was isolated in 67% yield and >20:1 
E:Z (18.4 mg) as a clear oil.54 1H NMR (500 MHz, CDCl3) δ 7.51 – 7.41 (m, 2H), 7.33 (dd, J = 
8.5, 7.0 Hz, 2H), 7.26 – 7.22 (m, 1H), 6.86 (d, J = 18.1 Hz, 1H), 5.69 (d, J = 18.1 Hz, 1H), 1.97 (s, 
1H), 1.66 (s, 3H), 1.26 (s, 12H). 13C NMR (151 MHz, CDCl3) δ 158.2, 145.9, 128.4, 127.1, 125.4, 
83.5, 75.5, 29.3, 25.0, 24.9. HRMS (ESI+) [M+Na]+ calcd for C16H23BO3Na+ 297.1638, found 
297.1627. IR (n/cm-1): 3459 (br, m), 2978 (m), 1635 (m), 1388 (m), 1372 (m), 1348 (s), 1322 
(m), 1165 (m), 1144 (s). 
 
(S,E)-1-((4S,6S)-2,2-dimethyl-6-phenyl-1,3-dioxan-4-yl)-2-methyl-4-(4,4,5,5-
tetramethyl-1,3,2-dioxaborolan-2-yl)but-3-en-2-ol (3.54). Following the general 
procedure, vinyl boronate ester 3.54 was isolated in 53% yield and >20:1 E:Z (10.5 mg) as a 
clear oil. 1H NMR (500 MHz, CDCl3) δ 7.45 – 7.31 (m, 4H), 7.29 – 7.27 (m, 1H), 6.65 (d, J = 18.1 
Hz, 1H), 5.68 (d, J = 18.0 Hz, 1H), 4.88 (dd, J = 9.7, 6.3 Hz, 1H), 4.37 (dq, J = 10.2, 3.3 Hz, 1H), 
3.61 (s, 1H), 2.01 (ddd, J = 13.2, 9.7, 6.3 Hz, 1H), 1.92 (ddd, J = 13.1, 9.1, 6.3 Hz, 1H), 1.85 (dd, J 
= 14.7, 10.3 Hz, 1H), 1.69 (dd, J = 14.8, 2.7 Hz, 1H), 1.49 (s, 3H), 1.45 (s, 3H), 1.34 (s, 3H), 1.27 
(s, 12H). 13C NMR (151 MHz, CDCl3) δ 159.3, 142.2, 128.6, 127.7, 126.1, 101.3, 83.3, 73.3, 68.7, 
64.9, 46.1, 40.6, 26.7, 25.1, 25.0, 24.9. HRMS (ESI+) [M+Na]+ calcd for C46H70B2O10Na2+ 
827.5053, found 827.5037. IR (n/cm-1): 3514 (br, w), 2979 (m), 2929 (m), 1639 (m), 1495 (m), 
1454 (m), 1379 (s), 1349 (s), 1320 (m), 1225 (m), 1166 (m), 1144 (s). [a]22D = -34.7 (c = 0.525, 











(3.55). Following the general procedure, vinyl boronate ester 3.55 was isolated in 50% yield 
and >20:1 E:Z (12.0 mg) as a clear oil. 1H NMR (600 MHz, CDCl3) δ 5.32 (s, 1H), 4.07 – 4.02 
(m, 1H), 3.13 – 3.06 (m, 1H), 2.16 – 1.95 (m, 2H), 1.83 – 1.75 (m, 1H), 1.70 (ddt, J = 9.8, 5.0, 3.0 
Hz, 1H), 1.63 (s, 1H), 1.56 – 1.45 (m, 1H), 1.39 (dddd, J = 20.8, 12.5, 10.6, 4.0 Hz, 3H), 1.26 (s, 
12H). 13C NMR (151 MHz, CDCl3) δ 167.0, 83.0, 74.5, 37.1, 31.5, 28.2, 25.0, 24.9, 24.3. HRMS 
(ESI+) [M+Na]+ calcd for C13H23BONa+ 261.1638, found 261.1628. IR (n/cm-1): 3421 (br, m), 
2977 (m), 2931 (m), 2857 (m), 1645 (s), 1371 (s), 1328 (s), 1144 (s). 
 
(1S,4R,E)-1-methyl-4-(prop-1-en-2-yl)-2-((4,4,5,5-tetramethyl-1,3,2-dioxaborolan-
2-yl)methylene)cyclohexan-1-ol (3.56). Following the general procedure, vinyl boronate 
ester 3.56 was isolated in 34% yield and >20:1 E:Z (9.9 mg) as a clear oil. 1H NMR (500 MHz, 
CDCl3) δ 5.32 (d, J = 1.0 Hz, 1H), 4.80 – 4.67 (m, 1H), 3.10 (ddd, J = 12.9, 3.5, 2.0 Hz, 1H), 2.38 
(ddd, J = 12.9, 11.7, 1.1 Hz, 1H), 1.98 (ddt, J = 11.5, 7.0, 3.6 Hz, 1H), 1.89 (dt, J = 13.2, 3.5 Hz, 
1H), 1.83 (ddd, J = 12.9, 3.9, 1.3 Hz, 1H), 1.77 (s, 2H), 1.64 – 1.56 (m, 2H), 1.51 – 1.42 (m, 1H), 
1.38 (s, 3H), 1.33 (s, 1H), 1.27 (d, 6H), 1.27 (d, 6H), 1.26 – 1.24 (m, 1H).  13C NMR (151 MHz, 
CDCl3) δ 167.0, 149.6, 108.8, 83.2, 46.9, 40.4, 35.0, 27.7, 26.7, 25.1, 24.9, 24.9, 21.4. HRMS 
(ESI+) [M+Na]+ calcd for C17H29BO3Na+ 315.2107, found 315.2098. IR (n/cm-1): 3419 (br, w), 
2977 (m), 2932 (m), 1637 (s), 1371 (s), 1325 (s), 1261 (m), 1144 (s). [a]22D = 32.4 (c = 0.495, 












cyclopenta[a]phenanthren-3-ol (3.58). Following the general procedure (0.04 mmol 
scale), vinyl boronate ester 3.58 was isolated in 47% yield (9.6 mg), >20:1 E:Z and >20:1 dr. 
1H NMR (600 MHz, CDCl3) δ 6.68 (d, J = 18.2 Hz, 1H), 5.64 (d, J = 18.2 Hz, 1H), 4.00 (dt, J 
= 7.5, 6.5 Hz, 1H), 3.95 (td, J = 7.2, 5.9 Hz, 1H), 3.92 – 3.84 (m, 2H), 1.30 (s, 3H), 1.28 (s, 12H), 
0.74 (s, 3H). 13C NMR (151 MHz, CDCl3) δ 161.1, 112.1, 83.4, 73.6, 65.4, 63.3, 58.6, 56.7, 42.3, 
40.0, 39.9, 38.1, 37.5, 35.3, 34.7, 31.8, 31.6, 26.7, 26.4, 25.0, 25.0, 24.7, 23.9, 23.8, 23.1, 21.0, 
13.2. HRMS (APCI+) [M(-OH)]+ calcd for C31H50BO4+ 497.3797, found 497.37501. IR (n/cm-
1): 3480 (br, m), 2975 (s), 2931 (s), 2883 (m), 1637 (m), 1446 (m), 1387 (s), 1371 (s), 1348 (s), 
1320 (s), 1270 (m), 1145 (s), 1052 (s). [a]22D = 20.7 (c = 0.48, CH2Cl2, l = 100 mm). Melting 




cyclopenta[a]phenanthren-17-ol (3.59). Following the general procedure (0.05 mmol 






















1H NMR (600 MHz, CDCl3) δ 6.77 (d, J = 18.2 Hz, 1H), 5.55 (d, J = 18.2 Hz, 1H), 3.61 – 3.40 
(m, 1H), 1.29 (s, 12H), 0.89 (s, 3H), 0.88 (s, 9H), 0.80 (s, 3H), 0.04 (s, 6H).  
Minor Diastereomer 
1H NMR (600 MHz, CDCl3) δ 6.77 (d, J = 18.2 Hz, 1H), 5.66 (d, J = 18.2 Hz, 1H), 3.61 – 3.40 
(m, 1H), 1.29 (s, 12H), 0.89 (s, 3H), 0.88 (s, 9H), 0.80 (s, 3H), 0.04 (s, 6H).  
13C NMR (151 MHz, CDCl3) δ 157.7, 85.1, 83.4, 72.3, 54.2, 50.3, 47.1, 45.3, 38.8, 37.4, 36.6, 
36.4, 35.8, 32.7, 32.1, 31.9, 28.9, 26.1, 25.0, 24.9, 24.9, 23.9, 21.0, 18.4, 14.5, 12.5, -4.4. HRMS 
(APCI+) [M(-OH)]+ calcd for C33H58BO3+ 541.4243, found 541.4243. IR (n/cm-1): 3498 (m), 
2928 (s), 2855 (s), 1632 (m), 1348 (s), 1144 (m), 1093 (m), 1068 (m), 1006 (m). Melting Point: 
194-195 ºC. 
 
(E)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)but-3-en-1-ol (3.62). Following 
the general procedure, vinyl boronate 3.62 was obtained in 20% yield calculated via comparison 
to a known amount of DMF used as an internal standard. A small quantity was obtained via 
silica gel chromatography for proof of identity and matched literature spectra.55 1H NMR (500 
MHz, CDCl3) δ 6.60 (dt, J = 18.0, 6.7 Hz, 1H), 5.56 (d, J = 18.0 Hz, 1H), 3.73 (t, J = 6.3 Hz, 
2H), 2.44 (qd, J = 6.4, 1.5 Hz, 2H), 1.26 (s, 12H). 
 
(S,E)-1-phenyl-3-(trimethylsilyl)prop-2-en-1-ol (3.66). Following the general procedure, 
vinyl silane 3.66 was isolated in 20% yield (3.9 mg) and >20:1 E:Z as a colorless oil and 
matched known literature spectra.56 A trace amount of product with B(pin) bound to the alcohol 
is also present. 1H NMR (500 MHz, CDCl3) δ 7.36 (d, J = 5.2 Hz, 4H), 7.29 (q, J = 1.0 Hz, 
1H), 6.20 (dd, J = 18.6, 5.2 Hz, 1H), 6.00 (dd, J = 18.7, 1.4 Hz, 1H), 5.19 (d, J = 4.9 Hz, 1H), 1.94 









(S,E)-1-phenyl-3-(trimethylsilyl)prop-2-en-1-ol (3.80). Compound 3.80 was isolated in 
23% yield (7.7 mg) as a byproduct of the dehydroboration reaction shown in Scheme 3.7. 
Major Diastereomer 
1H NMR (500 MHz, CDCl3) δ 7.43 – 7.29 (m, 4H), 7.23 (m, 1H), 4.83 – 4.67 (m, 1H), 2.31 (s, 
1H), 2.12 – 1.89 (m, 2H), 1.25 (s, 6H), 1.24 (s, 6H), 0.54 (dd, J = 12.4, 2.7 Hz, 1H), 0.01 (s, 9H). 
Minor Diastereomer 
1H NMR (500 MHz, CDCl3) δ 7.43 – 7.29 (m, 4H), 7.23 (m, 1H), 4.52 (m, 1H), 2.45 (d, J = 4.6 
Hz, 1H), 1.84 – 1.71 (m, 2H), 1.27 (s, 6H), 1.27 (s, 6H), 0.31 (dd, J = 12.4, 2.7 Hz, 1H), 0.02 (s, 
9H). 
13C NMR (151 MHz, CDCl3) δ 144.9, 128.5, 128.4, 127.5, 127.1, 126.1, 125.8, 83.2, 83.1, 77.6, 
75.6, 66.0, 35.9, 35.7, 29.9, 25.3, 25.2, 25.1, 25.0, 15.4, -1.4, -1.4. HRMS (ESI+) [M+Na]+ calcd 
for C18H31BO3SiNA+ 357.2033, found 357.2022. IR (n/cm-1): 3838 (br, m), 3459 (m), 1379 (s), 
1351 (s), 1247 (s), 1143 (s), 1066 (s).  
3.5.6 Product functionalizations 
Procedures for cross-coupling reactions 
 
(S,E)-1-((tert-butyldimethylsilyl)oxy)-6-methylhepta-3,5-dien-2-ol (3.70). Inside a 
glovebox vinyl boron 3.48 (39 mg, 0.12 mmol), Pd(PPh3)4 (3.5 mg, 0.003 mmol, 3 mol%), and 
Cs2CO3 (97.7 mg, 0.3 mmol, 3 eq) were weighed into an 8 mL vial with a stir bar and dissolved in 
toluene (0.120 mL). The vial was sealed with a septum lined cap and removed from the 
glovebox. Outside the glovebox, 1-bromo-2-methyl-1-propene (0.010 mL, 0.1 mmol, 1 eq) was 













80 ºC, 8 hBr3.48 3.703.69
 283 
ºC and stirred for 8 hours after which the reaction was cooled to 22 ºC and quenched with a 
saturated solution of ammonium chloride. The organics were extracted with diethyl ether (x3), 
dried over magnesium sulfate, and concentrated in vacuo. The crude product was purified via 
silica gel chromatography (20:1 hexanes:diethyl ether) in 65% yield and a single olefin isomer of 
3.70 (16.6 mg) as a clear oil. 1H NMR (500 MHz, CDCl3) δ 6.52 (ddd, J = 15.3, 11.0, 1.2 Hz, 1H), 
5.81 (dd, J = 10.9, 1.2 Hz, 1H), 5.48 (dd, J = 15.2, 6.6 Hz, 1H), 4.20 (m, 1H), 3.64 (dd, J = 10.0, 
3.6 Hz, 1H), 3.43 (dd, J = 10.0, 8.1 Hz, 1H), 2.61 (d, J = 2.7 Hz, 1H), 1.77 (s, 3H), 1.76 (s, 3H), 
0.90 (s, 9H), 0.08 (s, 6H). 13C NMR (126 MHz, CDCl3) δ 136.5, 128.9, 128.2, 124.5, 73.0, 67.4, 
26.2, 26.0, 24.9, 18.5, 18.5, -5.2, -5.2. HRMS (ESI+) [2M+Na]+ calcd for C28H56NO4Si2+ 
535.3615, found 535.3587. IR (n/cm-1): 3446 (br, m), 2955 (m), 2928 (s), 2857 (m), 1472 (m), 
1254 (s), 1110 (s), 1061 (m). [a]22D = -8.1 (c = 0.84, CH2Cl2, l = 100 mm). 
 
(S,E)-1-((tert-butyldimethylsilyl)oxy)-4-(pyridin-3-yl)but-3-en-2-ol (3.72). Inside the 
glovebox vinyl boron 3.48 (39 mg, 0.12 mmol), Pd(PPh3)4 (3.5 mg, 0.003 mmol, 3 mol%), and 
Cs2CO3 (97.7 mg, 0.3 mmol, 3 eq) were weighed into an 8 mL vial with a stir bar and dissolved in 
toluene (0.120 mL). The vial was sealed with a septum lined cap and removed from the 
glovebox. Outside the glovebox, 3-bromopyridine (0.010 mL, 0.1 mmol, 1 eq) was added via 
syringe followed by dry isopropyl alcohol (0.040 mL) and degassed water (0.040 mL). The 
reaction was then heated to 80 ºC and stirred for 8 hours after which the reaction was cooled to 
22 ºC and quenched with a saturated solution of ammonium chloride. The organics were 
extracted with diethyl ether (x3), dried over magnesium sulfate, and concentrated in vacuo. The 
crude product was purified via silica gel chromatography to yield the desired product 3.72 (2:1 
hexanes:ethyl acetate; pinacol removed via azeotropic distillation on a rotovap with 

















1H NMR (600 MHz, CDCl3) δ 8.60 (d, J = 2.2 Hz, 1H), 8.46 (dd, J = 4.8, 1.6 Hz, 1H), 7.68 (dt, J 
= 7.9, 2.0 Hz, 1H), 7.24 (ddd, J = 7.9, 4.8, 0.8 Hz, 1H), 6.68 (dd, J = 16.1, 1.4 Hz, 1H), 6.25 (dd, J 
= 16.1, 5.8 Hz, 1H), 4.42 – 4.31 (m, 1H), 3.75 (dd, J = 10.0, 3.8 Hz, 1H), 3.54 (dd, J = 10.0, 7.6 
Hz, 1H), 2.82 (s, 1H), 0.91 (s, 9H), 0.10 (s, 3H), 0.09 (s, 3H). 13C NMR (151 MHz, CDCl3) δ 
148.8, 148.5, 133.1, 132.5, 130.5, 128.1, 123.6, 72.7, 67.1, 26.0, 18.5, -5.2, -5.2. HRMS (ESI+) 
[M+H]+ calcd for C23H35BO5Na+ 280.1733, found 280.1719. IR (n/cm-1): 3243 (m, br), 2953 
(m), 2857 (m), 1472 (s), 1418 (m), 1253 (s), 1112 (s), 1060 (m). [a]22D = -2.9 (c = 0.97, CH2Cl2, l 
= 100 mm). 
Procedure for cycloproponation reaction 
 
(S)-2-((tert-butyldimethylsilyl)oxy)-1-((1R,2R)-2-(4,4,5,5-tetramethyl-1,3,2-
dioxaborolan-2-yl)cyclopropyl)ethan-1-ol (3.73). Following the procedure by Walsh and 
coworkers,5 vinyl boronate ester 3.48 (33.0 mg, 0.1 mmol, 1 eq) was weighed into a 8 mL vial 
containing a stir bar inside the glovebox. The vial was sealed with a septum lined cap and 
removed from the glovebox. The reaction was cooled to 0 ºC in an ice water bath and a solution 
of diethyl zinc (0.5 mL, 0.5 mmol, 1M in hexanes, 5 eq) was added dropwise followed by 
trifluoroethanol (0.036 mL, 0.5 mmol, 5 eq) and diiodomethane (0.040 mL, 0.5 mmol, 5 eq). 
The reaction was allowed to warm to room temperature and wrapped in aluminum foil to 
exclude light. After 18 hours, the reaction was cooled to 0 ºC in an ice water bath and quenched 
with ethyl acetate and aqueous ammonium chloride. The organics were extracted with ethyl 
acetate (x3), dried over magnesium sulfate, and concentrated in vacuo to give crude product. 
The product was purified via silica gel chromatography to yield 3.73 in 65% yield (22.1 mg) and 
>20:1 d.r. 1H NMR (600 MHz, CDCl3) δ 3.71 (dd, J = 10.0, 3.3 Hz, 1H), 3.54 (dd, J = 10.0, 
6.8 Hz, 1H), 3.03 – 2.86 (m, 1H), 2.47 (d, J = 3.8 Hz, 1H), 1.21 (s, 12H), 1.10 (tt, J = 7.9, 5.3 Hz, 












(d, J = 3.1 Hz, 6H), -0.24 (dt, J = 9.6, 5.9 Hz, 1H). 13C NMR (151 MHz, CDCl3) δ 83.2, 76.5, 
67.0, 26.0, 24.8, 24.8, 19.9, 18.4, 9.0, -5.2, -5.2. HRMS (ESI+) [M+Na]+ calcd for 
C17H35BO4SiNa+ 365.2295, found 365.2291. IR (n/cm-1): 3481 (br, m), 2978 (s), 2955 (s), 2929 
(s), 1471 (s), 1436 (s), 1372 (s), 1319 (s), 1145 (s), 1113 (s). [a]22D = 18.1 (c = 1.14, CH2Cl2, l = 100 
mm). 
3.5.7 Mechanistic studies 
 
Inside a glovebox, compound 3.65 (0.019 mL, 0.075 mmol, 1.5 eq) was weighed into an 8 mL 
vial containing a stir bar and dissolved in d8-THF (0.2 mL). LTMP (11 mg, 0.075 mmol, 1.5 eq) 
was weighed into a separate 8 mL vial and dissolved in d8-THF (0.4 mL). Both vials were sealed 
with septa lined caps and removed from the glovebox. Outside the glovebox, the solutions were 
cooled to 0 ºC in an ice water bath. The LTMP solution was then cannula transferred under N2 
to the solution of 3.65. The reaction was allowed to stir at 0 ºC for 30 minutes. Styrene oxide 
(0.005 mL, 0.05 mmol, 1 eq) and dry toluene (internal standard, 0.004 mL) were added via 
syringe. The reaction was than cannula transferred to an NMR tube sealed under N2 with a septa 
lined cap. NMR spectroscopy indicated 59% conversion to 3.82 and 3.83 in a 1.7 to 1 ratio and 
32% unopened 2. This conversion and ratio did not change upon heating to 60 ºC for 2.5 hours. 
11B NMR indicated the presence of only two boron containing species, 3.65 and 3.82/3.83 
indicating that further ring opening was unlikely to occur as there was no 3.81 remaining in the 
reaction. 1D-NOESY spectroscopy identified an nOe interaction between the benzylic hydrogen 
and methine hydrogen at the base of the boron and silicon groups in the major diastereomer 























Inside the glovebox compound 3.65 (0.019 mL, 0.075 mmol, 1 eq) was dissolved in THF (0.2 
mL) in an 8 mL vial containing a stir bar. LTMP (11 mg, 0.075 mmol, 1 eq) was dissolved into a 
separate 8 mL vial and dissolved in THF (0.4 mL). The vials were sealed with septa lined caps, 
removed from the glovebox, and cooled to 0 ºC in an ice water bath. The LTMP solution was 
then cannula transferred to the solution of 3.65. The mixture was allowed to stir at 0 ºC for 30 
minutes after which allyl bromide (0.019 mL, 0.225 mmol, 3 eq) was added via syringe. The 
reaction was heated to 60 ºC for 3 hours, then allowed to cool to 22 ºC and quenched with a 
saturated solution of aqueous ammonium chloride. The organics were extracted three times 
with diethyl ether, dried over magnesium sulfate, and concentrated in vacuo to give the crude 
product 3.84. Using an internal standard (DMF, 0.004 mL) and the known 1H chemical shifts 
of the product and starting material41,57 the conversion to product was determined to be 65% 











0 ºC, thf 30 min
2. allyl bromide (3 eq)






























1H-NMR (600 MHz, d8-THF)













11B-NMR (500 MHz, d8-THF)
3.65
B(pin)Me3Si






























































































































































































13C-NMR (151 MHz, CDCl3)
OH
3.47
































































































































































































































13C-NMR (151 MHz, CDCl3)
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